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Abstract 
Background 
Essential hypertension remains a major risk factor for coronary heart disease (CHO) 
and stroke, and its prevalence is greater, more severe, occurs earlier, and is less well 
controlled among black individuals than among white individuals, at all ages after 
young adult hood (Comoni-Huntley et aI, 1989). 
In Caucasians, studies have shown that J3radrenoceptor polymorphism accounts for 
the variability in the vascular responsiveness to the agonist isoprenaline (Cockcroft et 
aI, 1994 and Lang et aI, 1995). Individuals homozygous for GIn 27 J32-adrenoceptor 
showed reduced responses due to chronic down regulation of J32-adrenoceptor in the 
vasculature. Therefore, variability in response to isoprenaline was determined by f3r 
adrenoceptor gene polymorphism. 
Aim and Objectives 
This study investigated whether there is a relationship between the ArglGly16 and 
Gln/Glu 27 f32-adrenoceptor polymorphisms by examining whether the incidence of 
occurrence is prevalent in African Trinidadians. 
In addition, comparison data of vascular responses with arterial compliance using 
pulse wave analysis (PW A) was correlated. 
The study aimed to give evidence if these polymorphisms contributed fully or in part, 
to determine the disease severity, or response to therapy in hypertensive individuals. It 
also aimed to prove that PW A is a reliable and therapeutic tool, in diagnosing and 
treating blood pressure, as reliance on brachial artery recording of blood pressure, 
alone, is becoming a poor indicator and predictor of risk. 
Methods 
The study genotyped 408 African Trinidadian subjects for the f32_adrenoceptor 
polymorphism and used the technique of applanation tonometry to analyse the central 
pulse wave, generating information on arterial compliance, left ventricular function 
and coronary perfusion. Blood pressure was measured in triplicate using a semi-
automatic blood pressure meter after 15 minutes of supine rest and bloods lipids 
assessed using a validated portable lipid cartridge. This was achieved by subjects 
attending a nurse-led cardiovascular risk clinic. 
Results 
There is no significant association between the A r g ~ G l y l 6 6 polymorphism and the 
G l n ~ G l u 2 7 7 polymorphism and hypertension in African Trinidadians. Interestingly, 
the appearance of the Glu27 polymorphism was very uncommon in African 
Trinidadians and this is constant with findings by Candy et aI, 2000. 
11 
Conclusion 
There is no difference in the frequency of J32-polymorphisms between normotensive 
and hypertensive African Trinidadians, and are unlikely to be a contributing factor for 
essential hypertension. Therefore, hypertension would indicate that it is polygenic 
with complex gene to gene and gene environmental interactions, through multiple, 
indirect and intermediate phenotypes and interactions. 
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A Geographical, Cultural and a Historical Perspective of Trinidad and Tobago 
Introduction 
At the southernmost tip of the Lesser Antilles chain, between the Caribbean Sea and 
North Atlantic Ocean, just nudging the South American coastline of northeast 
Venezuela, lie the islands of Trinidad and Tobago (usually shortened to T&T). 
These twin islands are the most influential, unexplored and uncontrived of Caribbean 
islands, rich in indigenous culture. At its centre, Trinidad and Tobago has a strong 
cultural base with the most diverse and absorbing society of all the Caribbean islands. 
I was very privileged to spend my data collection period in these beautiful islands and 
absorb the abundance and diversity of a colourful culture and landscape, which were 
well beyond my work. 
Oddly, few have heard or explored the island of Trinidad, most know of its' smaller 
sister island of Tobago as a paradise holiday destination. 
Therefore, I feel the reader should have some insight into the history, background and 
present day influences on African Trinidadians and Tobagonians, that shape their 
lives, beliefs and their attitudes and possibly their health. 
Geography and Climate 
Trinidad and Tobago combined cover 5,128 (km2), its terrain is that of plains and low 
mountains, with 48% of the land covered in tropical forest and woodland. The climate 
YIll 
is typical of that found on the Equator, tropical with a rainy season but with constant 
temperatures between 20 0 e and 33°e, with an abundance of natural growing fiuits, 
flora and fauna. 
IX 
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Figure (I) Map of Tri.Illdad and Tobago 
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History and People 
Trinidad was the first inhabited island of the Caribbean, having been settled by 
Amerindians from South America as early as 5000 BC. The early settlers were 
Arawaks, peaceful farmers and fishers, however, after 1000 AD they were joined by 
Carib tribes with warlike cultures. 
When Christopher Columbus landed in Trinidad in 1498, the population numbered 
around 35,000, most living in coastal areas. However, in 1592, Spanish settlers 
arrived in Trinidad, largely wiping out the original inhabitants of Arawaks and Caribs, 
and with the survivors were gradually assimilated. 
Despite the Spanish Empire, it had neither the desire nor the resources to develop the 
island, treating the island as a convenient 'port of call' en route to the riches of South 
America. The island was repeatedly attacked by the French, Dutch and British, but 
with this constant political upheaval, brought illegal slave trading from other islands 
and ships off-loading Mrican immigrants. Trinidad remained under Spanish rule until 
the British captured it in 1797. However, despite the British occupation, slavery 
continued under a ruthless military regime. Thankfully, in 1807, the British 
Government was facing the anti-slavery lobby and by 1834, with the passing of the 
Act of Emancipation, slave trading was abolished over the British occupied islands of 
the Caribbean. 
By 1888, Trinidad and Tobago was incorporated into a single colony, as Tobago was 
finally ceded to Great Britain in 1814. 
In 1958, the United Kingdom tried to establish an independent Federation of the West 
Indies comprising most of the former British West Indies. However, disagreement 
Xl 
over the structure of the federation with Jamaica, Trinidad and Tobago's withdrawal 
soon led to its collapse. Trinidad and Tobago achieved full independence in 1962 and 
joined the British Commonwealth. 
Today, Trinidad and Tobago's people are mainly of African or East Indian decent. 
Virtually all speak English. Trinidad's East Indian culture came to the island in 1834 
with the emancipation of the African slaves. This was to fill the labour shortage that 
was created by the abolition of slavery. 
Other Immigrants 
Several companies of Iblack' American soldiers who had supported Britain in its 1812 
war against the United States were given grants of land in southern Trinidad, where 
they founded the villages named after the companies in which they served. Other 
immigrants, mainly freed slaves from other Caribbean islands, were attracted to 
Trinidad by high wages. Africans liberated by the British Navy on anti-slave patrols 
settled in urban areas, becoming craftsmen and construction workers, establishing 
strong cultural institutions and heritage. 
Today, the African population makes up 40% of Trinidad and Tobago's 1.3 million 
population (U. S Department of State Statistics, 1999), with the remainder consisting 
of East Indian 40.30/0, European 1%, Chinese 10/0, mixed 14%, and other 3.7%. 
I 
111e kiln Black is used as a political term to describe communities who have experienced discrimination and racism on the 
basis of skin colour, religious beliefs and cultural or ethnic identity_ 
XII 
Government 
Trinidad and Tobago is a unitary state, with a parliamentary democracy modelled 
after that of the United Kingdom. From 1962 until 1976, Trinidad and Tobago, 
although completely independent, acknowledged the British monarch as the 
figurehead chief of state. In 1976, the country adopted a republican constitution, 
replacing Queen Elizabeth with a president elected by parliament. The general 
direction and control of the government rests with the cabinet, led by a Prime Minister 
and answerable to the bicameral parliament. 
Economy 
In 1995, successful economic reforms were implemented to allow foreign investment 
and trade to flourish. However, persistently high unemployment remains one of the 
chief challenges of the government. The petrochemical sector has spurred growth in 
other related sectors, reinforcing the government's commitment to economic 
diversification. Tourism is growing, especially in the Tobago region. This investment 
is assisting greatly in driving the economy. 
Health Provision 
The main hospitals in Trinidad are Port of Spain General in the capital and Mount 
Hope complex in St Augustine. There are also small, well equipped regional hospitals 
in all of the main towns. Treatment is free at the point of delivery but limited with 
Xlll 
medical technology. Those who can afford private health care do so, and most 
specialist doctors have private practices. 
Medication is by prescription but some drugs can be purchased over the counter. This 
pharmaceutical formulae list is more extensive than in the United Kingdom, and many 
Trinidadians will seek limited medical advice and cheaper medication for ailments 
due to cost implications. 
As unemployment is high, taxation for health provision is limited and Trinidad is 
typical of a two-tier health system, not unlike that found in the United States. 
XIV 
Contents 
Page 
Chapter 1 Aims and Introduction 1 
1.1 Background and Policy 2 
1.2 'Accelerated Risk' in African Caribbean People 3 
1.2.1 Variation of Blood Pressure 5 
1.2.2 Hypertension and drug therapy in African Caribbean groups 5 
1.3 Vascular Causes of Essential Hypertension 6 
1.3.1 Structural and functional changes 6 
1.3.2 Haemodynamic changes 8 
1.3.3 Rarefaction 8 
1.3.4 The role of Vascular endothelium 9 
1.3.5 Endothelial Dysfunction 9 
1.3.6 Constricting factors of the endothelium 10 
1.3.7 Nitric Oxide (NO) 10 
1.3.8 Endothelium and the regulation of arterial stiffness 11 
1.3.9 Sympathetic nervous system and the regulation of arterial 
Stiffness 11 
1.3.10 The value of measurements of arterial stiffness as predictors of 
cardiovascular outcome 12 
1.3.11 Augmentation Index as a predictor of atheromatous disease 12 
1.4. Hypercholesterolemia 13 
1.5 Genetic Causes of Essential Hypertension 17 
xv 
Page 
1.5.1 Gene Mapping Techniques 17 
1.5.2 Environmental 'Triggers' 19 
1.5.3 The ~ r A d r e n o c e p t o r r Gene 20 
1.6 Other Risks - Renal Differences 23 
1.7 Pulse Wave Analysis 26 
1.7.1 Assessing arterial stiffness 28 
1.7.2 Applanation Tonometry 28 
1.7.3 Augmentation Index 29 
1.7.4 The Pressure Waveform and Arterial Stiffness 30 
1.7.5 Alternative method to detect Arterial Stiffness 31 
1.7.6 Pulse Contour Analysis (PCA) 32 
1.7.7 Alternative method for assessing blood flow by venous 
occlusion Plesthysmography 33 
1.8 Aims 34 
1.9 Objectives 34 
1.10 Original hypothesis 35 
1.11 Summary 32 
Chapter 2 Methods, Materials and Methodology 37 
2.1 Research Design 38 
2.2 Instruments and Data Collection 39 
2.2.1 Validity and Reliability 39 
2.2.2 Defining Validity and Reliability 40 
XVI 
Page 
2.3 Ethnicity of Trinidad and Tobago 41 
2.3.1 Ethnic Background 42 
2.3.2 Subjects and Sample size 42 
2.3.3 Sample Recruitment 43 
2.3.4 Pilot Study 44 
2.3.5 Ethics 45 
2.4 Selection Criteria of Subjects 46 
2.4.1 Inclusion Criteria 46 
2.4.2 Exclusion Criteria 46 
2.5 Experimental protocol, variables and control of research 
environment 47 
2.5.1 Summary of Blood pressure Measurement 50 
2.5.2 Questionnaire and Interview 52 
2.5.3 Ethnic Classification 53 
2.5.4 Test of Hypothesis 58 
2.6 Pulse wave Analysis-Technique (1) 58 
2.6.1 Introduction 58 
2.7 Screening Subjects 58 
2.7.1 Screening for Aspirin and Non-steroid anti-inflammatory drugs 58 
2.7.2 Screening of Lipid Profile 59 
2.7.3 Method of Lipid Analysis 59 
2.8 Genetics-Technique (2) 60 
2.8.1 DNA extraction method. 60 
XVII 
2.8.2 Introduction 60 
2.8.3 DNA extraction from clotted blood (whole blood) 60 
2.8.4 Lysis and preparation of whole blood sample 60 
2.8.5 Absorption of DNA 61 
2.8.6 Washing of DNA 61 
2.8.7 Elution of DNA 61 
2.9 Polymerase chain reaction (peR) 62 
2.9.1 Introduction and PCR amplification conditions 62 
2.10 Agarose Gel Electrophoresis 66 
2.11.1 Electrophoresis 66 
2.11.2 Visualisation of DNA fragments 66 
2.11 Allele specific oligonucleotide (ASO) hybridisation 68 
2.11.1 Introduction 68 
2.11.2 Genomic DNA, Polymerase chain reaction (PCR) 
and Allele specific oligonucleotide hybridisation (ASO) 68 
2.11.3 ASO filter preparation 69 
2.11.4 Labelling of Probes 69 
2.11.5 Methodology of Hybridisation 70 
2.11.6 ASO Hybridisation 71 
2.11. 7 X-ray film development 72 
2.11.8 Reading of filters to determine genotype 72 
2.12 Verification of Polymorphisms 76 
2.12.1 Sequencing 80 
XVIII 
2.13 Statistical and Data Analysis 80 
2.13.1 Chi-squared ((2) statistic 80 
2.13.2 Hardy-Weinberg Equilibri urn 81 
2.13.3 Test of Hardy-Weinberg equilibrium 8:2 
2.13.4 Hardy-Weinberg Equation 82 
2.13.5 Linkage disequilibrium analysis 83 
2.13.6 GraphPad Prism 83 
2.14 Suppliers and Solutions 83 
2.14.1 Materials and Solutions 84 
2.14.2 Enzymes and Buffers 85 
2.14.3 General use solutions 86 
Chapter 3 Demographics of African Trinidadians 89 
3.1 Results 90 
3.1.1 Statistical Analysis 90 
3.1.2 Mean Age and gender of subjects 90 
3.1.3 Body Mass Index 90 
3.1.4 Systolic Blood Pressure 91 
3.1.5 Diastolic Blood Pressure 92 
3.1.6 Pulse Pressure 92 
3.1.7 Mean Arterial Pressure 93 
3.1.8 Heart Rate 93 
3.1.9 Augmentation Index 94 
XIX 
3.2 Lipids 103 
3.2.1 Total Cholesterol 103 
3.2.2 Tri glyceri des 103 
3.2.4 High Density Lipids 103 
3.2.5 Low Density Lipids 103 
3.2.6 Very Low Density Lipids 103 
3.2.7 High Density Lipid Ratio 104 
3.2.8 Glucose 104 
3.3 Subjects Medical History 113 
3.3.1 Smokers 113 
3.3.2 Personal Medical History 113 
3.3.3 Medication 114 
3.3.4 Education 114 
3.3.5 Family History 115 
3.4 Discussion 117 
3.4.1 Age and Augmentation index 117 
3.4.2 Body Mass Index and Diet 118 
3.4.3 Blood Pressure, Pulse pressure and Heart rate 120 
3.4.4 Lipids and glucose 121 
3.4.5 Smoking 122 
3.4.6 Medication 122 
3.4.7 Hormonal therapy 124 
3.4.8 Herbal Medicine 124 
3.4.9 Education and socio-economic status 125 
xx 
3.4.l0 
3.4.11 
3.5 
Chapter 4 
4.1 
4.1.1 
4.2 
4.2.1 
4.2.2 
4.2.3 
4.2.4 
4.3 
4.3.l 
4.4 
4.4.1 
4.4.2 
4.4.3 
4.4.4 
Exercise 
Family history 
Summary 
Allele Frequencies of codon 16 and 27 
rJ2-Adrenoceptor Polymorphisms and the 
contribution to Hypertension 
Introduction and Genetics Results 
~ 2 2 Adrenoceptor 
Results 
Genotype Distribution 
Hardy-Weinberg equilibrium analysis 
Linkage disequilibrium 
Genotypic data for analysis 
Genetic Association Data 
Statistical Analysis 
Results 
Genotype vs Age 
Genotype vs BMI 
Genotype vs SBP 
Genotype vs DBP 
126 
127 
128 
129 
130 
130 
131 
131 
132 
134 
137 
137 
137 
138 
138 
138 
138 
142 
XXI 
4.4.5 Genotype vs PP 142 
4.4.6 Genotype vs MAP 142 
4.4.7 Genotype vs HR 146 
4.4.8 Genotype vs AIx 146 
4.4.9 Genotype vs Total Cholesterol 146 
4.4.l0 Genotype vs Triglycerides 146 
4.4.11 Genotype vs HDL 151 
4.4.l2 Genotype vs LDL 151 
4.4.l3 Genotype vs VLD L 151 
4.4.l4 Genotype vs HD L Ratio 151 
4.4.15 Genotype vs Glucose 151 
4.5 Discussion 159 
4.5.1 P2-Adrenoceptor polymorphism and hypertension 159 
4.5.2 Hardy-Weinberg equilibrium 159 
4.5.3 Linkage disequilibrium 160 
4.5.4 Allele Frequencies 160 
4.5.5 Polymorphism in the African Trinidadian population 
and associated studies 161 
4.6 Summary 162 
Chapter 5 Linear Regression 163 
5.1 Introduction 164 
XXII 
5.2 Results 
5.2.1 Augmentation index and Age 
5.2.2 Augmentation index and BMI 
5.2.3 Augmentation index and SBP 
5.2.4 Augmentation index and DBP 
5.2.5 Augmentation index and PP 
5.2.6 Augmentation index and MAP 
5.2.7 Augmentation index and HR 
5.2.8 Augmentation index and Total Cholesterol 
5.2.9 Augmentation index and Triglycerides 
5.2.10 Augmentation index and HDL 
5.2.11 Augmentation index and LDL 
5.2.12 Augmentation index and VLDL 
5.2.13 Augmentation index and HDL Ratio 
5.2.14 Augmentation index and Glucose 
5.2.15 Summary of data values 
5.3 Discussion 
5.3.1 Introduction 
5.4 Summary 
Chapter 6 Multiple Regression 
6.1 Introduction 
6.2 Analysis 
164 
164 
165 
165 
165 
165 
165 
166 
174 
174 
174 
174 
174 
175 
175 
184 
186 
186 
188 
189 
190 
190 
:\:\111 
6.3 Results 191 
6.3.1 Total Population Regression Model 191 
6.3.2 Linear Regression Analysis for 16 and 27Genotypes in both 
NT and HT groups Using Alx (AI) Model 195 
6.3.3. Regression Model for Hypertensive African Trinidadians 197 
6.3.4 Multiple Linear Regression Analysis for Hypertensive African 
Trinidadians 200 
6.4 Discussion 202 
6.S Summary 204 
Chapter 7 General Discussion and Conclusions 205 
7.1 General Discussion 206 
7.2 The ~ 2 - A d r e n o c e p t o r r 207 
7.2.1 ~ 2 - A d r e n o c e p t o r r polymorphism and vascular function 207 
7.3 PW A and the implementation in the clinical setting 208 
7.4 Study Strengths and Limitations 210 
7.S Future Work 214 
7.6 Summary 216 
Bibliography 217 
XXIV 
Table of Figures 
Forward 
Figure (I) 
Chapter 1 
Figure 1.1 
Figure 1.2 
Figure 1.3 
Chapter 2 
Figure 2.1 
Figure 2.2 
Figure 2.3 
Figure 2.4 
Figure 2.5 
Figure 2.6 
Figure 2.7 
Figure 2.8 
Figure 2.9 
Figure 2.10 
Figure 2.11 
Figure 2.12 
Map of Trinidad and Tobago. 
Schematic of the interactions between psychosocial 
and physiological factors of hypertension in blacks. 
Applanation tonometry. 
Central aortic waveform in a middle aged subject. 
Sample Copy of Screening Checklist 
and Participant Questionnaire 
A Schematic of a PCR reaction, resulting in the 
amplification of region of DNA, using two primers. 
Visualisation of DNA fragments. 
The PCR spanning the polymorphism (ASO). 
ASO x-ray plates for Arg16and Gly16. 
ASO x-ray plates for Gln27 and Glu27. 
Automated sequencing of Gln27 and ArgiGly16. 
Automated sequencing ofGly16 and GlnlGlu27. 
Automated sequencing of ArgiGly16 and GlnlGlu27. 
Automated sequencing ofGly16 and Glu27. 
Automated sequencing of Arg16 and Gln27. 
Automated sequencing ofGly16 and Gln27. 
Page 
x 
25 
26 
27 
54 
63 
67 
73 
74 
75 
77 
78 
78 
78 
79 
79 
xxv 
Page 
Chapter 3 
Figure 3.1 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying age ranges measured 
in years. 95 
Figure 3.2 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying body mass index ranges. 96 
Figure 3.3 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of systolic 
blood pressure. 97 
Figure 3.4 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
diastolic blood pressure. 98 
Figure 3.5 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
pulse pressure. 99 
Figure 3.6 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
mean arterial pressure. 100 
Figure 3.7 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of heart rate. 101 
Figure 3.8 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying Augmentation index ranges. 102 
Figure 3.9 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
total cholesterol. 105 
XXVI 
Figure 3.10 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of triglycerides. 106 
Figure 3.11 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges 
of high-density lipoprotein. 107 
Figure 3.12 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges 
of low-density lipoprotein. 108 
Figure 3.13 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
very low-density lipoprotein. 109 
Figure 3.14 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
high-density lipoprotein ratio. 110 
Figure 3.15 Bar Chart representing the frequency of normotensive 
and hypertensives African Trinidadians with varying ranges of 
glucose measured. 111 
Chapter 4 
Figure 4.1 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with age. 139 
Figure 4.2 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with body mass index. 140 
Figure 4.3 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with systolic 
blood pressure. 141 
Figure 4.4 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with diastolic 
blood pressure. 143 
Figure 4.5 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with pulse pressure. 144 
Page 
Figure 4.6 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with mean 
arterial pressure. 145 
Figure 4.7 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with heart rate. 147 
Figure 4.8 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with augmentation index. 148 
Figure 4.9 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with total cholesterol. 149 
Figure 4.10 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with triglycerides. 150 
Figure 4.11 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with high-density 
lipoprotein. 152 
Figure 4.12 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with varying 
ranges of low-density lipoprotein. 153 
Figure 4.13 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with 
very low-density lipoprotein. 154 
Figure 4.14 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with high-density 
lipoprotein ratio. 155 
Figure 4.15 Bar Chart representing the association of genotype of 
normotensive and hypertensives African Trinidadians with glucose. 156 
XXVlIl 
Page 
Chapter 5 
Figure 5.1 Linear regression of age against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 167 
Figure 5.2 Linear regression of body mass index against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 168 
Figure 5.3 Linear regression of systolic blood pressure against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 169 
Figure 5.4 Linear regression of diastolic blood pressure against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 170 
Figure 5.5 Linear regression of pulse pressure against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 171 
Figure 5.6 Linear regression of mean arterial pressure against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 172 
Figure 5.7 Linear regression of heart rate against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 173 
Figure 5.8 Linear regression of total cholesterol against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 176 
Figure 5.9 Linear regression oftriglycerides against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 177 
Figure 5.10 Linear regression of high-density lipoprotein against 
augmentation index in normotensive and hypertensives African Trinidadians. 178 
Figure 5.11 Linear regression of low density-lipoprotein against 
augmentation index in normotensive and hypertensives African Trinidadians. 179 
XXIX 
Page 
Figure 5.12 Linear regression of very low density-lipoprotein against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 180 
Figure 5.13 Linear regression of high-density lipoprotein ratio against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 181 
Figure 5.14 Linear regression of Glucose against 
augmentation index in nonnotensive and hypertensives African Trinidadians. 182 
Figure 5.15 Linear regression of heart rate against augmentation index in 
(a)hypertensives off anti hypertensive medication and (b) hypertensives 
on anti hypertensive medication in African Trinidadians. 183 
Chapter 6 
Figure 6.1 Scatterplot of correlation between age and Alx (AI). 192 
Figure 6.2 Scatterplot of correlation between systolic blood pressure 
and AIx (AI). 192 
Figure 6.3 Scatterplot of correlation between height in cms and Alx (AI). 193 
Figure 6.4 Scatterplot of correlation between heart rate and AIx (AI). 193 
Figure 6.5 Scatterplot of correlation between weight in kilograms (kg) 
and AIx (AI) of the HT group. 198 
Table of Tables 
Chapter 2 
Table 2.1 
Table 2.2 
Table 2.3 
Chapter 3 
Table 3.1 
Table 3.2 
Table 3.3 
Table 3.4 
Chapter 4 
Table 4.1 
Table 4.2 
Table 4.3 
Page 
peR conditions for amplification of ~ 2 2 Adrenoceptor Fragment. 65 
Oligonucleotide sequences of the probes used for 
ASO detection. 68 
The predicted frequencies among offspring to calculated 
Hardy Weinberg equilibrium. 82 
Results for age and age range, haemodynamic readings from 
PW A, lipid profiles and genotyping of subjects. 
Representation of smokers and non smokers in African 
Trin idadians. 
Anti-Hypertensive Drugs commonly used to control 
high blood pressure in African Trinidadians. 
Data representing smoking, personal medical history, 
educational background and family medical history. 
Allele Frequencies for polymorphisms o f G l n 2 7 ~ G l u , ,
and A r g 1 6 ~ G l y y in normotensive and hypertensive 
African -Trinidadians. 
Distribution o f G l n 2 7 ~ G l u u and A r g l 6 ~ G l y y genotypes 
in normotensive and hypertensive African-Trinidadians. 
Comparison between observed frequencies of genotypes 
for the G l n 2 7 ~ G l u u locus using the Hardy -Weinberg equation. 
112 
113 
115 
116 
131 
132 
133 
xx."". 
Page 
Table 4.4 Comparison between observed frequencies of genotypes 
for the A r g 1 6 ~ G l y y locus using Hardy -Weinberg equation. 134 
Table 4.5 Results for genotype of Normotensive individuals. 135 
Table 4.6 Results for genotype of Hypertensive individuals. 135 
Table 4.7 Results for each pair ofloci in the combined 
NT and HT groups. 136 
Table 4.8 Haplotypes for each pair of loci in combined NT and HT 
groups, ignoring double heterozygotes. 136 
Table 4.9 Haplotype numbers and the frequencies. 137 
Table 4.10 Genotype association data in normotensives with codon 16 
and codon 27. 157 
Table 4.11 Genotype association data in hypertensives with codon 16 
and codon 27. 158 
Chapter 5 
Table 5.1 Normotensive descriptive and correlation statistics data values. 184 
Table 5.2 Hypertensive descriptive and correlation statistics data values. 185 
Chapter 6 
Table 6.1 R coefficient approach, indicating a good measure of fit. 194 
Table 6.2 ANOV Ab for confirming significance association of 
regression line with AIx(AI). 194 
Table 6.3 Contribution of each predictor to the model. 194 
Table 6.4 Number of individuals for A r g ~ G l y 1 6 . . 195 
Table 6.5 Number of individuals for G l n ~ G l u u 27. 195 
Table 6.6 Test between variables and the dependent variable central 
Alx (AI). 196 
""XXII 
Page 
Table 6.7 Test between variables and the dependent variable central 
Alx (AI). 197 
Table 6.8 R coefficient approach, indicating a good measure of fit 
for African Trinidadian hypertensives. 199 
Table 6.9 ANOV Ab for confirming significance association of 
regression line with Alx(AJ) in African Trinidadian 
hypertensi ves. 199 
Table 6.10 Contribution of each predictor to the model in 
African Trinidadian hypertensives. 199 
Table 6.11 Multiple Linear Regression Analysis for 
African Trinidadians hypertensives for A r g ~ G l y I 6 . . 200 
Table 6.12 Multiple Linear Regression Analysis for 
African Trinidadians hypertensives for G l n ~ G l u u 27. 201 
X-XXIII 
Chapter 1 
Aims and Introduction 
1.1 Background and Policy 
In March 2000, The National Service Framework for Coronary Heart Disease 
(Department of Health (DoH), 2000) set out the United Kingdom government's 
strategy for tackling heart disease and stroke. The Secretary of State for Health 
announced that the government's aim was to enable everyone to enjoy better health. 
Thus, reduction in the rates of coronary heart disease (CHD) and stroke has become a 
key priority for the health of the nation. Despite a decline in death rates from CHD 
over the past 10-15 years, the United Kingdom still has the highest incidence of 
circulatory disease in Europe (WHO, 2000). This trend exists despite recent health 
improvements and initiatives, making the management of CHD in the UK a major 
challenge for health care providers and policy makers alike. 
Specifically with this framework, it outlined a strategy to build healthy communities 
and tackling inequalities in health care with further developments of services, which 
are sensitive to the needs of minority ethnic people and promote a great awareness of 
their specific health risks. This was supported by Tackling Health Inequalities, 1998. 
This highlighted the health needs of the minority ethnic group of 1 African blacks 
which are specifically considered in the development and implementation of policies 
aimed at reducing socio-economic inequalities and the reduction of coronary heart 
and vascular disease, hypertension and stroke. However, extensive research has been 
implemented to examine whether genetic predispositions to 1 African Blacks may be 
affected by environmental, climatic, migratory or socio-economic change. 
1 The term' Black' is used to describe peop\c of an African origin. 
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Genetic research has enhanced the evidence base so that health care provision can be 
sure of what needs to be done and that progress required to reduce particular health 
risks and equalities in ethnic groups. However, such research is complex and involves 
different cultures, languages and religious considerations. This requires the full co-
operation of ethnic minorities. There is a risk of token involvement, raising false 
expectation, and the failure to deliver long- standing change to services that maybe 
insensitive and inappropriate to ethnic needs (Saving Lives: Our Healthier Nation, 
1999). Therefore, a specific planned approach will not only answer the questions of 
genetic predisposition but also address planned care and a lasting approach in health 
promotion to minimise risk. 
1.2 'Accelerated Risk' in African Caribbean People 
Hypertension is particularly common in African Caribbean blacks, with prevalence as 
high as fifty percent over the age of forty years (Cappuccio et aI, 1997). Within This 
group hypertension appear to be more severe and accelerated with onset occurring at 
an earlier age. (British Hypertension Guidelines, 1999). Within this ethnic group, 
there are higher risks to complications, in particular stroke, renal failure and left 
ventricular hypertrophy. 
The term 'Black' is used to describe people of an African origin. In the case of this 
study, those people in the population studied were born and resided in Trinidad in the 
West Indies and defined their ethnicity as African Trinidadian. For those black people 
in the United Kingdom, the definition is African Caribbean. As gross phenotypic 
descriptions, the terms ' Mrican Trinidadians' , ' Mrican Caribbeans', and 
'Caucasians' take no account of the genotypic variations within each group. Indeed, 
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part of the purpose of this study is to begin to unravel some of the genetic 
heterogeneity within and between different ethnic groups. All subjects clearly 
regarded themselves as African Trinidadians (or Carib beans ) or Black. These terms 
are used, not only as phenotypic descriptions, but also as social constructs. 
Nevertheless, they often appear without qualification in scientific papers. 
People of African Caribbean decent and living in Western countries have long been 
known to have a greater disease burden in terms of essential hypertension and stroke 
(Cornoni-Huntley et aI, 1989). However, few studies have been conducted in the 
Caribbean islands (Kotanko et al, 1997) where essential hypertension is prominent 
feature. Many people from the Caribbean migrate to and from the U.K. and this may 
have a genetic impact on predisposition and epidemiology. Thus, essential 
hypertension remains one of the major risk factors for vascular and heart disease and 
stroke, and together with diabetes, contributes to an even greater risk in the African 
Caribbean community (Cornoni-Huntley et aI, 1989). 
The progression of essential hypertension leads to target organ damage (heart, brain 
and kidneys), which is more prevalent in African Caribbeans than Caucasians 
(Calhoun and Opril, 1995). The frequency of co-morbidities in African Caribbean 
people, such as diabetes and renal disease, make treatment all the more challenging. 
However, the reasons for this increased severity of hypertension in this ethnic group 
remain obscure (Kuznar, 2000). 
1.2.1 Variation of Blood Pressure 
Hypertension accelerates more rapidly in African Caribbean people (Kaplan, 1998). 
This was first demonstrated in the CARDIA study, a longitudinal study in 5116 
United States America (USA) adults aged 18-30 years (Liu et aI, 1989). Also, a 
population-based study found higher prevalence of hypertension and severe 
hypertension at a younger age in black people than in whites, even after adjustment 
for body mass index and weight-height ratio (Lackland et aI, 1992). In the United 
Kingdom (UK), a clinic-based study of African Caribbean people who were referred 
for hypertensive treatment, demonstrated that hypertensive patients were of a younger 
age than Caucasians (Kattar et aI, 2000). This follow-up study showed significantly 
higher mean values for 24-hr ambulatory systolic blood pressure in Caribbean 
subjects, compared with Caucasians, despite similar baseline clinic blood pressures. 
Similarly, a study of nocturnal blood pressure (Harshfield and Trieber, 1999) using 
24-hr blood pressure monitoring suggested a blunted response in blacks compared to 
whites. 
1.2.2 Hypertension and drug therapy in African Caribbean groups 
Hypertension tends to be very sensitive to dietary salt restriction and in those without 
evidence of any organ damage, a salt restricted diet will be sufficient to lower and 
control blood pressure (British Hypertension Guidelines, 1999). However, when drug 
intervention is needed, the use of diuretics and calcium channel blockers appears to 
be more responsive in this ethnic group (Sauders et aI, 1990; Wright et aI, 1991). 
Beta-blockers and ACE inhibitors have been found to be only marginally effective in 
monotherapy of African black patients (Sauders et aI, 1990; Wright et ai, 1991). This 
is due to the renin-angiotensin system being frequently suppressed. However, this is 
overcome in some black patients by giving a combination with drugs that activate the 
renin-angiotensin system. For example adding a diuretic, calcium channel blocker or 
alpha-blocker with and ACE-inhibitor or beta-blocker. With resistant hypertension in 
African blacks a combination of diuretic, calcium channel agonist, ACE inhibitor or 
alpha- blocker is effective 
1.3 Vascular Causes of Essential Hypertension 
Coronary artery disease is one of the most frequent accompaniments of raised arterial 
pressure. Atheroma is not seen in the pulmonary arteries unless there is pulmonary 
hypertension, indicating a central role for pressure itself in the genesis of 
atherosclerotic lesions. However, the importance of large vessel coronary heart 
disease complicating hypertension has probably been underestimated. Modest 
pressure elevation is common in the population. In severe pressure elevation the 
problem of stroke and cardiac failure dominate. 
High pressure initially induces useful compensatory hypertrophy but later 
decompensation results in heart failure (Berkin and Ball, 2001). 
Arterial compliance is considered as an independent risk factor for cardiovascular 
disease and stroke and resulting vascular damage that leads to end organ damage may 
be a combination of structural and haemodynamic changes. What initiates and 
augments the development of essential hypertension remains largely unknown though 
extensively investigated. 
1.3.1 Structural and functional changes 
A feature of hypertension is the increase in size of left ventricular mass. The number 
of cardiac myocyte cells does not increase but with raised pressure within the 
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vasculature there is cell hypertrophy (Berkin and Ball, 2001). In addition fibroblast 
and interstitial change occurs. Myocytes represent nearly two thirds of cardiac mass 
but only a quarter of cell content. With pressure elevation, small vessel changes occur 
not unlike other tissue responses to raised pressure. This response produces the 
increase of the wall thickness and a reduction in the wall lumen (Agabiti-Rosei et aI, 
1988). Continued occlusion of a large vessel leads to further damage to heart muscle 
and precipitates overt failure in an already compromised hypertrophied heart (Tarazi, 
1985, Hartford et al 1983). 
With hypertension arterial compliance is reduced (Safar et aI, 1992), and until 
recently it has been difficult to measure arterial compliance non-invasively 
(O'Rourke et aI, 1992; Wilkinson et aI, 1998a). A structural change in smooth muscle 
by thickening causes the vessel lumen to narrow. However, the luminal diameter of 
the vessel will compensate by stretching. Pulse wave analysis has revealed altered 
arterial compliance in hypertension (McVeigh et aI, 1991), diabetes (Westerbacka et 
ai, 1999 and 2000), even in adolescent Type 1 diabetics (Brooks et aI, 1999). 
Moreover, pulse wave analysis provides strong evidence of an association of 
increased conduit vessel stiffness with stroke and total mortality. 
However, these changes may not be greatly apparent in the microcirculation, as such 
alterations will affect peripheral vascular resistance. Moreover, it is larger vessels 
affected by athersclerosis and are more prominent in their contribution to stroke and 
myocardial infarction. 
Numerous hormonal and neurogenic factors have been put forward to contribute to 
these changes (Blaes and Boissel, 1983; Hartford et ai, 1983). The advantages in 
morbidity and mortality from treatment with beta antagonists and angiotensin 
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converting enzymes (ACE) inhibitors in patients with impaired systolic function, 
clinical heart failure after myocardial infarction or at high cardiovascular risk suggest 
at least two important adverse processes liable to partial correction with treatment. 
However, the reduction of blood pressure, despite drug intervention will reduce the 
incidence of heart failure and myocardial infarction (Hansson et aI, 1998). 
1.3.2 Haemodynamic changes 
With established hypertension, particularly in younger adults, increased heart rate and 
stroke volume with normal peripheral resistance has been reported. Increased 
peripheral resistance and loss of compliance with increasing arterial stiffness of large 
arteries is apparent with increasing mean arterial pressure and pulse pressure, which 
is due to systolic pressure elevation. Endothelial dysfunction plays a part in flow 
modulation due to impaired nitric oxide synthesis by the coronary endothelium. This 
leads to the loss of compliance due to systolic wall stress and thus stroke volume is 
increased (Berkin and Ball, 2001). 
1.3.3 Rarefaction 
Rarefaction can be termed as either structural or functional in its vascular action. A 
reduction of density of vessels results in either a lack of vessels (structural) to perfuse 
tissue or intermittent perfusion of tissue (functional). These structural and functional 
aspects of rarefraction result in increased vascular resistance. Structural rarefraction 
resulting in essential hypertension had been identified as early as 1920s (Boas and 
Frant, 1 9 2 2 ~ ~ Boas and Mufson, 1923), in the examination of conjunctival capillaries. 
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1.3.4 The role of vascular endothelium 
Endothelium is the layer of cells that is the inner lining of all blood vessels, which 
plays an important role in the regulation of vascular function. The endothelium 
releases a number of vasoactive mediators including nitric oxide (NO) and endothelin 
(ET), which alters vascular tone and arterial stiffness (Cockcroft et aI, 1997). 
Exogenous supply of NO, for example GTN, causes changes in the arterial waveform, 
indicating reduced arterial stiffness, without a reduction in peripheral blood pressure 
(Yaginuma et aI, 1986). Endothelin is a known potent vasoconstrictor (Gray et aI, 
1996). 
1.3.5 Endothelial Dysfunction 
Endothelial dysfunction occurs when there is an imbalance from the production of 
NO to that of the vasoconstrictor such as ET (Celermajor et aI, 1997). Two different 
mechanisms are responsible for promoting stiffness. Firstly, a direct and functional 
effect on vascular tone and secondly an alteration in vessel structure (Celermajor et 
aI, 1997). Loss of mitogenic effects of NO, and the enhancement of mitogenic effects 
of ET will promote vascular proliferation and atheroma formation. In laboratory 
studies involving the arterial infusion of L-W -Monomethyl-arginine (L-NMMA) in 
the forearm of hypertensive humans, indicates a reduction in endogenous NO 
production leading to diminished vasoconstriction and an increase in arterial stiffness 
(Calver et aI, 1992; Panza et aI, 1993). 
Other studies have shown impaired vasodilatation in the arteries of hypertensive 
patients with the infusion of acetylcholine (Treasure et aI, 1993), but the findings of 
Cockcroft et aI, 1994, suggests that stimulated vasodilatation in the forearm 
vasculature maybe selective in hypertensive patients. This suggests that endothelial 
9 
dysfunction maybe selective in its action when exposed to acetylcholine III a 
subgroup of hypertensive patients. 
1.3.6 Constricting factors of the endothelium 
The endothelium produces potent vasoconstrictors such as angiotensin nand 
endothelin-l (ET-l) (Webb et aI, 1990; Yanagisawa et aI, 1988). ET-I is a peptitide 
with commanding effect. Other forms ET-2 and ET-3 have also been found. 
However, ET -1 is the main contributors to the maintenance of basal vascular tone 
(Hayes and Webb, 1994) and is altered in such diseases as hypertension. 
ET -1 binds to two subtypes ETA and ET B . ETA is the most prominent receptor, which 
mediates vasoconstriction in the arteries and ET B mediates the release of endothelium 
dependent vasodilatory factors and has some resistance in vessels where it affects 
vasoconstriction. 
With this in mind, endothelium produced contracting and dilatory factors are greatly 
disturbed in hypertension and may be associated with genetic predisposition. 
1.3.7 Nitric Oxide (NO) 
Nitric oxide maintains vascular tone throughout the cardiovascular system by 
counteracting vasocontricting mechanisms (Vallance et aI, 1989a). The release of 
nitric oxide is continuous from endothelial cells (Palmer et aI, 1992), which 
specifically maintains blood vessel tone. 
In vitro studies have shown vasodilatation when acetylcholine stimulates the 
synthesis of nitric oxide from L-arginine, (palmer et aI, 1992; Rees et aI, 1989). In 
vivo studies indicate that basal production of nitric oxide opposes vasoconstriction 
mechanisms in forearm vessels (Vallance et aI, 1989b). This was with the arterial 
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administration ofL-NMMA, which reduced forearm blood flow by half. 
1.3.8 Endothelium and the regulation of arterial stiffness 
Arterial stiffness is a key independent determinant of cardiovascular risk (Blancher et 
aI, 1999). Structural components within the arterial wall, mainly collagen and elastin, 
together with transmural pressure are important determinants of large vessel stiffness 
(Avolio et aI, 1998). However, smooth muscle tone can also influence the stiffness of 
the elastic and muscular arteries (Gow et aI, 1972), suggesting there is also functional 
regulation of arterial stiffness in vivo. 
Nitric oxide (NO) and endothelin-1 (ET -1) are two important mediators released by 
the vascular endothelium, which exert major, but opposing influences on blood 
pressure (Haynes et aI, 1993), and basal vascular tone (Vallance et aI, 1989a). 
Previous data has recently shown that NO regulates large artery distensibility in vivo 
(Wilkinson et aI, 2002), and this may explain why conditions that are characterized 
by reduced NO bioavailability are also associated with increased arterial stiffness. 
However, the role of ET -1 in the regulation of arterial stiffness is, at present, still 
unclear. 
1.3.9 Sympathetic nervous system and the regulation of arterial stiffness 
The sympathetic nervous system (SNS) plays an important role in the regulation of 
blood pressure (BP) homeostasis and cardiac function. Elevated sympathetic activity 
not only plays a role in the induction of ischemia due to reflex tachycardia and 
coronary vasoconstriction, but also correlates with hypertension, insulin resistance 
and coronary risk. Therefore, the increased SNS activity is a predictor of mortality in 
patients with these cardio-vascular diseases (Rooke et aI, 1997). Interference of 
sympathetic activation may reduce cardiovascular risk. Thus, antihypertensive 
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pharmacotherapy and its influence on the SNS are of great importance (Rooke et al, 
1997). 
1.3.10 The value of measurements of arterial stiffness as predictors of 
cardiovascular outcome 
The measurement of arterial stiffness is a useful parameter in the assessment of 
cardiovascular risk or outcome (Asmar et aI, 2001). With clinical assessment of large 
arteries by PW NPWV the augmentation and velocity of blood flow can detect the 
potential etiologic role in cardiovascular disease. This assists in recognising arterial 
changes which constitute as an 'early risk marker' and can be useful in the 
assessment of drug intervention in the arteries (Asmar et aI, 2001). 
1.3.11 Augmentation Index as a predictor of atheromatous disease 
Augmentation has been shown to correlate significantly with findings of 
atherosclerosis by carotid ultrasonography, the most widely used clinical measure of 
atherosclerosis (Yamasaki et aI, 2000). Therefore, augmentation is a promising 
marker for screening purposes. PWV, while widely used to assess arterial stiffness, is 
time-consuming and provides information about compliance that is limited to a 
specific artery or segment. However, augmentation of central arterial pressure can 
simply and reliably assess systemic arterial stiffness. 
With increased arterial stiffness, central systolic blood pressure rises and diastolic 
blood pressure falls in the central arteries as a consequence of rebound of the 
previous pressure wave, which shifts the augmentation pressure from diastole to 
systole. The importance of assessment of the central waveform is underlined by a 
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strong correlation between aortic stiffness and degree of coronary artery disease at 
angiography (Hirai et aI, 1989). 
High augmentation has been significantly associated with greater higher plaque score, 
and higher prevalence of CVD (Fukui et aI, 2002). Early intervention and 
examination with respect to atherosclerosis is needed in patients with high 
augmentation, although direct cardiac catheterization and echo cardiography offers a 
more precise assessment of augmentation. However, PW AIV is a simpler, non-
invasive screening method for identifying individuals at cardiovascular risk. 
Previous studies have demonstrated for the first time that central arterial 
augmentation pressure was a reliable marker of atherosclerosis in type 2 diabetes 
(Fukui et aI, 2002). Therefore, this simple, non-invasive determination would permit 
large-scale, early screening for atherosclerosis in patient groups, who are at increased 
risk for cardiovascular disease. 
1.4 Hypercholesterolemia 
Hypercholesterolemia is a major precursor of atheromatous arterial disease (Dart et 
aI, 1991). This arterial disease can vary from atheroma to less advanced lesions such 
as intimal thickening, increased collagen deposition and foam cell infiltration. The 
precise mechanism is not completely understood but hypercholesterolemia is 
associated with endothelial dysfunction (panza et aI, 1993; Noon et aI, 1996). 
Endothelial dysfunction is associated with abnormal serum lipid profiles (Goode et aI, 
1995) in particular oxidised LDL (low-density lipoprotein) cholesterol (Chin et aI, 
1992; Salonen et aI, 1992). 
All lipids in human plasma are transported as complex proteins. Except for fatty 
acids, lipids are carried as lipoproteins. Atherosclerotic plaques consist of foam 
cells, which are transformed macrophages and smooth muscle cells that have become 
filled with cholesteryl esters. This is the result of the endocytosis of chemically 
modified lipoproteins via scavenger receptors. The accumulation of cholesteryl esters 
is due to the inability of those receptors to be down regulated by high intracellular 
levels of cholesterol. The most important chemical transformation of lipoproteins that 
creates ligands for the scavenger receptors is free radical mediated oxidation that 
occurs in the artery wall (Katzung, 1998). 
The entire vascular tree is surfaced with a monolayer of endothelial cells. The 
endothelium senses changes in the vascular tone and reacts by generating mediators 
(Wilkinson and Cockcroft, 1998). There are many mediators in the endothelium that 
can cause vasoconstriction or vasodilatation of the smooth muscle in the arteries. For 
example, endothelin and angiotensin II that cause vasoconstriction and nitric oxide 
and endothelium derived hyperpolarising factor that causes vasodilatation. Nitric 
oxide (NO) is synthesised from the conversion of the amino acid L-arginine to L-
citrulline by NO-synthase. NO freely diffuses to the smooth muscle where cGMP 
levels are increased. This causes relaxation of smooth muscle. In normal vascular 
tone, there is a basal NO release. NO may act as an antioxidant blocking the oxidation 
of LDL (Low density lipoprotein) and thus preventing the formation of foam cells in 
the vascular wall by inhibiting scavenger receptors to form ligands (Davis and Hagen, 
1993). 
Vascular plaque formation in hypercholesterolemia leads to reduced NO formation 
and endothelium-dependant vasodilator responses. Oxidisation of LDL may impair 
the L-arginine/nitric oxide pathway and eventually inhibits relaxation of the smooth 
muscle. This causes endothelial dysfunction that can tum subsequently to increased 
arterial stiffness and atherosclerosis by the following mechanism. In atherogenesis, 
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the arterial endothelium is chronically damaged by serum lipids, turbulent blood flow 
and other factors. This injury leads to lipid accumulation and the adhesion of 
monocytes and platelets. The aggregation leads to the formation of a fatty streak. 
With time the fatty streak may progress to an atheromatous plaque. This progression 
is dependent on the location of the fatty streak and the presence of risk factors (Davis 
and Hagen, 1993). 
Atherosclerosis is the pathway to cardiovascular disease and risk factors contributing 
to that are diabetes, hyperlipidemia and hypertension (Chobanian and Alexander, 
1996; Glasser, 1997). 
Hypertensive and hypercholesterolaemic individuals are at an increased risk of 
developing clinically significant target organ damage. Few studies have used arterial 
techniques to assess dysfunction of the vascular system in essential hypertension and 
hypercholesterolaemia. Hypertension has a multi-factorial aetiology and it may be 
certain that certain sub-populations of people are more at risk than others of 
developing target organ damage. Patients with hypercholesterolaemia also have 
impaired basal (Casino et aI, 1993) and stimulated (Chowienczyk et aI, 1992; Casino 
et aI, 1993, Noon et aI, 1998a) release of nitric oxide in the forearm vascular bed, and 
in the coronary circulation (Drexler & Zeiher, 1991). Hypercholesterolaemia leads to 
atherosclerosis, a process that is accelerated if hypertension is present. Thus, the 
capacity of the endothelium to maintain adequate tone and to prevent thrombus 
formation in hypercholesterolaemic patients may have important implications for 
atherogenesis. 
It is unclear whether impaired nitric oxide generation m hypertension and 
hypercholesterolaemia is confined to skeletal muscle resistance vessels and coronary 
vessels, and whether the defect is specific to nitric oxide generation or whether, in 
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humans, the impaired function also affects other mediators such as prostacyclin. 
Moreover, it seems that caution should be taken in assessing endothelial dysfunction 
using the acetylcholine test, as some patients with hypertension (previously treated or 
untreated) have no difference in cholinergic vasodilatation in the forearm compared 
with normotensive controls (Cockcroft et aI, 1994). Alternatively, the invasive 
methodology of forearm perfusion studies has not allowed sufficient numbers of 
patients to be examined to establish the epidemiology of endothelial dysfunction. 
Therefore, central to this thesis, is the development of a simple, non-invasive 
technique for investigating endothelial function both in health and in diseases such as 
essential hypertension and dyslipidaemia. The technique of applanation tonometry to 
assess the central pulse wave will be used to assess arterial stiffness as an 
independent risk factor for cardiovascular disease. No studies have assessed arterial 
stiffness in African Caribbean groups of people, despite accelerated risk in these 
populations. 
As well as essential hypertension, other risk factors for cardiovascular disease and 
stroke have been defined by various groups (Cameron et aI, 1995; Cooper et aI, 1997; 
Gulnick et aI, 2001). Unfortunately, the lack of consensus among these groups and 
periodic changes in risk factor listings have led to confusion among health 
professionals. As so many risk factors are inter-related, it is difficult to isolate the 
effect of a specific risk factor such as dyslipidaemia. For example, hypertension is 
known to exacerbate atherosclerosis (Ross, 1995). The known effects of physical 
inactivity, obesity, cigarette smoking, age, hypertension and diabetes mellitus all play 
a part on lipids and lipoprotein levels. Secondary to salt, perhaps no other factor has 
featured more frequently in the pathogenesis of cardiovascular disturbances and 
hypertension than fats. 
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In addition to the vascular structural alterations, the role of functional abnonnalities 
of the vascular endothelium focuses on the presence of hypertension and 
hypercholesterolaemia in vivo (John et aI, 2000). Potential mechanisms underlying 
impaired endothelial function and decreased bioavaliability of nitric oxide lead to the 
reduction of elasticity and the development of atherosclerotic lesions (John et aI, 
2000). However, in relation to ethnicity and lipid profile, African Americans tend to 
have a better risk profile than whites for cardiovascular disease, despite their higher 
propensity to hypertensive illness (Tyroler et aI, 1980). 
The development of hypertension in African Carib beans has been related to insulin 
resistance, which is a frequent feature of essential hypertension (Zeiher et aI, 1991; 
Boden et aI, 1996; Pitre et aI, 1996). The magnitude of insulin resistance has been 
related to systemic blood pressure. Of particular relevance to the problem of vascular 
tone is the capacity of insulin to produce vasodilatation. Therefore, the action of 
insulin on the vascular system can be greatly impaired if there is endothelial 
dysfunction as a result of another pathogenesis. 
1.5 Genetic Causes of Essential Hypertension 
A review of original and published data (Halbertstein, 1999) yields the consistent 
finding that chronic hypertension is endemic and prevalent throughout the Caribbean 
area, and the prominent involvement of genetic predisposition is suggested in several 
lines of evidence (Rigat et aI, 1990; Caulfield et ai, 1994; Barley et aI, 1996; Kaplan 
1998) including significant ethnic differences in blood pressure values. 
1.5.1 Gene Mapping Techniques 
Since the early 1990s, strides have been made in developing simple genetic tests to 
assess individual risk for a variety of disease processes. The detailed Human 
Genome Project will clarify understanding of the importance of genetic mechanisms 
in the targeting, assessment, prevention, and treatment of disease. Many Mendelian 
disorders have now been mapped and the genes responsible found. This is now 
technically straightforward. However, Mendelian diseases are rare compared to 
complex diseases such as essential hypertension. This is due to multiple interacting 
genes, possible low penetrance, external non-genetic factors and problematic 
diagnosis. So far there has been limited success in finding 'complex disease genes' 
that are highly penetrative and give clear definition to complex disease process. Gene 
mapping, to find genetic markers can be found by numerous techniques. 
Linkage analysis determines genetic markers to disease that are passed through 
ethnicity along with the disease interest (Xu et aI, 1999). This is the collection of 
DNA from individuals in an ethnic group. Genotyping a series of microsatellites 
spread across the genome would test whether the transmission of any these is 
correlated with the transmission of phenotype (Lander et aI, 1995). Alternative 
approaches involve direct testing of DNA polymorphisms for association with the 
disease. Association mapping is the identification of a particular mutation that 
increases susceptibility to a disease of interest. It is more common among affected 
individuals than among random controls. Linkage disequilibrium mapping is random 
genetic markers near a disease susceptibility mutation may be associated with the 
disease (Terwilliger, 1995). These processes can be used in several contexts; testing 
for association at a candidate gene; examining regions of suggestive linkage from 
ethnic studies; genome screens for association, in particular for the future and 
narrowing down the location of a mutation. Mapping complex disease loci is a major 
challenge for human genetics and powerful tests and methods are required for 
population genetic problems. For example, the identifying of allelic heterogeneity 
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and the location of disease mutation (Risch, 2000; Risch et aI, 1996). 
1.5.2 Environmental 'Triggers' 
Rarely is a genetic disease attributed to a single gene mutation. The overwhelming 
evidence is that essential hypertension is a polygenic disease, with environmental 
interactions and 'triggers' being just as important as the genetic predisposition (for 
review (Joly, 1999). 
Examples of environmental factors that may influence genes include: 
.:. The slavery hypothesis of natural selection favouring a salt-conserving 
physiology in ancestral populations, suppressing plasma renin activity, 
predisposing genetic variance (Halberstein, 1999) . 
• :. Climatic change on migration IS thought to influence genetic expressIon 
(Halberstein, 1999) . 
• :. Fear of racial provocation, increased levels of stress, and hormonal changes 
(McNaught, 1987) . 
• :. Traditional use of medicinal plants was successful because of the beneficial 
bioactivity of many antihypertensive phytochemical components, which have 
been supplemented, with widespread introduction of synthetic biomedical 
drugs (Halberstein, 1999). 
Genetic data has reinforced these concepts by demonstrating a link between 
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hypertension and particular alleles of candidate genes in some population groups 
(Gavras et aI, 1999). 
Essential hypertension in the vast majority of patients is believed to be a complex, 
polygenic, multifactorial disorder resulting from the interaction between several 
genes with each other and with the environment. Clinical strategies used to enhance 
searches for 'candidate genes', such as subgrouping of populations into relatively 
homogenous groups according to heritable anthropometric, clinical or biochemical 
characteristics. In this study, it will be investigated whether particular mutant genes 
are associated with phenotype, i.e., arterial stiffness. Previous findings have 
concluded that the survivors of vascular diseases are at an increased risk of carrying a 
particular genetic variation (genotype), and that some health professionals have 
accepted higher levels of blood pressure as normal when they occur in ethnic 
populations (Torkington, 1991). This may be a rationale for poor intervention and 
management. However, genetic markers have caused concern, and that testing for a 
recessive gene that can identify whether the individual has a higher risk of a disease 
process, may lead to discriminating policies by corporate companies. 
1.5.3 The J32-adrenoceptor gene 
In Caucasians, it has been shown that there are different forms of a gene that plays a 
part in the regulation of blood flow (the J32-adrenoceptor gene). Individuals with a 
particular mutant form have impairment in the ability of blood vessels to relax (dilate) 
(Cockcroft et aI, 2000). It may be that this particular form of the gene is more 
prevalent in African Caribbean people, as preliminary evidence from South Africa 
suggests (Candy et ai, 2000). 
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A recent study involving the infusion of the agonist drug isoprenaline, an agonist at 
the P2-adrenoceptor, demonstrated that African Caribbean subjects exhibit a blunted 
vasodilatory response to the drug compared to Caucasian subjects (Lang et aI, 1995). 
These findings suggest a contribution of particular genes to enhanced vascular 
reactivity in African Carib beans and may play a part in a pathogenesis of 
hypertension in these subjects. Moreover, recent evidence (Svetkey et aI, 1995) 
linking the P2-adrenceptor gene type with hypertension, may well be important in 
explaining racial differences in blood pressure. 
A genetic mutation of the P2-adrenoceptor gene has been identified (Riehaus et aI, 
1993). The polymorphism resulted in amino acid GIn 27 becoming Glu 27. The Glu 
27 type of receptor gene mutant fails to downregulate after exposure to an agonist to 
the same extent as the wild type, (Green et aI, 1995). It has been demonstrated that 
individuals with the gene types Glu 27 or GIn 27 exhibit different responses to the 
inhaled P2-agonist salbutamol (Hall et aI, 1995). In the vascular bed in healthy 
Caucasian subjects, P2-adrenoceptors downregulate to an extent following stimulation 
with an agonist that is dependent upon the form of the gene (Cockcroft et aI, 1997; 
Noon et ai, 1998), demonstrating vascular effects that may contribute to essential 
hypertension. 
Published data (Candy et aI, 2000) suggests that the frequency of the Glu 27 allele is 
considerably lower in South African people than in Caucasians. Large cohorts of 
subjects need to be recruited before a sufficient number of this polymorphism could 
be detected. In addition, the frequency of the prodownregulatory Gly 16 allele of the 
P2-adrenoceptor is higher in hypertensives with increased body mass index (Candy et 
aI, 2000) than in normotensives, and is also associated with essential hypertension in 
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African Caribbean people (Kotanko et aI, 1997). 
This genetic predisposition is more pronounced in African Caribbean people with a 
family history of hypertension and is associated with poor vascular response (Eichler 
et aI, 1990; Lang et aI, 1995). Thus, in addition to the mutation at codon Gln/Glu 27, 
the present study will investigate the codon Arg/Gly 16 mutation in an African 
Caribbean population. 
Similarities in some phenotypic expressions between hypertension in blacks and 
patients with Liddle's syndrome (Shimkets et aI, 1994), a monogenic form of 
hypertension, have suggested that abnormalities of the distal tubular epithelial sodium 
channel, a major regulator of the overall control of sodium balance that may underlie 
the development of high blood pressure in African Caribbean's (Schild et aI, 1995). A 
number of variants of the sodium channel J3-subunit coding sequences have been 
identified in subjects with hypertension (Chang & Fujita, 1996; Dong et aI, 1997; 
Persu et aI, 1998). These lead to a single amino acid change rather than a major 
truncation as seen in Liddle's mutations and are much more frequent in blacks than in 
whites, especially the most commonly identified T594M and G442V polymorphisms 
(Persu et aI, 1998). 
, , 
1.6 Other Risks - Renal Differences 
Hypertension in ethnic groups is often sensitive to dietary salt intake and in those 
without evidence of organ damage, thus, a low salt diet may occasionally be 
sufficient to control blood pressure (British Hypertension Society, 1999). Both 
normotensive and hypertensive African Caribbean individuals are known to be more 
salt-sensitive than whites, (Frayet aI, 1993; Calhoun & Oparil, 1995; Clark 1999). 
This suggests that African Caribbeans' have an excessive retention of sodium and 
water causing volume overload, thus, contributing to sustained high blood pressure. 
Salt-sensitivity occurs in that salt potentiates sympathetic nervous system-induced 
vascular reactivity. Moreover, neurohormonal responses are altered in salt-sensitive 
hypertension (Obeifuna et aI, 1991; Ono et aI, 1997), with aberrations in the serum 
renin-angiotensin-aldosterone system (RAAS). This may account for most salt 
excretion irregularities, as hypertensive patients often have a more gradual decline of 
plasma and urinary concentration of aldosterone after salt loading than occurs 
normally (Mills et aI, 1995). 
Safar et aI, (2000) suggested that high serum sodium levels are associated with aortic 
hypertrophy. These alterations often correlate with increased stiffness and secretory 
properties of vascular smooth muscle. Such mechanisms are reversed with lowering 
sodium levels. In African Caribbeans', the RAAS is impaired when sodium levels are 
high, thus, decreasing artery diameter and tone, resulting in increased blood pressure 
(Ergul, 2000). 
Racial differences In renal physiology, influenced by either genetic or SOCIO-
economic factors have been suggested as possible causes; however, these differences 
have not been made clear or explored fully. Figure 1.2 is a schematic representation 
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adapted from Fray and Douglas (1993) of the interaction between psychological and 
physiological factors that contribute towards the development of hypertension in 
blacks. Recurrent exposure to social and environmental stressors cause chronic 
activation of the sympathetic nervous system and other vasoactive substances, such as 
ET -1 and Angiotensin II, which then increase peripheral vascular resistance. In this 
model, genetic factors may playa role in the regulation of the stress response (i.e. 
catecholamines and ET -1), which influences both the renal function and vascular 
activity. ACTH indicates adrenocorticotrophic hormone. 
Psychosocial and Physiological Factors 
I 
Stress Response 
I 
Increased Sympathetic Activity 
Catecholamines. angiotensin II. endothelin. ACTH 
, 
Salt Retention 
I 
Volume 
Expansion 
I 
Abnormal 
Vasoreactivity 
I 
Increased peripheral vascular resistance 
I 
Hypertension 
Figure 1.1 A schematic representation adapted from Fray and Douglas (1993) of the 
interaction between psychological and physiological factors that contribute towards 
the development of hypertension in blacks. 
2S 
1. 7 Pulse Wave Analysis 
As arterial stiffness has become recognised as an independent risk factor In 
cardiovascular disease (McVeigh et aI, 1991 ; O'Rourke, 1999), measurement of 
stiffness could provide a better stratification for treatment, and for monitoring 
therapeutic response. Traditionally, arterial compliance was measured in vitro using 
excised arteries, but can be measured in vivo by ultrasound imaging of arterial 
diameter change, or by the simpler technique of pulse wave 
Sensor 
t 
Artery 
Bone 
Figure 1.2 Applanation tonometry (see text below). 
analysis (PW A) (Arnett et aI , 1994). This non-invasive, well-validated technique for 
measuring arterial compliance (Arnett et aI, 1994; Wilkinson et aI, 1998), involves 
holding a sensor on the skin over the point of maximal arterial pulsation of a large 
artery (such as, radial, brachial or carotid) and pressing down against the underlying 
bone (Kelly et aI, 1989). By flattening the curved surface of a pressure-containing 
structure the stresses inherent in the wall of the curved structure may be balanced, 
, 
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allowing accurate recording of the intra-arterial pressure. This is calibrated against 
brachial blood pressure to produce a peripheral pressure waveform, from which the 
central arterial pressure wave is generated using a computerised transfer factor based 
on invasive studies (O'Rourke, 1999). 
Second peak ~ ~
First peak ~ p p
pp 
Figure 1.3 A typical central aortic pressure waveform in a middle-aged subject. The 
second peak becomes more prominent with age or as the arteries stiffen, and is caused 
by wave reflection. The augmentation index is the difference between the second and 
first systolic peaks, expressed as a percentage of the pulse pressure (O'Rourke, 1999). 
1.7.1 Assessing arterial stiffness 
Increased arterial stiffness is an important, independent risk factor for cardiovascular 
disease (Arnett et aI, 1994). Pulse wave analysis (PW A) provides an ideal method for 
assessing arterial stiffness and central aortic pressure (SphygmoCor® AtCor 
Medical). It is a non-invasive, highly reproducible technique, easily applied in the 
clinical setting. The measurement of stiffness may provide for better risk stratification 
of patients, targeting treatment and monitoring therapeutic responses. Endothelial 
dysfunction may be partly responsible for increased stiffness seen in-patients with 
traditional cardiovascular risk factors. Indeed, arterial stiffness is becoming a 
therapeutic target as more of the underlying mechanisms are dissected. 
1. 7.2 Applanation Tonometry 
Accurate non-invasive assessment of the arterial pulse is possible in the radial, 
brachial, femoral or carotid artery using PW A. PW A uses applanation tonometry to 
detect these peripheral waves, which are recorded into the PW A software. This 
technique is used in ophthalmology to measure intra-occular pressure. If two curved 
surfaces can be flattened (like an artery) the circumferential pressures balance the 
internal pressure, and an accurate waveform can be recorded (O'Rourke, 1992, 1 9 9 6 ~ ~
Wilkinson, 1998). A probe with a high fidelity ultrasound micromanometer at its tip 
is used to flatten the artery. Superficial arteries overlying bone, like the radial artery, 
are practicably best to use. The peripheral waves are transformed into a central 
waveform by a validated transfer factor (Chen, 1 9 9 7 ~ ~ Wilkinson, 1998). This is based 
on invasive intra-arterial pressures, and shown to be highly reproducible. From the 
derived ascending pressure, the effects of wave reflection can be determined and 
central aortic pressure waveform is obtained. 
1.7.3 Augmentation Index 
Augmentation index (AIx) is a measure of arterial compliance and is generally 
negative in young and healthy people, but will become positive around the age of 40 
years. The learning period for PW A is short, and most operators begin to obtain good 
quality recordings after brief instructions in the technique. The variability of central 
AIx determined from applanation tonometry of the radial artery is small. 
The absolute value of AIx (%) depends upon age, sex, height and a number of other 
variables. In this instance the augmentation index was measured and recorded in 
p2jpl, and represented as a percentage. 
Equation 1 
AIx (%) = p2jpl 
Augmentation index (AIx (%)) is the scientific calculation and therefore considered 
the most appropriate measure for analysis for this study. The index is calculated by 
the two peaks as shown in chapter 1, figure 1.3. The first peak (pI) is the pressure 
generated by ventricular ejection and the second peak (p2) is due to wave reflection. 
The incisura is the closing of the aortic valves. The degree of the arterial stiffness is 
given by the augmentation and augmentation index. Augmentation index (AIx) is 
defined as the difference between the second and the first systolic peaks divided by 
the pulse pressure in percentages. Augmentation is the difference in height between 
the first and second peak and is expressed in mmHg. 
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1. 7.4 The Pressure Waveform and Arterial Stiffness 
The contour of the arterial pressure waveform varies along the arterial tree. This is 
due to differences in vessel stiffness, and the phenomenon of wave reflection 
(O'Rourke, 1992). Arteries are compliant structures and buffer the pressure changes 
caused by intermittent ejection of blood from the left ventricle. Pressure waves are 
reflected back from the periphery, most likely from the sites of impedance mismatch, 
and summate with the forward-going wave. Thus, the waveform at anyone site will 
be a combination of the forward and backward-going waves (Segers et ai, 2001). 
Normally, the reflected wave arrives back at the aortic root in diastole, thus, helping 
to maintaining coronary artery perfusion. However, with age, or conditions which 
stiffen the arterial tree, such as diabetes, hypercholesterolaemia and hypertension, 
(Chobanian et aI, 1996; Glasser et aI, 1997; Iannuzzi et aI, 1999), thus pulse wave 
velocity (PWV) and the amplitude of the reflected wave both increase (Avolio et aI, 
1985; Kelly et aI, 1989). Thus, a larger reflected wave returns to the aorta earlier, and 
adds to, or augments, central systolic pressure. The magnitude of peripheral pressure 
changes much less, although the waveform itself does change. Therefore, AIx is a 
useful index of arterial stiffness; providing information which cannot be obtained by 
measurement of brachial artery pressure with a sphygmomanometer. In particular, 
AIx reflects the manner in which the arterial tree interacts as a complete unit. Clearly, 
arteries do not function in isolation, and the value of measurement of stiffness in a 
single, short arterial segment with other techniques is, therefore, likely to provide less 
information. Moreover, ultrasonic measurements are more observer-dependent, and 
the technique takes longer to learn. 
The sphygmocor system has configuration settings to set quality control values to 
ensure accurate readings of waveforms. This is to ensure that the beat-to-beat pulses 
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in each waveform are similar, and that there is no marked drift of the signals outside 
the boundary of the quality control configurations. This allows a visual guide to the 
operator as to how well the individual pulses can be overlay to form an averaged 
pulse/waveform. 
1. 7.5 Alternative method to detect Arterial Stiffness 
The assessment and measurement of arterial stiffness is a relatively new concept and 
it was only recently that the reproducibility of an ultrasonic technique for the 
assessment of dynamic vessel wall properties (Glasser et aI, 1997) was studied. 
In addition to high-resolution ultrasound, another non-invasive method is pulse wave 
velocity (PWV), (Glasser et aI, 1997). PWV is applicable to large arterial segments 
only, and ultrasonic techniques are limited by the ability of the method to image 
accurately the anterior and posterior wall of the vessel under investigation. Thus, 
there are only applicable to large accessible arteries. Similarly, most techniques to 
date only provide data on stiffness of singular vascular beds and are invasive with 
certain risks. However, one increasingly used method is pulse wave velocity (PWV). 
It is a sophisticated system for estimating the pulse wave velocity between two 
superficial artery sites. This system is not too dissimilar to pulse wave analysis 
(PW A) and the use of a tonometer with electro-cardiograph (ECG) leads, connected 
to the electronics module, to non-invasively record a patients peripheral artery 
pressure and ECG waveform. To perform a measurement two sites are chosen. Site A 
would be the proximal artery (i.e. closest to the heart) and site B is the distal artery 
(i.e. furthest from the heart). The distance between the two is measured and recorded 
into the system in millimetres. A mean blood pressure is also entered. The tonometer 
is then placed at site B and recordings taken. Then the tonometer is placed at site A 
and ECG leads placed on the patient and a trace is commenced. Readings are then 
taken from site A. From these measurements, the system software is able to calculate 
the pulse wave velocity between the two artery sites. However, this procedure was 
not used for this study as it would have been too time-consuming and there is a risk of 
carotid rubbing, (most commonly used site for A) which can lead to cardiac 
arrhythmias, despite its non-invasive approach. Although the data on such a large 
cohort would have been very interesting, it was difficult to process with precision and 
medical assistance was not always readily available to cover any emergency. Pulse 
wave analysis has minimal intervention and risk with equal results. Presently, there is 
no accepted 'gold standard' for the assessment of vascular stiffness. Before this can be 
achieved two main aspects must be achieved. Firstly, techniques must be validated in 
the clinical setting and secondly large-scale studies not unlike this thesis need to be 
undertaken to discover whether arterial stiffness is a strong predictor of mortality than 
current risk factors. 
1. 7.6 Pulse Contour Analysis (PC A) 
Pulse Contour Analysis (PCA) or Pulse Trace is relatively new concept that is not too 
dissimilar from PWA. PCA is a powerful non-invasive device that measures large 
artery wall stiffness (SI) and vascular tone (RI). PCA uses pressure wave 
transmission and reflection theory to evaluate the speed with which the pressure pulse 
travels through large arteries, and estimate vascular tone, determined by the diameter 
of the smaller and medium arteries. The derived pressure pulse waveform changes as 
it travels through the arterial system (Nichols et aI, 1998). The speed or velocity at 
which the pressure pulse travels through the arteries is directly related to their 
stiffness (Nichols et aI, 1998). Other influencing factors are blood vessel diameter, 
... , 
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blood pressure and blood density. By measuring the speed by time it takes the 
pressure wave to travel through the arterial system, gives a simplistic and accurate 
way of measuring arterial stiffness (Millasseau et aI, 2002). This technique would 
have been an ideal and even more simplistic application had it have been available 
and validated at the time of the data collection stage. 
1.7.7 Alternative method for assessing blood flow by venous occlusion 
Plesthysmography 
This technique is widely employed but for this study it was impractical to study a 
large cohort of people quickly and carried certain risks with arterial cannulation and 
availability of vascular acting drugs. The equipment is bulky and could not be easily 
transported overseas, in view of electrical and computer compatibility. 
However, this is an ideal method for smaller cohorts because it provides more 
information than pulse wave analysis. 
1.8 Aims 
The aim of this study is to provide information on the causes of the 'Accelerated Risk 
Syndrome' III African Caribbean people. This information will reveal 
pathophysiological data that will aid a better understanding of risk, and to form a 
basis on which prevention or intervention can be instigated. 
1.9 Objectives 
This project will: 
.:. measure arterial stiffness in African Trinidadians; 
.:. correlate stiffness with blood pressure; 
.:. quantify incidence of (32-adrenoceptor mutations; 
.:. correlate stiffness with (32-adrenoceptor mutations; 
.:. investigate whether stiffness tracks with degree of dyslipidaemia. 
A secondary aim of the study is to determine whether genetic screening or pulse wave 
analysis are useful tools in early detection of risk in African Caribbeans' who have an 
'accelerated risk' of cardiovascular disease. 
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1.10 Original hypothesis 
The evidence presented in this literature review suggests an explanation for the 
"accelerated risk syndrome" in African Caribbean people, and that the onset of this 
syndrome occurs earlier than in Caucasians. Already, I have used pulse wave analysis 
to detect altered central pulse pressure, indicating stiffened arteries in a Trinidadian 
population. I will also assess blood pressure and genetic factors (see below). In 
addition, compared to Caucasians, I hypothesise that black normotensive subjects will 
have higher augmentation indices and increased blood velocities (stiffer arteries). 
Previous work by our group III Caucasians showed a relationship between the 
Gln27Glu form of the f32-adrenoceptor polymorphism and vascular reactivity to 
isoprenaline (Cockcroft et aI, 2000), and that the Glu-27 allele is much rarer in Black 
South African populations than in Caucasians (Candy et aI, 2000). Recent data have 
shown that the effect of f32-adrenoceptor polymorphism is more dependent upon 
haplotypes across the region of chromosome 5q containing the f32-adrenoceptor gene 
than single short nucleotide proteins (SNPs). At least 15 SNPs exist in the Caucasian 
and African Caribbean populations within the 31 kb region containing the 132-
adrenoceptor gene and its 5' regulatory regions (Drysdale et aI, 2000). Four common 
haplotypes exist which appear in part to predict clinical responsiveness in the airways 
(Drysdale et aI, 2000). These haplotypes can be adequately defined by genotyping for 
the 4 SNPs (-367, -47, codon 16 and codon 27) due to strong linkage disequilibrium 
between these SNPs and other SNPs forming the extended haplotypes. No studies to 
date have used haplotype-based approaches to delineate contribution of this locus to 
vascular reactivity. 
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1.11 Summary 
In summary, the aims of this study are to detect if; 
.:. African Trinidadian normotensive subjects have a higher augmentation (stiffer 
arteries) than normotensive Caucasians . 
• :. African Caribbean's with the Glu-27 polymorphism have stiffer arteries . 
• :. Individuals carrying the haplotype within the Gln27Glu polymorphism (Arg-
16, Gln-27) have increased vascular stiffness . 
• :. Data on lipid profiles of each individual in the Mrican Trinidadian cohort will 
determine that dyslipidaemia is associated with arterial stiffness. 
Combined, this data will provide information on the aetiology of the risk syndrome, 
on severity of disease, and may lead to better prevention and treatment. 
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Chapter 2 
Methods, Materials and Methodology 
~ 7 7
2.1 Research Design 
Research Design is determined by the research question, and precision, power and 
minimal bias, reflect good research (Polit and Hungler, 1999). Therefore, the research 
design and methods employed to undertake this study are quantitative. Quantitative 
methods are often associated with identifying and explaining causal relationships. 
However, quantitative methodology has been criticised for isolating phenomena from 
their contexts and leading to the development of general laws that are expected to be 
applicable in all cases (Duffy, 1985). Despite this, the establishment of a general law 
is appropriate when assessing a population's need for screening. Context can be 
applied to a causal relationship, factors influencing arterial compliance have been 
researched and the literature will explore these factors in discussion when applied to 
the care and management of cardiovascular risk in ethnic groups. The use of a 
quantitative methodology should isolate factors or a factor that influences arterial 
compliance and thus blood pressure, the literature used is to assist the context in 
which the findings of the study can be applied. 
As quantitative methodologies are either experimental or non-experimental, some 
experimental designs involve random assignment of subjects to a control or 
experimental group manipulating the independent variables and controlling the 
research situation (Polit and Hungler, 1999). To identify a causal relationship, the 
cause must be found to precede the effect, and an empirical relationship found cannot 
be explained as a result of chance or a third variable (Polit and Hungler, 1999). Due to 
a high degree of research control, experimental designs are the most powerful method 
of testing causal relationships (Bowling, 2000). A quantitative experimental 
methodology is employed for this study. The design involves the random assignment 
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of subjects to a control or experimental group, manipulating the independent variables 
and controlling the research situation. 
In the present study, the experimental and control groups were moderately equivalent, 
and were investigated systematically under conditions that were identical, in order to 
minimise variation between them. 
This feature is described as a true or classic experiment ensuring that the investigator 
has control over the independent variable as well as the power to place participants 
into groups. The design included a pre-test, which included an interview and self-
administered questionnaire. This was necessary in order to measure the effects of 
intervention in the experimental group and the direction of any associations. 
As an experimental design can only be performed when the independent variable can 
be brought under control of the experimenter in order that it can be manipulated, and 
when it is ethically acceptable for the investigator to do so. Consequently, it was not 
possible to investigate important social issues within the confines of the experimental 
design. 
2.2 Instruments and Data Collection 
2.2.1 Validity and Reliability 
The concept of validity and reliability are major components to the strength and 
credibility of any research. When critically examined, it is not only the quality and 
quantity of the research findings that are considered, but those aspects that contribute 
to the authenticity of evidence, and to the plausibility of the conclusions and findings. 
However research evaluation models have emerged as focusing on multiple data , 
collection techniques and, thus, the stakeholders accommodating different values 
(Guba and Lincoln, 1989). Therefore, what is judged and that what is regarded in 
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tenns of validity and credibility is based on the values and perspectives of individuals 
reviewing the research. The issue of validity and reliability has more contentions 
when the qualitative evaluation approach is used, and faced with many threats. 
Conventional scientific methods, on the other hand, are viewed as being more 
objective than subjective but similarly can be viewed as too rigid and repetitive as a 
'hard' science (Duffy, 1985). The following account will firstly look at the issues of 
reliability and validity in quantitative research and then will critically address the 
threats to reliability and validity in the present quantitative scientific study, and will 
identify strategies for dealing with them. 
2.2.2 Defining Validity and Reliability 
Numerous researchers have stressed the importance of validity and reliability of 
findings in research. (Field and Morse, 1985; Guba and Lincoln, 1985; 1989; Pol it 
and Hungler, 1999). 
Validity can be defined as either internal or external. Internal validity refers to the 
extent to which the instrument is really measuring what it purports to measure, and 
external refers to research findings that are generalised and can be applied to a wider 
population of interest and different settings (Bowling, 2000). This means that the 
concept of validity is justifiable by its claim to knowledge and has relevance, and 
strength of evidence used to support such claims. 
Conventionally, in quantitative research, as a measure of truth and accuracy, validity 
is of great significance as it is the measure of truth and is imperative to the research 
design. Internal validity, which is referred to more frequently in experiential studies, 
examines causality to the extent whereby a true reflection of reality is greater than the 
result of extraneous variables (Connack, 2000). Therefore, internal validity is able to 
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ascertain the 'true value' of the inquiry and how it works. Robson, (1993) identified a 
number of supposed threats to internal validity. These included maturation, 
instrumentation, statistical regression, history, testing, experiential mortality and a 
selection for which the inquiry design must compensate by controlling and/or 
randomising processes. 
Alternatively, external validity addresses whether or not findings from a study can be 
generalised beyond the sample from which it was derived (Polit et aI, 2001). Just as 
there are threats to internal validity, in conventional inquiry, also there are threats to 
external validity, which include selection effects, the setting, history and construction 
(Robson, 1993). If addressed early on, any study should be able to be applied to the 
larger population from which the smaller sample was drawn. The study's constancy, 
stability, predictability, dependability and accuracy of results define reliability. This is 
determined by the research instrument, reproducing similar results when applied in 
identical situations at different times or occasions. However, in conventional 
investigation, reliability can have several threatening factors, these include careless 
measurement and assessment of the research process, poor instrument measurement 
or decay, human error, longevity of assessment, and by ambiguities of various sorts. 
2.3 Ethnicity of Trinidad and Tobago 
Over the years there has been great perplexity and debate over the terminology of race 
and ethnicity and its inconsistency of measurement (Sheldon and Parker, 1992). Race 
has been defined as a biological concept, distinguishing groups of people by their 
phenotypical features passed on through generations. However, race has been 
criticised for its limited biological value (McKenzie and Crowcroft, 1996), due to its 
poor marker for genetic variation. The existence of definable racial groups is not so 
~ 1 1
self evident and the concept has been opposed for imposing fixed differences on 
groups of people. More palatable epidemiological research prefers the term ethnicity 
to describe social concepts, national identity and shared cultural characteristics 
(Sheldon and Parker, 1992). Since boundaries can change according to context, it is 
also difficult to measure with precision (Bhopal, 1997). Both concepts are confounded 
by socio-economic status and the diversity within racial and ethnic groups makes 
research findings susceptible to faulty interpretation. Therefore, genetic makeup is the 
most powerful determinant of biological difference and investigation was undertaken. 
2.3.1 Ethnic Background 
If clinical and genetic data had been collected in the United Kingdom, the cohort 
would have been smaller and phenotype broader. In Mrican Trinidadians the genetic 
variation is nominal as subjects all originated from Trinidad and the population was 
widely available. This in view of time, and non-diversity of race, this was considered 
more appropriate for study than in the United Kingdom. However, the external 
validity of the research can be generalised to the wider population and in particular 
African Caribbean's who have migrated to the United Kingdom. 
2.3.2 Subjects and Sample size 
For findings to be generalised, the sample needs to be representative of its population. 
Random probability sampling ensures that each element of the population has an 
equal chance of selection (Polit and Hungler, 1999). This was possible as there was a 
large diverse population within Trinidad. A representative sample was strengthened 
by choosing a homogenous target population and controlling extraneous variables 
through exclusion criteria and group matching. The power of a study is the ability to 
detect relationships among variables. This is increased through precision of 
measurement, reduction of variability caused by extraneous variables and an 
increased sample size (Polit and Hungler, 1999). Power analysis offers a statistical 
method of determining the sample size that is needed to reject a false null hypothesis 
or accept a true null hypothesis. This requires knowledge of the likely strength of 
relationship between variables. 
Previous work in Caucasians showed a relationship between the Glu/Gln 27 form of 
the (32_adrenoceptor polymorphism and vascular reactivity to isoprenaline (Cockcroft 
et aI, 2000), and that the Glu-27 allele is much rarer in Black South African 
populations than in caucasians (Candy et aI, 2000). The mutant polymorphism in the 
South African sample was greater than 5%, therefore, a power calculation indicated 
that 500 African Trinidadians were needed to be recruited to examine the genetic 
incidence, and magnitude of effect of other variables, such as, lipid profiles, blood 
pressure, and augmentation index. 
2.3.3 Sample Recruitment 
To access the sample of African Caribbean people, Dr. Clifford Thomas, Consultant 
Cardiologist from the Department of Clinical Medical Sciences at Eric Williams 
Medical Complex (ERMC) , University of the West Indies, Trinidad was contacted 
and collaboration for the study established. 
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2.3.4 Pilot Study 
Once ethical approval was obtained from the University of Nottingham Medical 
Ethics committee and from the University of the West Indies, a pilot study was 
initiated. The pilot study was to carry out a small-scale version of the main study and 
assess its feasibility. This revealed any revisions that needed to be made before the 
main study. The principle focus of the pilot study was the assessment of the adequacy 
of the data collection plan. It was important to know whether, for example, technical 
equipment was compatible with the electrical current supplied, whether the 
respondents understood questionnaires, or whether any questions were objectionable 
in any way. Primarily the pilot subjects were chosen from the same population and 
ethnic background for the major study. By monitoring reactions and overall 
impressions of the project, feedback was given to whether the study was viable. This 
established whether the main study group would have any objection to participating in 
the study. By assessing difficulties and obtaining feedback from participants and staff 
identified weaknesses and strengths of the study. For example, any comments on 
completing forms, transport availability, appointment flexibility, patient information 
and comprehension of information sheet, the importance of consent and inclusion and 
exclusion criteria, finding the clinic in the hospital, health education and other logistic 
aspects. Data were collected and scrutinised with minor refinements to the 
questionnaire and appointment bookings of time extended and minimised to ten 
people per morning. In view of the insignificant nature of the revisions, no second 
trial run incorporating these revisions was thought necessary. 
2.3.5 Ethics 
Ethical approval had been obtained from the University of Nottingham, Medical 
School Ethics Committee, and the faculty of Medicine Ethics Committee at St 
Augustine, Campus Trinidad, University of West Indies. Subjects were given written 
and verbal information about the nature of procedure benefits and risks of the 
research. Time was given to consider whether or not to participate, and subjects were 
asked if they understood the information given to them and whether they had any 
further questions. The questionnaire was then filled out by the participant and 
assistance given if needed. Details were then scrutinised for inclusion criteria and, if 
compatible, the subject was then asked to complete the signing of a consent form, 
witnessed and countersigned by the investigator. All information gathered was kept 
confidential and each subject was given an identification number for correlation. 
Essential hypertension is a widespread and common feature among African-
Trinidadians. The investigating procedures used were safe and non-invasive but 
carried the risk of causing anxiety and 'labelling' of asymptomatic subjects. To 
minimise this, procedures were explained and subjects were informed that the 
investigations were for research purposes only. The results for lipid profile and pulse 
wave analysis were disclosed to the participant on completion along with health 
education and promotion if required, and if needed, they were referred to their general 
practitioner. 
2.4 Selection Criteria of Subjects 
2.4.1 Inclusion Criteria 
The selection criteria used for the study were as follows: 
• Aged 18 or above. 
• Of strong African-Trinidadian descent going back three forefathers. 
• For control group: Normotensive. 
• For case group: Hypertensive. (WHO definition of hypertension (Zanchetti et aI, 
1993)). 
• Abstained from alcohol and caffeine containing products for 24 hours. 
• Fasted for approximately 8 hours prior to appointment. 
2.4.2 Exclusion Criteria 
The exclusion criteria used for the study were as follows: 
• Under 18 years of age. 
• Renal or any organ failure that results in extensive and existing 
complications. 
• Pregnant women. 
• Patients taking large quantities of medication for acute or chronic conditions, 
which may affect blood pressure. 
• Not of African-Trinidadian decent. 
• Non-steroid anti-inflammatory drugs or aspirin for approximately 7 days prior to 
study. 
2.5 Experimental protocol, variables and control of research 
environment. 
To prevent confounding data it is essential to control any extraneous variables as 
carefully as possible. All participants were asked to arrive at clinic having fasted for 
at least six hours and having abstained from caffeine and alcohol for 24 hours and 
aspirin and non-steroid anti-inflammatory drugs for seven days prior to screening. 
This would prevent 'masking' the effect of blood flow and dilatation of blood vessels, 
as caffeine and alcohol are stimulants and have a dilatory effect on blood vessel 
function (Kaplan, 1998). To control this variable, a letter or verbal instruction by 
telephone was undertaken, prior to their appointment, so that potential subjects were 
compliant to study criteria. They were asked at the screening appointment if they had 
adhered to this instruction. Each participant was seen in the morning at the clinic 
(EWMC) for a single appointment. Assistance was provided, where necessary, in with 
filling out the questionnaire, providing detailed, accurate information on ethnicity, 
smoking, family and personal history of hypertension, cardiovascular disease 
(including stroke) and diabetes and any current medication. This was to determine if 
the potential participant met the inclusion criteria. 
Before employing PW A, height and weight and blood pressure were measured. 
Height was measured without shoes to the nearest centimetre ( em), using a height 
chart attached to a wall. Weight was measured without shoes and outdoor clothing, to 
the nearest 0.1 kilogram (kg). Subjects were rested in the supine position in a quiet 
room maintained at a temperature of 22°C to 23°C, controlled by air conditioning. A 
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quiet atmosphere also helped to reduce anxiety that could elevate blood pressure or 
heart rate readings. 
Three recordings of blood pressure were taken using the Takeda VA-7S1 seml-
automated sphygmomanometer on the participants non-dominant arm, using the 
correct size cuff size, taking blood pressure readings over a fifteen-minute period, 
with the mean of the readings used for the analysis (British Hypertension Society 
(BHS), 1999). The first reading was disregarded, if in some individuals it were found 
to be abnormally raised, in comparison to their previous blood pressure readings, 
undertaken elsewhere. Applanation tonometry (see section 2.6 and figure 1.3) was 
then performed to assess arterial compliance using information derived from the 
central pulse wave. Pulse wave analysis was then performed using a tonometer placed 
on the participants' non-dominant arm, radial artery, whilst the subject was 
recumbrant. Three subsequent recordings, separated by two to five minutes were 
taken with quality control parameters calibrated and set. 
Three, ten second periods of good quality waveforms in each subject were recorded. 
The average of the three blood pressure measurements and the average of three PW A 
measurements were used for analysis. The investigator performed all recordings, and 
the two groups were intermixed to prevent bias. Once completed, the fasted 
participant had a venous blood sample taken for lipid profiling, glucose level and 
genotyping. Results of blood pressure, and fasting lipid and glucose levels 
(Cholestech; Bayer) were given to the participant at the end of the session and 
appropriate health advice was offered, with referral if required. Each appointment 
lasted between thirty minutes and one hour. 
Blood pressure and arterial compliance has been found to be preserved at night 
(Harshfield et al, 1988). For this reason, and given that the subjects were fasted, 
arterial compliance was assessed in the morning. This controlled for any diurnal 
variation in these measurements (Kool et aI, 1992). Environmental stimuli can explain 
changes in vascular reactivity and play an important role in leading to an increased 
vascular tone. Pre-capillary arterioles throughout the body might play a part in 
vasoconstriction triggered by exposure to environmental stresses (Folkow, 1982). 
Thus, temperature, electrical interference and noise control were required for comfort 
and to reduce anxiety levels in the subjects. Less potent environmental stimuli, 
including relatively minor irritations that occur from intermittently, could, under 
experimental conditions, lead to substantially greater vasoconstriction and subsequent 
blood pressure response than would ordinarily occur. Caffeine and alcohol intake 
increases blood pressure chronically, influencing arterial compliance (Kaplan, 1998). 
Data from a large Kaiser-Permanente database (Klasky et aI, 1977) which included 
over 10,000 'black' patients, showed substantially higher blood pressures in subjects 
who drank three to five alcoholic drinks per day than those who drank less. Cause and 
effect relations are not proven. However, the consensus recommendations for limiting 
alcoholic drinks appear to be generally prudent for 'black' as well as white 
populations. 
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2.5.1 Summary of Blood Pressure Measurement and reasons 
The following principles were adhered to in measuring blood pressure are as follows: 
.:. Follow the British Hypertension Guidelines on technique (Ramsey et aI, 
1996) . 
• :. Use blood pressure measurement devices that are validated, maintained 
and regularly calibrated. This was the SphygmoCor® (AtCor Medical) and 
Takeda UA-751 semi-automated sphygmomanometer . 
• :. Measured blood pressure was taken lying down, but could be taken sitting, 
as long as the participant is relaxed. All participants were lying down . 
• :. Removal of tight clothing, so it does not restrict the cuff, support the arm 
and ensure the hand is relaxed. This allows accurate readings to be 
recorded . 
• :. Use an appropriate size of cuff This should encompass the arm 1.5 to 1.8 
times the circumference of the participant's non-dominant arm. This 
ensures full occlusion of blood flow to the forearm and record accurate 
blood pressure on release . 
• :. A minimum of three blood pressure readings was taken at the visit. The 
first reading was disregarded in calculation if the participants' blood 
pressure measurement served as an assessment for 'white coat' or 'office' 
hypertension (Mancia et aI, 1995). This guideline was adapted to 
compensate that the participant had assessment of blood pressure on only 
one visit and not four clinic visits to determine blood pressure threshold 
(British Hypertension Guidelines 1999). 
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.:. The average of the following blood pressure readings were used and data 
entered into the SphygmoCor® to assess central cardiac indices . 
• :. Pulse wave analysis was then performed using a tonometer placed on the 
participants' non-dominant arm, radial artery, whilst lying down and three 
subsequent recordings were taken with quality control parameters 
calibrated and set. 
.:. The average of three blood pressure and PW A measurements were used 
for analysis. This was to ensure that all readings conformed and were 
consistent with the recommended experimental technique to ensure 
reliability, accuracy and validity . 
• :. Muscle strength and mass will have an effect on blood pressure. The 
dominant arm is more likely to have greater muscle mass and strength due 
to continual isometric use and thus enhanced aerobic characteristics. 
Therefore, the dominant arm would not be a true enough reflection of 
blood pressure systemically (BHS, 1999). People from African decent 
have physiological differences in muscle fibre that makes them more 
resistant to muscle fatigue and have proved to be more athletic (Noakes, 
1993). However, despite people of African origin have greater endurance 
in exercise, muscle strength is lower compared to caucasians (Noakes, 
1993), and that the key differences in strength and mass lies within the 
muscle tissue and not the cardiovascular system (Noakes, 1993). 
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2.5.2 Questionnaire and Interview 
In the planning and piloting stage, the construction of a questionnaire was thought 
appropriate to capture personal details including gender, date of birth, ethnicity going 
back three forefathers, educational background, personal and family medical history, 
present medication and smoking status. This was used to validate ethnicity, inclusion 
and exclusion criteria, personal and contact details, medical history, and socio-
economic status. Questions were designed to be simple and familiar, so that all 
subjects could understand them. Questions were closed and dichotomised. The 
advantage of this was that they were quicker to analyse and easier for the investigator 
to validate at interview, as well as the subjects comprehension. The closed questions 
were not felt to force the respondent into inappropriate categories as the topics and 
background was commonly known. No clues were evident about the answers that 
were expected for inclusion or exclusion criteria. The format of the questionnaire was 
easy and basic, with non-threatening questions. However, some questions did refer to 
personal and family medical history and technical terminology was used. Opening 
and closing statements on the questionnaire offered assistance to those who had 
difficulty in interpreting medical jargon. Care was given when the respondent had 
difficulty choosing a response possibly through lack of knowledge of their personal or 
family medical history. The questionnaire had an open question at the end of the 
questionnaire to allow the respondent to write in their own words any other details 
they thought appropriate about themselves and their participation in the study. 
A closed question was thought unwise when asked about ethnicity. This was thought 
to give the respondent prompts about the type of answer that was expected (Bowling 
2000). Therefore the respondent was required to describe their ethnicity and their 
background in their own words, to avoid form and prompts. Included with the 
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questionnaire was an information sheet, describing the format of questions asked 
followed by the tests performed. After the respondent completed the self-administered 
questionnaire, the investigator conducted a personal interview. This was short and 
factual, lasting for approximately five minutes. Closed questions were scrutinised for 
errors and ethnicity verified verbally, checking background with the subject. It was 
important to establish a good rapport, as this had a positive motivation factor on the 
respondent. Being friendly, positive, trustworthy, committed, preserving and adopting 
a neutral manner were essential in avoiding bias of the investigator. In contrast, the 
investigator was aware that racial and cultural differences, for example language, 
which might result in inconstancies and less reliable results (Cosper, 1972). To 
minimise language difficulties an African Trinidadian member of staff was available 
in the clinic to assist. However, this problem was rare. See figure 2.1 for copy of the 
questionnaire used in the study. 
2.5.3 Ethnic Classification 
Ethnic monitoring was achieved by a self-classification system, based on the 1991 
census guide to ethnic definition. This would ensure findings were comparable and 
applicable to practice (Bhopal, 1997). Subjects were asked what their racial origin 
was, but no applicable categories were expressed for classification. The subject was 
asked to define themselves and their forefathers in their own words. Those identified 
as black Mrican, black Caribbean, Black Trinidadian or Tobagian were included in 
the study. Those identifying him or her as mixed (specified) or other (specified) were 
excluded. 
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Screening Checklist for Trinidad Blood Pressure Study 
Name 
I.DNumber 
Agel d.o.b 
. d hn' .. GeneratIOn an et IC ongm .................................................................... . 
Date of Visit ..................................................................................... . 
• Height (cms) ......... . PWAIV 
• Weight (kg) ........... . Augmentation (%) 1 ....... Index 1 .... . 
2....... 2 .... . 
• BMI .................. . 3 ...... . 3 ..... 
Mean 
Central Pressure DIP ........ . Pulse Pressure 1 ........ . 
2 ........ . Mean ..... . 
3 ..... , ... 
Blood Pressure 
1 ........ , .... ,. 
2 .............. . MeanBIP ............ . 
3 ............. ,. 
Lipids (mmols/l) 
1. Total Cholesterol ......... . 2. Triglycerides ............ . 
3. HDL .............. . 4.LDL ..................... . 
5. VLDL ..................... . 6. HDL Ratio .............. . 
7. Fasting glucose ............ . 
Cardiovascular Risk Assessment Form 
If you are unsure about any of the questions, please ask a member of the medical team 
who will gladly help you complete this form. 
1. Personal Details 
Name 
Date of Birth 
Address 
Contact telephone number 
Name of Referring Doctor or G.P ____________ _ 
(Please circle or tick that which applies to you) 
Gender: Male IF emale Education: Primary/ Secondary/ Tertiary 
2. Ethnicity 
Please fill in below your parents and grandparents ethnic background 
Parents: 
Mother Father 
----
----
Grandparents Maternal: 
Mother Father ___ _ 
----
Grandparents Paternal: 
Mother Father ___ _ 
----
How do you define your ethnicity? ______ _ 
3. Medical History 
Have you been diagnosed with any of the following conditions? 
Please circle or tick which applies. 
A) High blood Pressure YeslNo 
C) High Cholesterol 
E) Stroke 
G) Cardiac Failure 
4.Family History 
YeslNo 
YeslNo 
YeslNo 
B) Diabetes YeslNo 
D) Angina Y eslN 0 
F) Heart Attack YeslNo 
H) Renal Problems YeslNo 
Has anyone in your family suffered from? 
A) High blood Pressure YeslNo B) Diabetes YeslNo 
Who and at what age Who and at what age 
C) High Cholesterol YeslNo D) Angina YeslNo 
Who and at what age Who and at what age 
E) Stroke YeslNo F) Heart Attack YeslNo 
Who and at what age Who and at what age 
G) Cardiac Failure YeslNo H) Renal Problems YeslNo 
Who and at what age Who and at what age 
5. Medication 
Are you taking any medications and if so what is it and how much per day? 
TabletslDrugs Amount taken each day ( in mg if possible) 
6. Smoking 
Do you smoke or have you in the past? 
(please circle or tick that which applies) Yes/No 
If yes, how many per day 
How long in years 
Do you smoke now? Yes/No 
When did you give up? 
7. Any other information 
Is there anything else you would like to tell us about your health? 
Thank you for filling out this questionnaire. 
In collaboration with the University of the West Indies, Medical Sciences Faculty and 
the University of Nottingham, Health and Medicine Department, United Kingdom 
Figure 2.1 Sample Copy of Screening Checklist and Participant Questionnaire 
2.5.4 Test of Hypothesis 
To test a number of hypotheses empirically, concepts are defined and explanation 
required on how they will be measured (Bowling, 2000). This is to enable correct 
interpretation and comparison to other similar studies. For example, when the 
independent variable was ethnicity the dependent variables were arterial compliance, 
blood pressure, fasting lipid and glucose levels, and genetic polymorphism. 
2.6 Pulse wave Analysis-Technique (1) 
2.6.1 Introduction 
Pulse wave analysis allows the generation of the ascending aortic pressure waveform 
from the arterial pulse pressure. It is recorded non-invasively by applanation 
tonometry (Chapter 1, section 1.7.2) in the radial or carotid artery. This is made 
possible by the use of high fidelity tonometers, by characterization of hydraulic 
properties of the artery in an upper limb or the neck, and through the employment of 
mathematical engineering techniques in advanced computer languages or systems 
(O'Rourke et aI, 1996). 
The description of application of PWA is described in section 2.5 and 2.5.1 of this 
chapter. 
2.7 Screening SUbjects 
2.7.1 Screening for Aspirin and Non-steroid anti-inflammatory drugs. 
Subjects were asked if they had taken aspirin or any non-steroidal, anti-inflammatory 
drugs (NSAID) in the past seven days. Such drugs improve acetylecholine-mediated 
vasodilatation in patients with atherosclerosis (Noon et aI, 1998). This would 
influence arterial compliance and not give a true reflection of arterial stiffness. If 
58 
subjects had taken aspirin or non steroidal anti-inflammatory drugs (NSAID's) they 
were asked to return at a later date to allow a 'wash out' period of time for the drugs 
not to be effective. 
2.7.2 Screening of Lipid Profile 
All subjects had a fasted, venous blood sample, taken for lipid profile at the end of the 
clinic visit and fat intake was assessed through dietary questions. As the cost of 
testing for hypercholestesterolaemia was high in the West Indies, the application of 
Cholestech (Bayer) slides for lipid profile and glucose was found to be more cost 
effective, portable for clinic use and efficient with instant results, and well validated 
in comparison to laboratory analysis. 
2.7.3 Method of lipid analysis 
Subjects had a tourniquet applied to the upper arm and blood drawn from a brachial 
vein using a 21g needle (Leur-lock Terumo) and Sml syringe (Terumo). A small drop 
was applied to the well area of the Cholestech slide and placed within the Cholestech 
(Bayer) analyser for analysis. This process took approximately S minutes. The 
remaining whole blood was placed in a Vacutainer (BD Systems) for genotyping. The 
results would appear on a digital screen. The results were recorded on the clinical 
research form (CRF) and a duplicate form was made for the subjects' reference. The 
used slide was then removed from the analyser and disposed of in a designated 
disposal unit for sharps and blood product waste. 
2.8 Genetics-Technique (2) 
2.S.1 DNA extraction method. 
2.8.2 Introduction 
The swiftness and proficiency of DNA (deoxyribonucleic acid) extraction has been 
advanced by the availability of commercially prepared extraction kits and the choice 
of method depends on the material available for analysis. The general principle of 
DNA extraction is the lysing of cells, followed by separation of the DN A 
contaminants of whole blood lysate, which could interfere with further reactions such 
as PCR (polymerase chain reaction). 
2.S.3 DNA extraction from clotted blood (whole blood) 
Purification of DNA from 200JlI of clotted blood (whole blood) was achieved using 
the QIAmp blood kit from Qiagen. 5mls of whole blood were collected into sodium 
EDTA (diaminoethanetetra-acetate acid) tubes, to provide material for DNA 
extraction. Samples were then stored at -20°C until DNA extraction was performed. 
2.S.4 Lysis and preparation of whole blood sample 
A 5ml clotted blood sample was defrosted carefully at laboratory temperature ( 22°C 
± 1°C ) for approximately one hour and 200J.lI was pipetted into a 1.5ml eppendorf 
tube. 25JlI Qiagen protease ( as supplied by the kit) was added, followed by 200J.lI 
lysis buffer AL ( as supplied by the kit), the cap closed and vortexed for 15 seconds to 
promote efficient lysis. The sample was then placed in a water bath at 70°C and 
incubated for 10 minutes. 210JlI isopropanol (100% v/v solution) was added and the 
sample vortexed briefly to mix. This helps increase the yield of DNA extracted from 
the blood. 
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2.8.5 Absorption of DNA 
A QiaMP spin column was placed into a 2ml collection tube (supplied in the kit) and 
600j.l1 of the dilution was carefully pipetted into the spin column without moistening 
or staining the rim of the column. The column cap was closed and centrifuged at 
13,OOOrpm for 1 minute. The spin column was then removed and placed into a clean 
collection tube. The remaining filtrate from centrifuging was disposed of carefully in 
accordance to guidelines for the disposal of blood products. 
2.8.6 Washing of DNA 
The spin column cap was gently opened and 500j.l1 of Wash buffer AW (supplied in 
the kit) was added. The column was centrifuged at 13,OOOrpm for 1 minute. Again the 
spin column was removed and placed in a clean collection tube and a second 500j.l1 of 
wash buffer AW was added. This time the sample was centrifuged at 13,OOOrpm for 3 
minutes to remove all buffer A W from the column. All filtrate from the washing 
process was discarded safely. 
2.8.7 Elution of DNA 
Following washing, the spin column was placed in a 1.5 eppendorf tube. 200j.l1 of 
sterile water heated to 70 0 e was pipetted into the column. The cap was closed and 
incubated at 700 e for 5 minutes. This increases yield compared to room temperature 
incubation. The sample was then centrifuged at 13,OOOrpm for 1 minute to elute the 
DNA from the column. The DNA sample was then marked with the appropriate 
reference number and the 1.5ml eppendorftube was then placed in the -20oe freezer 
to prevent DNA breakdown. 
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2.9 Polymerase chain reaction (peR) 
2.9.1 Introduction and peR amplification conditions 
In order to generate fragments of DNA spanning the specific region of interest (in 
this case the 132 AR gene) PCR was used. The basis for the PCR reaction is to use 
oligonucleotide primers to hybridise opposite strands and target the DNA sequence 
that is to be enlarged and extended. The heat-stable enzyme Taq DNA polymerase 
catalyses the elongation of the primer. 
A series of temperature changing cycles allows template denaturation, pnmer 
annealing and extension of the annealed primers by the Taq polymerase, resulting in 
an exponential increase in the target DNA. See figure 2.2 
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5' ACT AA3' 
Reverse Primer 
5' ACT A A G GAG G TAG T T 3' 
3'TGATTCC TCC ATGAA5' 
Template DNA 
3'ATGAA5' 
I Fonvard Primer 
5' ACT A A G GAG G TAG T T 3' 
Heat -stable Taq 
DNA polymerase 
~ ~ 3'TGA TT C C TC C A TGAA5' 
DNA strand separates at 95°C -Denaturation 
I 
5' ACT A A G GAG G TAG T T 3' Cool to annealing temperature 60°C 
--- - ---- -- --- - --------- - -,... ......... 
_ I. -{=-3'ATGAA5' 
t 5'ACTAA3' -{=-.I _ ........ ~ - - - - - - - - - - - - - - - - - - - - - - -3' T GAT T C C T C CAT G A A 5' 
Heat to 75°C, Taq polymerase Cl.1:ends the complimentary DNA strand 
Repeated cycles result in amplification of the region of DNA betwccn the two primers. 
Figure 2.2 A Schematic of a peR reaction, resulting in the amplification of region of 
DNA, using two primers. A. Kornberg ; DNA Rep lica/ioll 1980 
A typical amplification reaction for PCR was as follows: 
.:. 5 ~ 1 1 lOx PCR reaction buffer 
.:. 3 ~ 1 1 MgCh (25 mM stock, 1.5 mM in reaction) 
.:. 2 ~ 1 1 dNTPs (5Mm stock, 0.2Mm dCTP, dGTP, dATP, and dTTP in 
the reaction) 
.:. X ~ l l 5' Primer (0.1 nmol) 
.:. X ~ l l 3' Primer (0.1 nmol) 
.:. X ~ l l target DNA (50-100ng) 
.:. X ~ l l sterile water to make up to 4 8 ~ 1 1 volume total 
.:. 1 ~ 1 1 Taq DNA polymerase 
The combined volume ( 4 8 ~ 1 ) ) reaction was overlaid with one drop of light white 
mineral oil (Sigma). This prevented the constituents of the reaction from evaporating 
during the reaction cycles. 
The reactions were placed in a Biometra thermocycler. A 'Hot start' PCR was used. 
The sample was heated to 95°C for 5 minutes, (which allows the DNA to denature 
fully), before the addition of 1 ~ 1 1 Taq DNA polymerase, pipetted into the reaction 
below the overlaid mineral oil. The first cycle was then 60°C annealing for 90 
seconds followed by 72°C for another 90 seconds for DNA extension. For subsequent 
cycles, denaturation was performed for 90 seconds at 95°C, followed by annealing for 
90 seconds at 60°C and the extension for 90 seconds at 72°C. The complete reaction 
consists of 36 cycles. 
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At the end of the reaction, a final 10 minutes at 72°C, extension was performed. Once 
complete the PCR reaction was placed in placed in the refrigerator at 4°C before use 
for the next stage. 
Table 2.1 PCR conditions for amplification of f3-2 Adrenoceptor Fragment. 
Gene Primer sequence Annealing Cycle Fragment 
polymorphism Temperature Number Size 
f3-2 Forward primer 
Adrenoceptor 5'CCCAGCCAGTGCGCTT ACCT3' 
A R G 1 6 ~ G L Y Y
60°C 36 234bp 
& 
Reverse primer 
5'CCGTCTGCAGACGCTCGAAC3' 
G L N 2 7 ~ G L U U
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2.10 Agarose Gel Electrophoresis 
2.10.1 Electrophoresis 
The standard gel used for the studies described in this thesis was composed of 1% 
agarose dissolved by microwave in lOOmIs of lxTAE buffer and 5 III (lOmglml) 
ethidium bromide. This was left to cool in a glass jar. Space combs and dividers were 
placed in position in the electrophoresis tank and the cooled gel solution was gently 
poured into the tank. Once set the combs and dividers were removed and the set gel 
was covered with 1 x T AE buffer. 1 III of loading dye was added to 6111 PCR product, 
and steadily pipetted into one of the wells on the gel. Each gel had the capacity to 
perform 24 PCR samples. The tank was then attached to the voltage conductor (power 
unit) and a current of 35 volts (40 milliamps) was passed through the gel for 
approximately 30 minutes. This allows separation of the PCR product on the basis of 
fragment size. Once complete the buffer solution was poured off and the gel examined 
under UV illumination. 
2.10.2 Visualisation of DNA fragments 
The gel was removed carefully from the electrophoresis tank and placed gently onto a 
short wave (302nm) UV transilluminator. The ethidium bromide in the agarose gel 
imbeds within the DNA, enabling the fragments to be viewed under UV illumination 
A Polaroid photograph was taken for identification and verification ofPCR products. 
See figure 2.3. 
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Figure 2.3 A 1 % agarose gel representing PCR fragments spannmg 
A r g ~ G l y 1 6 6 and G l n ~ G l u u 27. 
All lanes marked 5-1 underwent peR conditions of 60°C through 36 cycles. 
(produced by Dr. Amanda Wheatley). 
2.11 Allele specific oligonucleotide (ASO) hybridisation 
2.11.1 Introduction 
Allele specific oligonucleotide (ASO) hybridisation is a technique (Gunneburg et al, 
1993), that enables genotype to be determined by using allele-specific 
oligonucleotides to compete for binding to sequences containing single nucleotide 
polymorphisms (SNPs). It is an efficient and effective assay for screening large 
numbers of subjects or populations. 
2.11.2 Genomic DNA, Polymerase chain reaction (peR) and Allele specific 
oligonucleotide hybridisation (ASO) 
PCR fragments spanning the region of interest were generated as described in Table 
2.2 and figure 2.4, used for ASO. 
Table 2.2 Oligonucleotide sequences of the probes used for ASO detection. 
SNP Position Oligonucleotide probe sequence 
~ 2 - A d r e n o c e p t o r r ARG 16 5' GCACCCAATAGAAGCCATG 3' 
~ 2 - A d r e n o c e p t o r r GL Y 16 5' GCACCCAATGGAAGCCATG 3' 
~ 2 - A d r e n o c e p t o r r GLN 27 5' CACGCAGGAAAGGGACGAG 3' 
~ 2 - A d r e n o c e p t o r r GLU 27 5' CACGCAGCAAAGGGACGAG 3' 
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2.11.3 ASO filter preparation 
Hybond N+ membranes (Amersham) and blotting paper (Whatman) were cut to size, 
to fit the 96 well dot blot apparatus (Gibco BRL Life Technologies). Two pieces of 
blotting paper and one Hybond N+ membrane were soaked in 2x sse (see materials), 
before being placed on the dot blotting apparatus. Two pieces of blotting paper were 
placed over the 96 holes making sure all the well holes were covered and then the 
Hybond N+ membrane placed on top. The apparatus was then assembled by placing 
the lid and tightened into place by 8 screws. A vacuum was then applied to draw off 
excess fluid. Two filters were prepared for genotyping each SNP, one filter for each 
allele. Each sample was prepared by adding 101-11 of the peR product to 4001-11 of 
O.4M NaOH with Bromophenol blue dye, (enough to colour the solution), 4001-11 of 4x 
sse was then added and the contents mixed in a 1. Sml eppendorf tube. 2001-11 of each 
sample was pipetted into duplicate wells on the dot blotting apparatus, and the 
remainder was saved for the second membrane for the other polymorphism being 
assayed. The filter was drained gently by vacuum and when complete, the 8 screws 
were loosened and the membranes were left to dry on a piece of absorbent paper. Blue 
dots from the dye were evident suggesting that the peR product had successfull y 
permeated the filter and thus the next stage of hybrid is at ion could be undertaken. 
2.11.4 Labelling of Probes 
Two oligonucleotides containing the two polymorphic forms of the particular SNP 
were designed for each polymorphism for ASO analysis. Table 2.2 demonstrates the 
oligoneucleotides for the 132 Adrenoceptor polymorphisms. 
69 
The following components were pipetted carefully into a 1.5 microfuge tube and in 
the following order. 
1. 5.5 JllofH20 
2. 1 JlI 10x polynucleotide kinase buffer 
3. IJlI Oligo (either Arg 16, Gly 16, GIn 27 or Glu 27 dependent on which probe is 
being used). 
4. 2JlI [y_32p ] ATP 
5. 0.5 JlI T4 polyneucleotide kinase (Strategene) 
The combined components were then placed on a hot block and incubated for 1 hour 
at 37°C and then for 10 minutes at 70°C to denature the enzyme. The labelled probes 
were then either used immediately for hybridisation or were stored at -20°C. 
2.11.5 Methodology of Hybridisation 
The oligonucleotide employed is a segment of synthetic DNA, short in length 
designed to enhance the area of DNA containing the specific polymorphism. A single 
mismatch between an oligonucleotide probe and template DNA will substantially 
decrease annealing capacity, which leads to discrimination between different alleles. 
Allele specific oligonucleotide (ASO) is a competitive assay, which strives to amplify 
DNA products that are applied to duplicate membranes (X and Y) with the dot 
blotting apparatus. Membrane X is incubated firstly with unlabelled oligonucleotide 
probe ('cold') homologous to the mutant form of the receptor, and membrane Y with 
unlabelled oligonucleotide probe ('cold') homologous to the wild-type form of the 
receptor. Secondly, the membranes are hybridised with 32P-(Phosphorous) labelled 
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probes (radioactive, 'hot') in the opposing order. Membrane X is exposed to the 
homologous probe of the wild-type form receptor, and membrane Y to homologous 
probe of the mutant form of the receptor. 
2.11.6 ASO Hybridisation 
The dried filters were carefully labelled and placed between two pieces of gauze. If 
more than one filter was hybridised, an additional piece of gauze was over-laid, so 
each filter was separated. They were then rolled up and placed in a tight fitting screw 
top hybridisation bottle. The bottles were labelled and 20mls of 5x SSPE 1 % SDS 
buffer wash added with 10-50J.lI of COLD unlabelled oligonucleotide probe was 
pipetted carefully into the bottle containing the membranes. The bottles were placed 
in an incubator at 52°C in a hybridisation oven, which gently rotates for 1 hour. Once 
incubated the bottles were opened and the liquid poured off and disposed of Another 
buffer wash of 20mls of 5x SSPE 1 % SDS was added and the process repeated, this 
time with the HOT probe ( 32p labelled). This time the HOT probe was added to the 
corresponding bottles, for example Arg 16 probe was added to the Arg 16 membranes 
and bottle. Once the incubation cycle was completed the radioactive probe and 
solution was poured off in the appropriately designated disposal unit. The filters were 
washed x 4: Firstly, 20mls 2 x SSPE 0.1% SDS was added to the bottles and rotated 
in the incubation oven at room temperature for 30 minutes, then the solution poured 
off. This wash was repeated using 20mls 2 x SSPE 0.1 % SDS for another 30 minutes. 
The third and fourth wash consisted of 20mls 5 x SSPE 0.1 % SDS being added to the 
membranes and bottle and rotated in the incubation oven at 52°C for 15 minutes. 
The filters were then placed between x-ray plates, covered by cling film and placed in 
an X-ray cassette with intensity screens and placed in the -80°C freezer overnight. 
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2.11. 7 X-ray film development 
Once the x-ray film (Fuji) had been exposed on the filter membranes, usually 
overnight, they were processed for development. A 1:5 dilution of developer (Kodak) 
and rapid fixer (Ilford Hypam) were made and each placed in a plastic container tray. 
Distilled sterile water was also placed in a tray. In a dark room with nominal exposure 
light (red lamp) the film was lifted out of the x-ray plate cassette and the right hand 
comer creased to orientate the image. The film was placed in the developer and gently 
rocked for 2 minutes to allow full coverage, but minimal disturbance of the image. 
The film was transferred to the water tray rinsing and then to the fixer tray and gently 
rocked for 2 minutes to fix the image. A final rinse in the water tray was undertaken 
before the film was hung to dry. This development process was used for all 
genotyping imaging. 
2.11.8 Reading of filters to determine genotype 
The two membranes were read in parallel, with one membrane displaying signal for 
wild-type homozygotes, and heterozygotes, and the other displaying the mutant 
homozygotes and heterozygotes. Control samples with known genotype were used on 
all membranes to confirm determination of homozygote and heterozygote signals. 
See Figures 2.5 and 2.6. 
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Denatured peR highlighting genotype. 
peR on filter A 
32p 
32p 
32p 
Wild -type probe 
32p e 
Wild Type 
Homozygote 
Heterozygote 
Mutant probe 
32p 
• 
Mutant Homozygote 32p 
3 3 ~ ~
• 
p eR on filter B 
Autograph of ASO hybridisation results. PCR product/reaction are spotted onto the filters in 
duplicate for comparison and are read side by side. 
Filter A 
Wild type 
• 
• 
• 
• 
Filter B 
Mutant probe 
• 
• 
• 
• 
Genotype 
Wild Type Homozygote 
.. 
Heterozygote 
.. 
Mutant Homozygote 
.. 
Figure 2.4 Allele specific oligonucleotide hybridisation. The PCR spans the polymorphism. This is denatured and 
spotted onto tV.IO separate fillers (A and B as shown above) These are placed in hybridisa lion tubes \\'ith a 'Cold' 
probe. Hybridisabon WilJl Ole 'Hot' probe binds Ole specific alleles on each filler. The results arc read from an 
autoradiogTaph due to ASO. 
., 
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Figure 2.5 
Arg 16 and Gly 16 ASO Hybridisation filter plates. Duplicate spots represent a single subject. A 1 + 2 
is a negative control and A3 + 4 is a water control sample. Comparison of filter plates would 
determine the subject as being either heterozygote or homozygote . For example, the posi ti ve signal in 
the left hand filter for B 1 + 2 indicates a homozygous Arg 16 indi vidual. B3 + 4 indi cates a 
homozygous Gly 16, and C 1 + 2 indicates a heterozygote. 
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Figure 2.6 
Gln27 and Glu27 ASO hybridisation filter plates. Duplicate spots represent a single subject. A 1 + 2 
is a negative control and A3 + 4 is a water control sample. Comparison of filter plates would determine 
the subject as being either heterozygote or homozygote. (See previous figure for explanation) . 
2.12 Verification of Polymorphisms 
Automated sequencing has advanced at a rapid rate over the past decade with SNPs 
being easily detectable in double peaks of chromotograms (See Figures 2.7, 2.8, 2.9, 
2.10,2.11, 2.12). Sequencing is used to define and confirm the mutation once it has 
been found to exist by one of the other scanning or genotyping techniques. This 
process is very expensive and was only used to verify some polymorphism of each 
type to conclude the accuracy of hybridisation. 
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Figure 2.7 
Automated sequencing of Gln27 and Arg/Gly16 , 
The single peak represents alleles of GIn 27 and the ununiformed 
double peaks are representing one allele from the mutation and 
wild type, thus being heterozygous on the sequencing probe of 
Arg/Gl y16, 
j, 
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Figure 2.8 
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IXTl.1 
Automated sequencing ofGly16 and GlnlGlu27, 
The single peak represents alleles of Gly 16 and the ununiformed 
double peaks are representing one allele from the mutation and wild 
type, thus being heterozygous on the sequencing probe of 
GlnlGlu27 
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Figure 2.9 
Automated sequencing of Arg/Gly16 and Gln/Glu27 
The ununiformed double peaks are representing one allele 
from the mutation and wild type, thus being heterozygous on 
the sequencing probe of Arg/Gly 16 and GlnlGlu27 . 
Figure 2.10 
Automated sequencing of Gly 16 and Glu27. 
The single peak represents alleles of Gly 16 and Glu27. Thi s 
represents a double mutant homozygote. 
.J 
...c 
j 
'" G , ~ · " J ' i i
Figure 2.11 
Automated sequencing of Arg16 and Gln27. 
The single peaks represents alleles of Arg 16 and Gln27 
Sequencing probe represents wild type or dominant 
homozygotes. 
~ ~ ~ ~
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Figure 2.12 
Automated sequencing ofGly16 and Gln27. 
The single peaks represents alleles of Gl y 16 and Gln27 
Sequencing probe represents a mutant and wild type 
homozygotes . 
2.12.1 Sequencing 
The technique used to distinguish band SIzes without usmg 32p is automated 
sequencing. A PCR product is produced and purified, amplified using electrophoresis 
then cut from agarose gel. This is then melted and prepared so it can be reloaded onto 
a polyacrylamide gel and electrophoresis can be repeated. This time, a laser beam is 
then passed through the strands at the bottom of the gel. The laser detects which 
fluorescent tag has been excited depending on which primer is present in the band. 
This information is directly sent to a computer display, producing a read out of 
different coloured peaks, one colour for each base. Automated sequencing was 
achieved on an ABI prism (377) sequencing system. This was kindly performed and 
produced by Ms. Ingrid Davies of the Biochemistry Department and Dr. Amanda 
Wheatley of the Department of Therapeutics, University of Nottingham. 
2.13 Statistical and Data Analysis 
This is a brief outline of the statistical analysis, which is used for this thesis. The 
following chapters provide the analysis of the data collected. 
2.13.1 Chi-squared <X2) statistic 
This test is used for comparing overall patterns of performance using frequency 
scores. Categories are identified and thus frequencies of scores fall into cells. Cells 
contain the counted items and can test by association only. They are useful 10 
particular when comparison and distribution between two groups are unequal. 
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In this case it is used to test whether the numbers of subjects with specific genotypes 
is different between hypertensive and normotensive groups. 
This is formulated and tested using the equation: 
Equation 2 
L (Observed - Expected)2 
Expected 
L(O-E) 
E 
A p value is determined using the X2 table and degrees of freedom are (n-l) where n 
is the value or number of parameters in the equation. A p value that is less than 0.05 is 
significant and therefore a null hypothesis can be rejected. If not, the null hypothesis 
remains true and thus no significant difference is determined between the groups. 
2.13.2 Hardy-Weinberg Equilibrium 
In a large random-mating population with no selection, migration or mutation the 
gene frequencies and the genotype frequencies are constant from generation to 
generation; and furthermore, there is a simple relationship between the allele 
frequencies and the genotype frequencies. Their properties are described by a theorem 
known as the Hardy- Weinberg law. A population with a constant allele and genotype 
frequency is said to be in Hardy- Weinberg equilibrium. The relationship between 
allele and genotype frequencies is important as population and quantitative genetics 
rest upon it. 
For example if the allele frequencies of two alleles among the parents are p and q then 
the predicted genotype frequencies among offspring are p2, 2pq and q2. (See table 
2.3). 
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Genes in parents Genotype in offspring 
Al A2 AlAI AIA2 A2A2 
Expected p q pL 2pq t 
Table 2.3 Represents the predicted frequencies among offspring to calculated Hardy 
Weinberg equilibrium. 
2.13.3 Test of Hardy-Weinberg equilibrium 
If data are available for a locus where all the genotypes are recognisable, the observed 
frequencies of the genotypes can be tested for agreement with a population in Hardy-
Weinberg equilibrium. According to this Hardy-Weinberg law, the genotype 
frequencies of offspring are determined by the allele frequency of the parents. If a 
population is in equilibrium, the allele frequency is the same in the parents and their 
offspring. Therefore, the allele frequency observed in the offspring can be used as if 
it were the parental gene frequency to calculate the genotype frequency expected. 
2.13.4 Hardy-Weinberg Eq uation 
Equation 3 
p2 + q2 + 2pq = 1 
P = observed frequency of the wild type allele 
q = observed frequency of the mutant type allele 
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p2 denotes the anticipated frequency of homozygous wild type individuals and q2 
represents the homozygous mutant individuals in a population where the alleles are in 
equilibrium whilst 2pq is the number of heterozygous subjects. 
2.13.5 Linkage disequilibrium analysis 
Linkage disequilibrium is the phenomenon of non-random assortment of alleles at loci 
which are physically close to each other. A given mutation will arise in a particular 
background of other mutations or polymorphisms, will only become randomly 
distributed in a population as generations pass. 
The closer together in physical terms the two polymorphisms, the less likely that 
crossover will occur between them, and therefore, the longer it will take for linkage 
disequilibrium between two sites to disappear. In practice, most SNPs in close 
approximation (e.g. within a gene) are in at least partial linkage disequilibrium. 
2.13.6 GraphPad Prism 
GraphPad Prism® was used to combine linear regression (curve fitting), analyse 
biostatistics, and produce the scientific graphing. It was felt that this software was 
most appropriate to efficiently assist in the analysis of data, produce high quality 
graphs and organise the experimental data. 
2.14 Suppliers and Solutions 
Molecular biology kits were supplied by Scot-lab Nucleon II and Qiagen for genomic 
DNA extraction from whole blood. Promega Wizard® was used for peR DNA 
purification and Gibco BRL Life Technologies for dsDNA cycle sequencmg. 
Biochemicals were from Sigma, Gibco BRL Life Technologies, and Fisher 
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Pharmaceuticals. DNA manipulation enzymes were from Promega, Roche, and 
Stratagene. Amersham provided hybridisation membranes and radio chemicals. 
Oligonucleotides were supplied by Oswell. Lipid and glucose cartridges and analyser 
were supplied by Cholestech (Bayer). Photographic equipment was from a number of 
suppliers; Film and camera for agarose gel photographs were from Polaroid and 
developer from Kodak. Rapid fixer from Ilford Hypam and X-ray film from Fuji. 
SphygmoCor@, Pulse Wave Analysis System was developed and supplied from 
AtCor Medical and analysis of data by GraphPad@, Prism Inc. version 3.0. 
2.14.1 Materials and Solutions 
Nucleon n DNA extraction kit components 
Reagent A: 
10 Mm TRIS-HCL, 
320 Mm Sucrose, 
5mMMgClz 
1 % Triton X-I 00 
Adjust to pH 8.0 using NaOH 
Reagent B: 
400mM Tris-HCL, pH 8.0 using 40% NaOH 
60mMEDTA 
150mMNaCI 
10/0 SDS 
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2.14.2 Enzymes and ButTers 
T4 Polynucleotide Kinase storage butTer ( Stratagene) 
50mM Tris-HCL, Ph 7.6 
25rnMKCL 
O.lmMEDTA 
1 mMDTT 
O . 1 ~ M A T P P
50% glycerol (v/v) 
T4 Polynucleotide Kinase lOx reaction butTer (Stratagene) 
500mM Tris-HCL, pH 7.5 
70mMMgCh 
10mMDTT 
T4 Polynucleotide Kinase storage butTer (Promega) 
20mM Tris-HCL, pH 7.5 
25mMKCL 
O.lmMEDTA 
2mMDTT 
O . 1 ~ M M ATP 
50% glycerol (v/v) 
T4 Polynucleotide Kinase lOx reaction butTer (Prom ega) 
700mM Tris-HCL, pH 7.6 
50mMMgCh 
50mMDTT 
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Taq DNA Polymerase storage buffer (Promega) 
50mM Tris-HCL, pH 8.0 
100mMNaCI 
O.lmMEDTA 
1mMDTT 
1% Triton X-IOO 
50% glycerol 
Taq DNA Polymerase lOx reaction buffer (Promega Storage buffer A, without 
MgCh 
500mMKCL 
100mM Tris-HCL, pH 9.0 at 25°C 
1 % Triton X-I 00 
2.14.3 General use solutions 
10% AMPS 
19 Ammonium pursulphate 
10mis H20 
6x Agarose gel loading dye 
0.05% bromophenol blue 
0.050/0 xylene cyanol 
40% sucrose 
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O.SM EDTA (pH 8.0) 
186.1g EDTA (disodium ethylenediaminetetra-acetate.2H20) 
dissolve in 800mls H20, adjust to pH 8.0 with NaOH (approx. 20g ofNaOH pellets). 
Autoclave to sterilise. 
Ethidium Bromide (lOmglml) 
1 g ethidium bromide 
lOOmIs H20 
Stir for several hours until dye has dissolved. Wrap container in aluminium foil and 
store at room temperature. 
10% SDS 
109 sodium doecyl sulphate 
lOOml H20 
20X sse 
17S.3g NaCI 
88.2g Sodium Citrate dissolved in 800ml H20 to pH 7.0 using ION solution NaOH 
and make up to 1 litre. Autoclave to sterilize. 
20x SSPE 
17S.3g NaCI 
27.6g NaH2P04--H20 
7.4gEDTA 
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dissolved in 880ml in H20, adjust to pH 7.4 using 1M NaOH and make up to 1 litre. 
Autoclave to sterilize. 
50X TAE 
242g tris base 
57.1ml acetic acid 
100ml O.SM EDTA pH 8.0 make up to 1 litre with distilled H20, autoclaved to 
sterilize. 
5XTBE 
54g tris base 
27.Sg boric acid 20ml O.SM EDTA pH 8.0 make up to 1 litre with distilled H20, 
autoclaved to sterilize. 
Chapter 3 
Demographics of African Trinidadians 
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3.1 Results 
3.1.1 Statistical Analysis 
GrapbPad Prism® (GrapbPad Software Inc., 1999) was used to analyse biostatistics, 
and produce the scientific graphing. All data since summarised using mean and 
standard deviation (+ SD). Comparison was by analysis of variance, with Bonferroni's 
correction for multiple comparisons. 
All the following data is summarised in Tables 3.1, 3.2, 3.3 and 3.4. 
3.1.2 Mean Age and gender of subjects 
The mean age was higher in the hypertensive subjects (HT=53.15 ± 10.47 (n=156)). 
There were fewer hypertensive subj ects than normotensives (NT=43 .41 ± 11. 5 5 
(n=252)). There were a larger proportion of female subjects in both groups, and the 
age ranges were lower in the NT subjects compared with the HT group. 
Figure 3.1 bar charts represent the frequency and mean of NT and HT Mrican 
Trinidadians with varying age ranges measured in years. 
3.1.3 Body Mass Index 
On the basis of mean values for BMI, both NT and HT groups were categorised as 
being 'overweight' (BMI > 25.0 kg m-2). 
In the HT subjects the mean BMI value was 29.2 + SEM 5.5 kg m-2. NT subjects had 
a BMI 27.6 ± SEM 5.2 kg m-2 and in the whole population the mean BMI was 27.6 ± 
SEM 5.2 kg m-2 . The NT subjects had a higher proportion of subjects within the BMl 
ranges of 20 to 30 kg m-2, whereas the HT group had a higher proportion of BMI in 
the 26 to 35 kg m-2 ranges. This suggests that hypertensive African Trinidadians have 
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a higher BMI and this may be a contributing factor to high blood pressure. Figure 3.2 
represent the frequency of NT and HT Mrican Trinidadians with varying body mass 
index ranges. 
3.1.4 Systolic Blood Pressure 
The mean systolic blood pressure (SBP) was higher in the HT subjects (146.0 ± 
21.96) than the NT subjects (l18.2±12.89). The HT group SBP was classified as 
Stage 1 hypertensive, as defined by the Hypertension Society (1999). 
Figure 3.3 shows that in the NT group, SBP was most commonly in the 101-120-
mmHg range (optimal classification SBP :::; 120) followed by 121-140 mmHg range 
(normal to high normal classification SBP :::; 139). Some subjects did present with a 
SBP of higher or equal to 140 mmHg (SBP ~ ~ 140 mmHg) , however were not 
diagnosed as hypertensive as blood pressure readings were based on two or more 
readings taken at one or more visits and after initial screening. There was the 
possibility that some subjects may have been presenting with isolated systolic 
hypertension as defined as SBP of 140 mmHg and a DBP below 90 mmHg. However, 
on the basis of average blood pressure levels, the absence of target organ disease and 
additional risk factors, the subjects were advised to recheck their blood pressure in six 
months to one year in accordance with recommendations for follow up based on 
initial blood pressure readings (Hypertension Society, 1999). 
Figure 3.3 shows a higher frequency of SBP in groups 121-140 and 141-160 mmHg 
ranges. These groups are categorised as stage 1 and 2 of hypertension. The 121-
140mmHg range represents Mrican Trinidadians who were previously diagnosed with 
hypertension and were receiving anti-hypertensive drug therapy. This is shown in 
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Table 3.1. However, despite 82 subjects receiving medication for blood pressure, the 
mean SBP was still classified as hypertensive. 
3.1.5 Diastolic Blood Pressure 
The mean diastolic blood pressure was higher in the HT subjects (89.95 ± 9.69) than 
the NT subjects (73.2+7.87). The HT group was categorised as borderline stage 1 
diastolic hypertensive and the NT category for DBP defined as optimal. 
Figure 3.4 shows the highest frequency of DBP in the 61-80 mmHg range and the 
highest frequency of DBP in the 81-100 mmHg range. Again, 82 subjects had been 
previously diagnosed as hypertensive and were receiving anti-hypertensive 
medication. 
3.1.6 Pulse Pressure 
The mean pulse pressure was lower in the NT subjects (45.0 ± 9.8) than the HT 
subjects (56.0 ± 17.0), with the overall total for the combined groups being 49.3 ± 
14.1. 
However, both groups were within acceptable limits and below 60 mmHg. This 
suggests that isolated systolic blood pressure was not common, despite elderly 
subjects being represented within the cohort. 
Figure 3.5 represents the frequency of normotensive Mrican Trinidadians with 
varying ranges of pulse pressure, and demonstrates that there was a small group with 
pulse pressure that was> 60 mmHg. These may have been subjects may have been 
elderly, indicating reduced vascular compliance in large arteries, or subjects who were 
exceptionally small in height, female and with varying or increased heart rate, and 
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were thus classified as normotensive according to the Hypertensive Society (1999) 
guidelines. 
There is a wider spread of pulse pressure in the hypertensive group. The frequency is 
greater in the 41-60mrnHg range, followed by the 61-80-mmHg range. This shows 
vascular stiffness, despite subjects being treated on anti-hypertensive medication, an 
aspect of which routine blood pressure measurement from conventional brachial 
blood pressure measurements would not disclose. 
Interestingly, pulse pressure was not higher in the NT female group compared to NT 
males which maybe due to the NT females being younger and pre-menopausal. This 
picture is reversed when compared to the HT females who were older and had a 
higher pulse pressure compared to HT males. 
3.1.7 Mean Arterial Pressure 
As expected, the mean arterial pressure was higher in the HT group (108.6 ± 12.6) 
compared to the NT group (88.2 ± 8.7) (Figure 3.6, also see sections 3.1.4 and 3.1.5 
of this chapter. 
3.1.8 Heart Rate 
There was minimal variability between the NT and HT groups, with HT males having 
the highest mean reading, (73.1 + 51.6). There were no significant differences in heart 
rate between groups based on genders or the classification of blood pressure, 
(P > 0.05). Refer to figure 3.7. However, three individuals were on monotherapy of 
beta blockers and nineteen individuals on combined hypertensive therapy with beta 
blockers. 
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3.1.9 Augmentation index 
The mean augmentation index was higher in the HT subjects (144.32 ± 25.0) than the 
NT subjects (128.1+ 21.57). Females in both NT and HT groups had a higher 
augmentation index, in particular the HT females compared to both groups of males. 
This will be due to the HT females being older (54.6 ± 10.16) than any other group in 
this study. 
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Figure 3.3 Frequency of systolic blood pressure of (a) normotensive (n=2S2; 
mean 118.2 ± 12.89) and (b) hypertensive (n=1S6; mean 146.0 ± 21 .96) 
African Trinidadians. 
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Figure 3.4 Frequency of diastolic blood pressure of (a) normotensive (n= 
252; mean 73.2 ± 7.87) and (b) hypertensive (n= 156; mean 89.95 ± 9.69) 
African Trinidadians. 
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Figure 3.5 Frequency of pulse pressure of (a) normotensive (n= 252; mean 
45.0 ± 9.8) and (b) hypertensive (n= 156; mean 56.0 ± 17.0) African 
Trinidadians. 
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Figure 3.6 Frequency of mean arterial pressure of (a) normotensive (n= 252; 
mean 88.2 ± 8.7) and (b) hypertensive (n= 156; mean 108.6 ± 9.69) African 
Trinidadians. 
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Figure 3.7 Frequency of heart rate of (a) normotensive (n= 252; mean 67 .02 
± 9.91) and (b) hypertensive (n= 156; mean 71 .0 ± 34.2) African Trinidadians. 
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Figure 3.8 Frequency of augmentation of (a) normotensive (n=252; mean 
128.1 ± 21 .57) and (b) hypertensive (n=156; mean 144.32 ± 25.0) African 
Trinidadians. 
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3.2 Lipids 
3.2.1 Total Cholesterol 
The mean total cholesterol was higher in the HT subjects (5.29 ± 1.03) compared with 
NT subjects (4.55 ± 1.24). Figure 3.9 shows bar charts of the frequency of NT and HT 
African Trinidadians with varying ranges of total cholesterol. 
3.2.2 Triglycerides 
The mean triglyceride level was higher in the NT subjects (2.01 ± 1.11) compared 
with the HT subjects (1.38 ± 0.73). Figure 3.10 represents bar charts of the frequency 
of NT and HT African Trinidadians with varying ranges oftriglycerides. 
3.2.3 High Density Lipids 
With reference to Figure 3.11 there was no significant differences between the NT 
and HT groups for high-density lipoprotein levels. However, NT male subjects did 
present with a marginally lower level ofHDL (1.06 ± 0.34). See table 3.1 
3.2.4 Low Density Lipids 
The mean low-density lipoprotein was higher in the HT subjects (3.32 ± 0.97) 
compared to the NT subjects (2.82 ± 1.13). Refer to figure 3.12. 
3.2.5 Very Low Density Lipids 
The mean of very low-density lipoprotein was higher in the HT subjects (0.52 ± 029). 
compared to the NT subjects (0.40 ± 0.28). Refer to figure 3.13. 
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3.2.6 High Density Lipid Ratio 
The mean high-density lipoprotein ratio was higher in the HT subjects (4.32 ± 1.28) 
compared to NT subjects (3.84 ± 1.07) See figure 3.14. 
3.2.7 Glucose 
The mean glucose was higher in the HT subjects (4.98 ± 1.55) compared to NT 
subjects (4.55 ± 1.32) See figure 3.15. Interestingly, the male HT group did present 
with the highest mean glucose (5.06 ± 1.97). Refer to table 3.1 
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Figure 3.9 Frequency of total cholesterol of (a) normotensive (n=252; 
mean '4.55±1 .24) and (b) hypertensive (n=156; mean 5.29±1.03) African 
Trinidadians. 
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Figure 3.10 Frequency of triglycerides of (a) normotensive (n=252; mean 2.01 ± 1.11 ) and 
(b) hypertensive (n =156; mean 1.38 ± 0.73) African Trinidadians. 
106 
(a) 
160 
140 
-"-. 120 
-~ ~ 100 
c 
Q) 80 
::l 
C'" 60 Q) 
~ ~
LL 40 
20 
0 
<0.5 0.5-1.0 1.1-1.5 1.6-2.0 2.1-2.5 >2.5 
Range mmol r1 
HDL NT 
(b) 
160 
140 
-
"-. 120 
-~ ~ 100 
c 
Q) 80 
::l 
C'" 60 Q) 
~ ~
LL 40 
20 
0 
<0.5 0.5-1 .0 1.1-1 .5 1.6-2 .0 2.1-2.5 >2.5 
Range mmol 1-1 
HDL HT 
Figure 3.11 Frequency of high density lipoprotein of (a) normotensive (n= 252; 
mean 1.24 ± 0.39) and (b) hypertensive (n= 156; mean 1.31 ± 0.37) African 
Trinidadians. 
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Figure 3.12 Frequency of low density lipoprotein of (a) normotensive (n= 
252; mean 2.82 ± 1.13) and (b) hypertensive (n=156; mean 3.32 ± 0.97) 
African Trinidadians. 
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Figure 3.13 Frequency of very low density lipoprotein of (a) normotensive (n= 252; 
mean 0.40 ± 0.28) and (b) hypertensive (n=156; mean 0.52 ± 0.29) Afr ican 
Trinidadians. 
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Figure 3.14 Frequency of high density lipoprotein ratio of (a) normotensive (n= 252; 
mean 3.84 ± 1.07) and (b) hypertensive (n= 156; mean 4.32 ± 1.28) African 
Trinidadians. 
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Figure 3.15 Frequency of glucose of (a) norrmtensi've (n= 252; rrean 4.55 ± 1.32) and 
(b) hypertensi'..€ (n=156; rrean 4.98 ± 1.55) African Trinidadians. 
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Table 3.1 Results for age and age range, haemodynamic readings from PW A, lipid profiles and genotyping of subjects. 
NORMOTENSIVES HYPERTENSIVES 
Male Female Total Male Female Total Overall P-Anova 
Total 
Subjects 102 150 252 64 92 156 408 (100%) 
Age range years 20-75 20-79 20-79 34-84 25-84 25-84 20-84 
Meanage±SD 44.38 ± 10.86 42.7 ± 11.99 43,41 ±lU5 51.0 ± 10.65 54.6 ± 10.16 53.15 ± 10,47 47.1±12.1 < 0.001 
(years) 
BMI (kg m·2) 26,4 ± 3.97 26.7 ± 5.2 26.6 ± 4.74 28.75 ± 5.0 29.5 ± 5.83 29.5 ± 5.5 27.6 ± 5.2 < 0.001 
SBP (mmHg) 121.2 ± 11.7 116.1 ± 13.32 118.2± 12.89 141.9 ± 25.21 147,4± 19,4 146.0 ± 21.96 128.8 ± 21.6 < 0.001 
DBP(mmHg) 74.1±7.1 72.5 ± 8.35 73.2 ± 7.87 90.5 ± 11.25 89.5 ± 8,48 89.95 ± 9.69 79.6 ± 11.9 < 0.001 
PP (mmHg) 47.1 ± 10.1 43.6 ± 9,4 45.0 ± 9.8 53.5±17.8 57.8 ± 16.3 56.0 ± 17.0 < 0.001 
MAP (mmHg) 89.8 ± 7.5 87.1 ± 9.3 88.2 ± 8.7 108.3 ± 15.0 108.9± 10.7 108.6± 12.6 96.0 ± 14,4 < 0.001 
HR (beats/min) 64.2 ± 9,43 68.9 ± 9.81 67.02± 9.91 73.1 ± 51.6 69.5 ± 11.8 71.0 ± 34.2 68.54±22.6 > 0.05 
AIx (AI) % 120.2± 19.37 133.5 ± 21,41 128.1± 21.57 127.86± 16.35 149.36±26.32 144.32 ± 25.0 132.9 ± 23.7 < 0.001 
Lipids 
Total 4.61 ± 1,47 4.53 ± 1.06 4.55 ± 1.24 5.23 ± 1.02 5.33 ± 1.04 5.29 ± 1.03 4.84± 1.21 < 0.01 
Cholesterol 
mmols'! 
Triglycerides 
mmols'! 
2.17±1.25 1.90 ± 0.99 2.01 ± 1.11 1.34 ± 0.6 1,40 ± 0.81 1.38 ± 0.73 1.77 ± 1.02 > 0.05 
HDLmmols'! 1.06 ± 0.34 1.36 ± 0.37 1.24± 0.39 1.30 ± 0.36 1.32 ± 0.37 1.31 ± 0.37 1.27 ± 0.38 > 0.05 
LDLmmols'! 2.99 ± 1.34 2.70 ± 0.95 2.82 ± 1.13 3.27 ± 0.95 3.36 ± 0.99 3.32 ± 0.97 3.01 ± 1.1 > 0.05 
VLDL mmols"! 0,43 ± 0.27 0.39 ± 0.28 0,40 ± 0.28 0.5 ± 0.23 0.53 ± 0.32 0.52 ± 0.29 0,45 ± 0.28 > 0.05 
HDL Ratio 4.52±3.19 3.38 ± 1.07 3.84 ± 2.25 4.25 ± 1.2 4.38 ± 1.34 4.32 ± 1.28 4.02 ± 1.95 < 0.05 
Glucose mmols'! 4.55 ± 1,48 4.55 ± 1.20 4.55 ± 1.32 5.06 ± 1.79 4.93 ± 1.36 4.98 ± 1.55 4.72 ± 1.43 < 0.01 
Genotype 
Arg 16 24 32 56 16 20 36 92 (22.5%) 
Het 16 53 88 141 30 48 78 219 (53.8%) 
Gly 16 25 30 55 18 24 42 97 (23.8%) 
GIn 27 54 113 167 37 61 98 265 (64%) 
Het 27 43 33 76 23 27 50 126 (30.9%) 
t...> Glu 27 5 4 9 4 4 8 17(4.2%) 
3.3 Subjects Medical History 
3.3.1 Smokers 
Table 3.2, shows the number of smokers in the NT and HT groups. Referring to table 
3.4 there were more male smokers in the NT group (n=18) with only one NT female 
smoker. In the HT groups, male smokers were less prominent (n=7) and only one HT 
female smoker. Overall, male smokers (n=25), represented the highest number of 
smokers from both groups and the overall percentage total from all groups was only 
6.6% (n=27). 
Table 3.2 Representation of smokers and non-smokers in African Trinidadians 
Smokers Non Smokers 
Normotensives (NT) n= 19 (7.5%) n=233 (92.5%) 
Hypertensives (BT) n= 8 (5.1%) n= 148 (94.9%) 
3.3.2 Personal Medical History 
A personal medical history was taken from all subjects and this mainly focussed on 
cardiovascular disease. NT subjects reported no episodes of cardiovascular events, 
with only n=15 subjects reporting being treated for hypercholesterolaemia. This was 
or was being achieved through drug therapy or non-pharmacological intervention by 
the reduction of saturated fats in their diet. Of the hypertensives, 27 subjects had or 
were being treated for high plasma lipids. This overall was 10.3% (n=42) of the total 
population studied. 
Hypertensives had reported being diagnosed with angina 1.7% (n=7), stroke 0.98% 
(n=4), myocardial infarction 0.49% (n=2), and renal disease (unspecified) 0.49% 
(n=2). Although numbers were small, and these conditions only appeared in the 
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hypertensive group, some members of both groups gave a family history of their 
condition. (See table 3.4). 
3.3.3 Medication 
Table 3.3 shows the anti hypertensive medication used for the treatment of 
hypertension. This refers solely to the HT group. 
In the HT group 52.6% (n=82) were taking regular drug therapy for hypertensioR 
females being more compliant than males. The most popular monotherapy was 
thiazides followed by calcium channel blockers. Few subjects were on combined 
therapy, which may have been due to cost rather than therapeutic value to control of 
blood pressure. The remaining 47.4% (n=74) were not taking any anti-hypertensive 
drug therapy, however some of these subjects would have been newly diagnosed and 
would not previously have known they had hypertension. 
Drug therapy other than anti-hypertensives taken by both groups varied but had no 
impact on blood pressure. No subjects were entered into the study with other 
significant acute or chronic illnesses. 
3.3.4 Education 
Subjects in both NT and HT groups (n=202(49%)) had completed secondary 
education and 141 subjects from both groups (34.5%)) had completed university or 
higher education study (Refer to table 3.4). 
ll-l 
Table 3.3 Anti-Hypertensive Drugs used to control high blood pressure in the study 
population. 
Anti-Hypertensive Examples of drugs n= Hypertensives on Percentage (%) of all 
monotherapy used for commonly used this type of hypertensives n=156 
hypertensive African medication 
Trinidadians 
Thiazides & Bendroflurazide; n=34 2l.8% 
Loop Diuretics Indapamide; 
Brenadine; Amiloride; 
Frusemide 
Calcium Channel Nifedipine; Diltizem n= 15 9.6% 
Blockers 
Angiotensin converting Enalapril; Lisinopril n=9 5.8% 
enzymes inhibitors 
(ACE) 
Beta Blockers & Non Atenolol; Metapropolol n=3 l.9% 
Beta Blocker 
Sympatholytics 
Obeah (Herbal Teas) Unknown combination n=2 1.3% 
Combined anti- Combination of either n=19 12.2% 
hypertensive therapy Thiazides; ACE; 
CaCBs; Beta Blockers. 
No medication Either newly diagnosed n=74 47.4% 
or non-pharmalogically 
controlled. 
3.3.5 Family History 
61.2% (n=250) gave a family history of hypertension and 41.9% (n=171) gave a 
family history of diabetes. 27.2% (n=lll) gave a family history of morbidity and/or 
mortality from stroke. 
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Table 3.4 Data representing smoking, personal medical history, educational 
background and family medical history. 
NORMOTENSIVES HYPERTENSIVES 
Personal Medical HistoIT Male Female Total Male Female Total Overall Total 
(%) 
Smokers 18 1 19 7 1 8 27 (6.6%) 
Hypertensive 0 0 0 64 92 156 156 (38.2%) 
Diabetic 0 0 0 0 0 0 0(0%) 
Hypercholesterolaemia 7 8 15 14 13 27 42 (10.3%) 
Angina 0 0 0 2 5 7 7 (1.7%) 
Stroke 0 0 0 3 1 4 4 (0.98%) 
Myocardial infarction 0 0 0 0 2 2 2 (0.49%) 
Cardiac Failure 0 0 0 0 0 0 0(0%) 
Renal Disease 0 0 0 0 2 2 2 (0.49%) 
Medication 
Anti-Hypertensive 0 0 0 27 55 82 82 (20%) 
Other than anti- 13 37 50 13 18 31 81 (19.8%) 
hypertensi ves. 
Education o[subtects 
Primary 19 13 32 10 23 33 65 (15.9%) 
Secondary 51 75 126 31 45 76 202 (49.5%) 
Tertiary 32 62 94 23 24 47 141 (34.5%) 
Family" HistoIT (jncludes 
immediate ramily) 
Hypertension 41 97 138 41 71 112 250 (61.2%) 
Diabetes 40 75 115 26 30 56 171 (41.9%) 
Hypercholesterolaemia 10 23 33 6 8 14 47 (11.5%) 
Angina 8 15 23 5 7 12 35 (8.5%) 
Stroke 24 37 61 22 28 50 111 (27.2%) 
Myocardial Infarction 13 23 36 9 14 23 59 (14.4%) 
Cardiac Failure 7 10 17 7 11 18 35 (8.57%) 
Renal Disease 3 14 17 4 7 11 28 (6.86%) 
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3.4 Discussion 
3.4.1 Age and Augmentation index 
Arterial compliance differences are usually observed in ethnic groups following 
adolescence (Gillum, 1979; Kaplan, 1998). Therefore, the target population was adult. 
However, there are no known studies that have investigated the augmentation of an 
African Caribbean population using the technique of pulse wave analysis. Many 
studies have described their results using augmentation as a marker for arterial 
stiffness and its diagnostic application, which have been previously described in 
chapter 1. 
As age advances, vascular changes, both structural and functional occur. Blood 
pressure increases with diminishing arterial compliance due to the arterial walls and 
elastic fibres becoming hardened and fatigued, affecting endothelial function (Black et 
aI, 1999). The absolute value of augmentation depends upon age, sex, height and a 
number of other variables (Cockcroft et aI, 1997; Cameron et aI, 1998). 
Augmentation will double over a 50-60 years period (Black et aI, 1999) as will arterial 
stiffness. 
These variables are taken into account and are clearly reflected in the results obtained. 
However, it should be noted that there is a mismatch in the NT and HT groups with 
the mean age for HT being significantly higher than the NT group. Age has been 
proven to be an independent variable of augmentation (Benetos et aI, 1997; Kelly et 
aI, 1989) and further analysis by linear and multiple regression (in chapters 5 and 6) 
determines whether variables of cholesterol, sex, BMI are independent or dependent 
of augmentation. 
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3.4.2 Body Mass Index and Diet 
A typical Trinidadian diet is not to dissimilar to Creole, utilising the technique of 
caramelising meats and vegetables, well seasoned with hot spices and often cooked in 
copious amounts of coconut milk. This African style cuisine could have a complex 
effect on blood pressure and arterial compliance. A strong association with elevated 
blood pressure is increased body mass index with obesity increasing cardiac output 
with impaired peripheral vasodilatation. This was apparent in the smokers described 
in this chapter with hypertensives having a higher BMI 29.2 ± 5.5 (SEM) to that of 
the normotensive group 26.6 + 4.74 (SEM). 
This association between hypertension and obesity has been well documented in 
numerous clinical and epidemiological studies. Data from the Framingham study 
(Kannel et aI, 1967) showed that subjects who were overweight at the start of the 
study later developed hypertension more often than subjects who were not 
overweight, (Kannel et aI, 1969). Central obesity is much more strongly linked to 
hypertension, diabetes, and cardiovascular disease than peripheral fat distribution, 
with black Africans (Blair et aI, 1989), and may explain the low levels of high density 
lipoprotein (HDL) levels among blacks of both sexes compared with whites (Haigh et 
aI, 1983). Indeed, a significant inverse correlation of body mass index and high-
density lipoprotein cholesterol was noted in a random sample of low socio-economic 
status black women in Baltimore (Haigh et aI, 1983). 
Insulin resistance is strongly linked to body fat distribution, and this may in part 
explain the increasing prevalence of Type II diabetes as well as essential hypertension 
in black populations. Hyperinsulinemia may contribute to hypertension via activation 
of the sympathetic nervous system and renal salt retention (Sowers et aI, 1991) and 
insulin resistance appears in young black men with borderline hypertension (Falkner 
118 
et aI, 1990). Such observations emphasise the importance of insulin resistance in the 
pathogenesis of hypertension in black individuals. 
With this in mind, all subjects were screened for diabetes, with a fasting glucose as 
well as lipid profile. Dependent on the subjects' results, health education was offered 
and further investigation into the subjects' dietary intake was examined. Interestingly, 
subjects reported a high intake of saturated fatty acids, sugar and sodium intake, with 
minimal exercise. This composed of large quantities of fried chicken, heavily spiced 
foodstuffs and a high intake of sugar and salted assorted nuts (a popular and abundant 
available snack, with a strong cultural belief that they have aphrodisiac properties for 
men). Sweet alcoholic beverages such as rum and alcoholic lager are widely available 
locally, as they are distilled and produced very cheaply, and some male subjects 
reported to drink these products in large quantities. However, no newly diagnosed 
diabetics were identified when attending the clinic in this study. 
This propensity for salt and the desire to add to food is still apparent despite long 
documentary evidence of salt sensitivity in black Africans and their descendants. 
(Fray and Douglas, 1993). Similarly, there is a greater desire for intense sweet tastes 
which maybe a factor in the elevated incidence of obesity and diabetes in Mrican 
blacks (Shiffman et aI, 2000). However, total cholesterol and glucose, in both groups 
were within normal range despite the elevated BMI. 
African Caribbean's have a higher prevalence of hypertension at every level of BMI 
compared to Caucasians, which suggests that ethnic differences hold some strength in 
the association between BMI and hypertension (Schiffman et aI, 2000). Interest in 
ethnicity-specific definitions of obesity has been hindered by the of lack of data 
whether or not obesity-related co morbid conditions occur at different levels of body 
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mass index (BMI) in different ethnic groups (Bell et aI, 2000). This could warrant 
further investigation to identify individuals at risk from obesity. 
3.4.3 Blood Pressure, Pulse pressure and Heart rate 
Raised blood pressure has been long recorded as an early onset in African Caribbean's 
(Fray and Douglas 1993). The classification of blood pressure was overall optimal in 
the NT group and Stage 1 classification of hypertension in the HT group. The most 
significant independent variable affecting blood pressure for the NT group was age. 
The true levels of blood pressure in the HT may have been underestimated due to 
52.5% (n=82) of the subjects being on anti-hypertensive medication. Had a 'washout' 
period been possible on these subjects then the blood pressure readings may have 
been different. The findings are consistent with previous studies (Lui et aI, 1989; 
Lackland et ai, 1992; Chatvurdi et ai, 1993; Burt et a11995; Cappuccio et al, 1997). 
Pulse pressure was significantly different between the NT and HT subjects. Again, 
age was the most obvious independent variable to influence results. Interestingly, 
pulse pressure was raised with increasing augmentation and blood pressure, but this 
was not reflected with heart rate (> 0.05) in particular in the HT subjects. Increased 
pulse pressure in blacks is consistent with previous findings (Lui et aI, 1989; 
Chatvurdi et ai, 1993; Burt et al 1995). An increasing PP and SBP does reflect arterial 
stiffening, and age is strongly correlated to pulse pressure. 
Despite there being little significant difference in HR between the NT and HT groups, 
it is known that a resting heart rate is a potential independent risk factor for morbidity 
and mortality both cardiovascular and from non cardiovascular disease, and there is a 
strong association between elevated heart rate, influence on augmentation and sudden 
death (Sa Chuna et al, 1997). Young black adults have been found to have lower 
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heart rates than whites, with differences disappearing in middle age (Lui et ai, 1989). 
Interestingly, this is not reflected in this study, which HR is only marginally raised in 
the HT subjects compared with the NT subjects. This maybe due to biasing factors, in 
particular that approximately half of the HT cohort was being treated on anti-
hypertensive medication in particular those subjects taking beta blockers which will 
slow heart rate, thus reduce arterial stiffening and aid arterial sensitivity. 
3.4.4 Lipids and glucose 
Racial differences rather than nutritional trends have explained why serum lipids, 
excluding high-density lipoprotein (HDL) have been lower in blacks than Caucasians 
(Mazzarolo-Cruz et aI, 1994; Zoratti, 1998). The findings from this study are in 
keeping with previous observations, with lipid results being within acceptable levels 
despite a reported high intake of saturated fats, which may reflect genetic rather than 
dietary factors (Cappuccio et aI, 1997; Khattar et aI, 2000). 
Previous literature shows that male blacks have lower rates of cardiovascular disease 
than male Caucasians, despite having higher prevalence of hypertension, cigarette and 
alcohol consumption and diabetes (Kaplan, 1998). No significant differences have 
been detected in females (Zoratti, 1998). Research suggests (Poulter, 1987; Vorster et 
aI, 1987), a low level of oxidised stress protects against the development of 
cardiovascular disease despite a higher propensity to hypertensive illness. 
Interestingly, serum lipids and apolipoproteins, total and fractionated bile excretion 
and gallbladder motility have been evaluated with large intake of mineral water with 
high sodium content (Capurso et aI, 1999). The reduction in serum and LDL 
cholesterol levels observed during active treatment ran parallel to increased excretion 
of bile acids in the stools. This suggests that salt rich water reduces serum and LDL 
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cholesterol levels through a mechanism of increased excretion of faecal bile acid 
sterols. This would be consistent with the reported high intake of salt rich products 
that subjects desired to consume in this study. 
Thus, blacks, may have lower levels of serum and LDL cholesterol due to the high 
levels of circulatory sodium, and the use of thiazides in the treatment of hypertension 
in this group might raise the total and LDL cholesterol, due to salt eradication. 
3.4.5 Smoking 
Cigarette smoking diminishes arterial compliance by impairing endothelium-
dependent dilatation and predisposes to atherosclerosis (Celermajer et aI, 1996). 
Those who have or continue to smoke have been found to have poor arterial 
compliance than non-smokers. 
Measurement of tobacco intake was complex and difficult to acquire, as few subjects 
reported to smoke, despite cigarettes and tobacco products being available cheaply 
and widely. This was due to more females attending the clinic who considered 
cigarette smoking as undesirable in terms of gender image and were more aware that 
smoking has a detrimental effect to health. This study has reported lower smoking 
levels among African Trinidadians, however when compared to national data in other 
commonwealth areas this is the reverse and higher levels are recorded (Chatvurdi et 
aI, 1993; Cappuccio et aI, 1997; Acheson, 1998; Khattar, 2000). 
3.4.6 Medication 
Unlike the treatment of acute diseases, where the effect of therapy is known within a 
short time, treating hypertension entails a substantial investment of money, time and 
risk of medication side-effects for a potential benefit that may not become evident 
until some time later. African Trinidadians with hypertension are at greater risk of 
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complications, including mortality, and thus revlewmg the efficacy of vanous 
therapies in lowering blood pressure and their success in preventing the complications 
of CVD is wise. 
Due to cost of medication being a factor when treating a patient with limited financial 
resources, a major concern would be that cost is over-emphasised, minimising 
potential hazards. However, there is extensive marketing of newer, more expensive 
antihypertensives, which may exaggerate the side effects of popular inexpensive 
antihypertensives. Whilst clinical practitioners' overriding concern is to provide for 
the best therapy regardless of cost, to ignore cost would be particularly naIve in 
populations such as African Trinidadians where financial resources for drug therapy 
are limited. Subjects in both groups reported concerns over cost of medication, not 
surprisingly, those who were in a lower economic level, the greater the concern cost 
became and reluctance to take any drug therapy for disease processes. Also, 
compliance of drug therapy became an issue, as the more expensive drug therapy the 
less likely subjects would be compliant in taking medication (Schulman et aI, 1986). 
Not all this group were on monotherapy, but this figure supports the literature that 
over half can be controlled on monotherapy in spite of racial or ethnic resistance 
(Saunders et aI, 1990; Wright et aI, 1991). 
Other than anti-hypertensive therapy, some subjects from both groups took other 
forms of medication. This was either complimentary to their anti-hypertensive 
medication such as aspirin, or medication for minor ailments that did not exclude the 
subject from the study. 
123 
3.4.7 Hormonal therapy 
Arterial compliance diminishes quickly in women following menopause (Bulpitt et aI, 
1999). However, with hormone replacement therapy (HRT) this has provided a 
continuing protective measure, preventing acceleration of stiffening of vessels, not 
unlike that prior to menopause (Rajkumar et aI, 1997). Only 3 female subjects were 
taking HR T, and were not excluded from the study, as females who were pre or 
postmenopausal, the same age and not taking HR T were included. This would have 
little significant impact on the data collected. 
3.4.8 Herbal Medicine 
Traditional herbal medicine IS one of the most widely practised aspects of the 
traditional Mrican belief system known, as 'obeah' is herbal medicine. Trinidadians 
make use of herbal medicines, and most know the uses of the common plants, barks, 
roots and herbs that make up the material medica of what is called 'Bush '. 
Concoctions are usually brewed into a tea and drunk or infused into the skin through 
'bush bathing '. 
Elements of these traditions remain strong in Trinidadian attitudes towards health, 
with blood pressure a custom of cooling and purging are used to lower, purify and 
cleanse the circulating blood in the system. This is achieved by using 'cooling herbs " 
such as wild senna, mauby or pawpaw bark. The 'purging' is induced by the ingesting 
aloes or castor oil. There are no data or verification that such potions are effective or 
conclusive with their application. However, due to the poor public health system, this 
type of medicine is the only the option for treatment for some Trinidadians. No 
subjects who participated in the study took 'obeah' solely for their ailments, this 
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includes essential hypertension. It was as a complimentary medication, sometimes 
alongside conventional drug therapy. 
There is no comparison data on alternative medication in the treatment of 
hypertension to suggest they are effective in the treatment of hypertension in African 
Trinidadians. 
3.4.9 Education and socio-economic status 
Disease patterns are frequently confounded by socio-economic differences especiall y 
when related to ethnicity (Bhopal, 1997). Socio-economic status examines the 
underlying causes or risk factors that relate to health. With hypertension, smoking, 
excessive alcohol, obesity, physical inactivity, physical (isometric) and psychological 
stress, high sodium and low potassium and calcium intake will affect arterial 
compliance. 
As shown in Table 3.4, information on education of subjects was acquired at 
interview to assist in the classification of occupations into social classes and whether 
social inequalities existed due to education and demographic position. However, 
despite its power in revealing social disparity the basis for clarifying occupations into 
social classes has been criticised for lacking explanatory power (Chandola, 2000). 
Therefore, by measuring the level of education that was obtained by the subjects and 
employment gained, this gave a greater indication of the principles of structure of a 
modern society, which is viewed as being more stable and generic (Rose and Prevalin, 
2000). This classification was based on the National Statistics of Socio-Economic 
Classification (NS-SEC) (Chandola, 2000), which has been previously applied to 
occupational work samples and can measure social classification through occupational 
position and educational background. It was aimed at uncovering whether subjects 
who had gained a higher level of education were more aware of the impact and 
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consequences of essential hypertension. There has been a significant inverse 
association between relative weight, hypertension, and duration of formal education 
as previously reported (Hypertension Detection and follow-up Program Co-operative 
Group, 1977). In the United States, a disproportionate number of blacks have limited 
education and financial resources (Task Force, 1986). Among black African women, 
the presence of obesity clearly varies inversely with socio-economic status (Rimm et 
aI, 1974; Gam et aI, 1977; Oken et aI, 1977). However, most subjects expressed 
concern of family medical history of CVD and sought participation as a result. This is 
shown by the data obtained, with 61.2% (n=2S0) of the total population studied 
having a family history of hypertension, 41.9% (n=171) diabetes, and 27.2% (n=111) 
stroke, which may have been more reflective of why subjects accessed the 
cardiovascular risk assessment clinic. 
3.4.10 Exercise 
Data suggested that exercise among African Trinidadians was not a strong feature and 
undertaken infrequently and sporadically. This is consistent with data found with 
other ethnic groups (Acheson, 1998). 
Most subjects reported that strenuous exercise could be physically draining due to the 
tropical climate of heat and humidity. Most public and private dwellings do not have 
sophisticated air conditioning due to expensive installation and maintenance. 
Therefore, daily life has to be conducted at a slower pace to compensate for heat 
exhaustion. Most subjects did little exercise due to the climate and that public 
transport is accessible, reducing physical walking. Trinidad's bus and taxi system is 
effective and operates cheaply due to the island's petroleum production, keeping oil 
prices low. 
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3.4.11 Family history 
Having a family history of cardiovascular disease (CVD) may increase the risk of 
arterial stiffness. Several studies have shown lower blood cholesterol levels in African 
Caribbean's, that appear to reflect an inherited cause of essential hypertension rather 
than purely dietary factors or environmental factors, (Cappuccio et aI, 1997; Khattar 
et aI, 2000). During interview with subjects, they were asked what mode of referral 
brought them to the cardiovascular risk assessment clinic. Most subjects expressed 
that they had an immediate family member who had or has a history of vascular 
disease. This suggests that African Trinidadians have a strong awareness of their 
mortality and propensity to hypertension, stroke and diabetes. Interestingly, subjects 
who were from a poorer socio-economic background travelled the furthest to access 
the clinic and due to family history were acutely aware of the detrimental impact that 
coronary heart disease (CHD) and hypertension could have emotionally and 
financially on not only themselves but their families. 
Self-referral was mainly evident with hypertensive subjects expressing further insight 
into the nature of their disease and if hereditary factors had played a significant part in 
the development of hypertension. 
As both groups had a strong immediate family history of hypertension, CHD, and 
stroke this may be a likely reason why subjects attended and volunteered for the 
research study. Since this applies to both groups, data collected are unlikely to affect 
comparison. 
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3.5 Summary 
.:. Blood pressure may be influenced by the African Trinidadian's environment 
and socio-economic and cultural factors . 
• :. Age is an independent variable that affects arterial stiffness In Mrican 
Trinidadians . 
• :. Heart rate does not appear to contribute to aortic stiffening, despite raised 
systolic and diastolic pressures . 
• :. Genetic factors may playa role, for example, in the degree of obesity or renal 
insufficiency and sodium handling and lipid levels. 
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Chapter 4 
Allele Frequencies of codon 16 and 27 ~ 2 2
Adrenoceptor Polymorphisms and Genetic 
Association Data 
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4.1 Introduction and Genetics Results 
4.1.1 P2-Adrenoceptor 
The Bradrenergic receptor gene ( ~ 2 - A R ) ) is a major target for the treatment of 
pulmonary disease. In addition, the ~ 2 - A R R are important in the regulation of vascular 
tone (Johnson, 1999). The aim of the study described in this chapter was to determine 
whether genetic variation in the human ~ 2 2 AR might contribute to altered vascular 
reactivity. 
The B2-AR is situated on the endothelial cell, and when stimulated alters the vascular 
tone with the release of nitric oxide (NO). There is evidence that the beta-adrenergic 
receptors are down regulated in white hypertensives, whilst blacks possess a higher 
beta-receptor density (Lifton, 1996). A number of studies have also studied the 
possibility that polymorphism in the ~ 2 - A R R may contribute to the development of 
hypertension (Jindra et ai, 2002; Tomaszewski et ai, 2002; Meirhaeghe et al, 2001; 
Kato et aI, 2001; Xie et ai, 2000; Candy et aI2000). 
The gene encoding the J32-adrenoceptor contains nine single nucleotide polymorphism 
(SNP) (Reihaus et ai, 1993). Five of these SNPs are degenerate and are not thought to 
cause a detrimental effect on the adrenoceptor, as the amino acid sequence remains 
unaltered from the wild type receptor. However, the remaining four SNPs do cause 
amino acid changes within the receptor. The work described in this chapter 
concentrates on the two common coding region polymorphisms, where SNPs at 46 
(A-G) and 79 (C-G) cause amino acid changes from arginine 16 to glycine 
( A r g I 6 ~ G l y ) ) and glutamine 27 to glutamate ( G l n 2 7 ~ G l u ) . .
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The specific aim of the work presented in this chapter were: 
i) To determine allele frequencies for the polymorphisms A r g 1 6 ~ G l y y and 
Gln27--)Glu in normotensive and hypertensive African Trinidadians. 
ii) To determine the extent of linkage disequilibrium between these 
polymorphism in this population. 
iii) To examine for association between these polymorphisms and (a) 
hypertension and (b) markers of vascular reactivity in these populations. 
4.2 Results 
4.2.1 Genotype Distribution 
An initial analysis was performed on the combined data set of normotensive and 
hypertensives subjects in order to define the allele frequency of the f32-adrenoceptor 
polymorphisms in the African Trinidadian population. This is shown in table 4.1. 
Table 4.1 Allele Frequencies for polymorphisms of G l n 2 7 ~ G l u , , and A r g 1 6 ~ G l y y in 
normotensive and hypertensive African -Trinidadians, represented in percentages and 
then in decimal fractions. 
Polymorphism Normotensives Hypertensives Total 
Population 
GIn 27 frequency 81.3% (0.81) 78.8% (0.788) 80.4% (0.8) 
Glu 27 frequency 18.7% J9.19) 21.1% (0.211) 19.6% (0.2) 
A r ~ ~ 16 frequency 50.1% (0.501) 48% (0.4801 49% {0.49) 
Gly 16 frequency 49.8% (0.498) 52% (0.520) 510/0 (0.51) 
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Table 4.2 shows the distribution of genotypes within the subjects studied. 
Table 4.2 Distribution of Gln27 ~ G l u u and Arg 1 6 ~ G l y y genotypes in normotensive 
and hypertensive African-Trinidadians. 
Genotype Normotensive Hypertensive 
Homozygous GIn 27 167(66.3%)- 98(62.80/0) 
Heterozygous Gin/GIu 27 76(30.2%) 50(32.0%) 
Homozygous Giu 27 9(3.6%) 8 (5.1%) 
Homozygous Arg 16 56(22.2%) 36(23.0%) 
Heterozygous ArglGIy 16 141(55.9%) 78(50.0%) 
Homozygous Gly 16 55(21.8%) 42(26.90/0) 
Numbers of individuals are shown, followed by percentages in brackets. 
There was no significant difference in either allele or the genotype distribution in the 
NT or HT groups for either the codon 16 or 27 polymorphism in the African 
Trinidadian population for either G I n 2 7 ~ G l u u and A r g 1 6 ~ G l y y (p> 0.05). 
4.2.2 Hardy-Weinberg equilibrium analysis 
The Hardy-Weinberg test is used to check that the observed genotype frequencies do 
not deviate from those expected allele frequencies seen in the population. Such 
deviation can occur due to population heterogeneity, error in genotyping, or when one 
allele confers a survival advantage. 
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Expected genotype frequencies were calculated from the observed allele frequencies 
using the Hardy-Weinberg equation. 
I.e. 
Equation 4 
p= observed frequency of the wild type allele. 
q= observed frequency of the mutant allele. 
As there was no significant difference in genotype distribution between the two 
groups, the combined data from the normotensive and hypertensive population were 
used to test for Hardy-Weinberg equilibrium. 
The predicted number of individuals of each genotype can be calculated from the 
allele frequencies observed and compared with the observed genotype frequencies. 
The data are shown in Tables 4.3 and 4.4. 
Tables 4.3 and 4.4 describe the expected and observed frequencies of genotypes 
using the Hardy Weinberg equation. 
Table 4.3 Comparison between observed frequencies of genotypes for the 
G I n 2 7 ~ G l u u locus using the Hardy -Weinberg equation. 
Genotype Allele Expected Observed (O-E/ 
Frequency E 
Gin 27 (p2) 0.64 261.1 265 0.06 
10.8 2) 
Het 27 (2pq) 0.32 130.6 126 0.1 
~ 0 . 8 8 x 0.2) 
Glu 27 (q2) 0.04 16.3 17 0.03 
.,{0.22) 
Total 1 408 408 0.19 
G l n 2 7 ~ G l u u 27 Hardy-Weinberg 
0.82+ 0.22 + 2(0.8 x 0.2) =1 X2 (ldf) = 0.19 P= > 0.05 
I " .' '\ 
Table 4.4 Comparison between observed frequencies of genotypes for the 
Arg164Gly locus using Hardy -Weinberg equation. 
Genotype Allele Expected Observed (O-EY 
Frequency E 
Arg 16 0.24 98 92 0.36 
( 0.49)2 
Het 16 (2pq) 0.5 204 219 1.1 
2(0.49 x 0.51) 
Gly 16 0.26 106 97 0.76 
(0.51 )2 
Total 1 408 408 2.22 
Arg 16-4Gly16 Hardy Weinberg 
0.492 + 0.512+ 2(0.49 x 0.51) = 1 X2 (ldf.) = 2.22 p= > 0.05 
There were no significant differences between the observed and expected values for 
either polymorphism, therefore the population was shown to be in Hardy-Weinberg 
equilibrium with respect to polymorphisms at codon ArgiGly 16 and GlnlGlu27 
4.2.3 Linkage disequilibrium 
In order to examine potential linkage disequilibrium between two polymorphisms, 
(which has been previously described in Caucasian populations, Dewar et aI, 1997), 
haplotypes were constricted where possible. Whilst it is possible to estimate 
haplotypes for double heterozygotes using the Estimated Haplotype Frequency 
(EH program) (Terwillinger and Ott 1992 and 1994) in practice this does not provide 
a marked increase in information in a large data set. 
The distribution of the haplotypes in the normotensive and hypertensive groups was 
estimated using the data shown in Tables 4.5, 4.6 and 4.7. 
Table 4.5 Genotyped Normotensives at both loci (NT, n=252). 
ArglArg Het Gly/Gly 
Gin/Gin 49 96 22 
Het 4 45 27 
Glu/Glu 1 3 5 
Total 252 
Table 4.6 Genotyped Hypertensives at both loci (HT, n=156). 
Arg/Arg Het Gly/Gly 
Gin/Gin 33 42 23 
Het 3 31 16 
Glu/Glu 0 4 4 
Total 156 
Table 4.7 Results for each pair of loci in the combined NT and HT groups. 
16 
27 Arg/Arg Arg/Gly Gly/Gly 
Gin/Gin 82 138 45 
Gln/Glu 7 76 43 
Glu/Glu 1 7 9 
Total 408 
This data was then used to calculate haplotype frequencies in the total population 
represented in Table 4.8. 
Table 4.8 Represents the number of haplotypes for each pair of loci in combined NT 
and HT groups, ignoring double heterozygotes. 
Arg/Gln = (82 x 2) + 138 + 7 = 309 
Arg/Glu = 7 + (lx 2) + 7 = 16 
Gly/Gln = 138 + (45 x 2) + 43 = 271 
Gly/Glu = 7 + (9 x 2) + 43 = 68 
It can be seen that a great number of individuals' predominantly carry the Gly/Glu 
haplotype than the Arg/Glu haplotype (and similarly the Arg/GIn is greater than 
Gly/Gln) indicating the presence of linkage disequilibrium. 
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Data taken from table 4.8 can be expressed as in table 4.9 to show haplotype numbers 
and frequencies. Double heterozygotes have been omitted. 
Table 4.9 Haplotype numbers and the frequencies determined using the data in 
Table 4.8 for Levin's 8 calculation. Double heterozygotes have been omitted. 
16 v 27 
Arg 16 Gly 16 
GIn 27 309/0.47 27110.41 
GIn 27 16/0.02 68/0.10 
4.2.4 Genotypic data for analysis 
Linkage disequilibrium analysis was performed on 408 individuals. Table 4.7 shows 
the distribution of genotypes for each codon. Table 4.9 shows the frequencies of 
haplotypes without double heterozygotes using Levin's 8 calculation of linkage 
disequilibrium. 
4.3 Genetic Association Data 
4.3.1 Statistical Analysis 
GraphPad Prism® (GrapbPad Software Inc., 1999) was used to combine analyse 
biostatistics, and produce the scientific graphing. All data are summarised in tables 
4.10 and 4.11, with means and standard deviations (SD ±) correlated to genotype. 
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4.4 Results 
4.4.1 Genotype vs. Age 
There is no significant difference between genotype groups when assessed by age. 
However, the GluiGlu, homozygotes in codon 27 show the youngest mean age in the 
NT group and the oldest mean age in the HT group. Refer to figure 4.1 
4.4.2 Genotype vs. BMI 
There is no significant difference between genotype groups when assessed by BMI in 
either the NT or HT groups. The NT and HT groups were classified as being 
, overweight'. Refer to figure 4.2 
4.4.3 Genotype vs. SBP 
There was no significant difference between genotype groups when assessed by SBP 
in the NT group. However, the Arg! Arg homozygotes in codon 16 of the HT group 
did have the lowest SBP with differences of4.1-7.3 mmHg and the mutant genotype 
ofGly/Gly homozygotes in codon 16 show the highest SBP in the HT group. Refer to 
figure 4.3 
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4.4.4 Genotype vs. DBP 
There was no significant difference between genotype groups when assessed by DBP 
in either the NT or HT groups. The NT group had the highest DBP (75.0 ± 8.1) in the 
Giu/GIu homozygote group in codon 27 and the HT group had the highest DBP (92.1 
± 9.7) in the Gly/Gly homozygote group in codon 16. Refer to figure 4.4 
4.4.5 Genotype vs. PP 
There was no significant difference between genotype groups when assessed by PP in 
the NT and HT groups. As expected the PP was higher in the HT group, due to the 
population in this group being older. Refer to figure 4.5 
4.4.6 Genotype vs. MAP 
There was no significant difference between genotype groups when assessed by MAP 
in the NT and HT groups. The HT group had the highest MAP (Ill. 1 ± 13.5) in the 
Gly/Gly homozygote group in codon 16. Refer to figure 4.6 
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4.4.7 Genotype vs. HR 
There was no significant difference between genotype groups when assessed by HR in 
the NT and HT groups. This also applied to HR comparison between the NT and HT 
groups. Refer to figure 4.7 
4.4.8 Genotype vs. Alx 
There was no significant difference between genotype groups when assessed by AIx 
in the NT and HT groups. As expected the AIx was higher in the HT group. Refer to 
Figure 4.8 
4.4.9 Genotype vs. Total Cholesterol 
There was no significant difference between genotype groups when assessed by total 
cholesterol in the NT and HT groups. However, the HT group did have higher means 
in all genotypes compared to the NT group. Refer to figure 4.9 
4.4.10 Genotype vs. Triglycerides 
There was no significant difference between genotype groups when assessed by 
triglycerides in the NT and HT groups. Refer to Figure 4.10 
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4.4.11 Genotype vs. HDL 
There was no significant difference between genotype groups when assessed by HDL 
in the NT and HT groups. Refer to Figure 4.11 
4.4.12 Genotype vs. LDL 
There was no significant difference between genotype groups when assessed by LDL 
in the NT and HT groups. However, the HT group did express higher LDL levels in 
all genotype groups compared to the NT group. Refer to Figure 4.12 
4.4.13 Genotype vs. VLDL 
There was no significant difference between genotype groups when assessed by 
VLDL in the NT and HT groups. However, the HT group did express higher VLDL 
levels in all genotype groups compared to the NT group. Refer to Figure 4.13 
4.4.14 Genotype vs. HDL Ratio 
There was no significant difference between genotype groups when assessed by HDL 
ratio in the NT and HT groups. However, the HT group did express higher HDL ratio 
levels in all genotype groups compared to the NT group. Refer to Figure 4.14 
4.4.15 Genotype vs. Glucose 
There was no significant difference between genotype groups when assessed by 
glucose in the NT and HT groups. Refer to Figure 4.15 
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Table 4.10 Genotype association data in Normotensives for codon Arg/GIy16 and codon Gin/GIu 27 
Codon 16 Codon 27 
Arg/Arg Arg/Gly GIy/GIy P GIn/GIn GIn/GIu GlulGIu 
Subjects 56 141 55 167 76 9 
Meanage±SD 44.3±12.2 42.97 ± 11.5 43.6 ± 10.8 >0.05 44.1 ± 12.1 42.6 ± 11.1 40.0 ± 7.7 
(years) 
BMI(kgm·2) 27.2 ± 4.6 26.3 ±4.8 26.7±4.5 >0.05 26.9 ± 5.0 25.9 ± 4.2 27.0 ±9.6 
SBP (mmHg) 118.9 ± 13.3 117.6 ± 12.1 119 ± 14.2 >0.05 118.5 ± 13.2 117.4± 12.2 119.5 ± 10.7 
DBP(mmHg) 73.9 ±7.1 72.8 ± 7.46 73.3 ± 9.42 >0.05 73.2 ± 7.6 72.9 ± 8.4 75.0 ± 8.1 
PP (mmHg) 45.0 ±9.95 44.8 ± 9.9 45.7 ± 9.4 >0.05 45.3 ± 10.1 44.5 ±9.4 44.9 ±7.3 
MAP (mmHg) 88.9 ± 8.4 87.8 ± 8.0 88.5 ± 10.3 >0.05 88.3 ± 8.62 87.7± 8.8 89.6 ± 8.4 
HR (beats/min) 67.7 ± 10.5 66.4 ± 9.9 68.1 ± 9.2 >0.05 67.9 ± 1.0 65.3 ±9.5 65.7± 9.6 
AG/P2I/P1 126.8 ± 25.85 130.2 ±20.5 124.3 ± 18.3 >0.05 129.5 ± 22.9 125.5 ± 18.3 124.5 ± 16.5 
Lipids 
Total 4.6 ± 1.36 4.5 ± 1.1 4.78 ± 1.4 >0.05 4.55 ± 1.2 4.6 ± 1.23 4.44 ± 1.7 
Cholesterol 
mmols·1 
Triglycerides 1.85 ± 0.94 1.99 ± 0.4 2.24 ± 1.3 >0.05 1.94 ± 1.1 2.17 ± 1.18 1.94 ± 1.05 
mmols·1 
HDLmmols·1 1.24 ± 0.46 1.25 ± 0.4 1.2 ± 0.35 >0.05 1.26 ± 0.4 1.9 ± 0.4 1.35 ± 0.46 
LDLmmols·1 2.96 ± 1.12 2.74 ± 0.97 2.86 ± 1.45 >0.05 2.81 ± 1.1 2.83 ± 1.2 2.94 ± 1.43 
VLDL mmols·1 0.4 ± 0.19 0.4 ± 0.23 0.45 ±0.42 >0.05 0.4 ± 0.3 0.42 ± 1.2 0.37±0.22 
HDLRatio 3.7 ± 1.6 3.7 ± 1.23 4.4 ± 4.1 >0.05 3.7 ± 1.3 4.2±3.53 3.5 ± 1.2 
Glucose mmols·1 4.6 ± 1.32 4.6 ± 1.3 4.4 ± 1.4 >0.05 4.5 ± 1.31 4.8 ± 1.3 3.5 ± 1.9 
P 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
>0.05 
Table 4.11 Genotype association data in Hypertensives for codon Arg/Gly16 and codon Gln!Glu27 
Codon 16 Codon 27 
Arg/Arg Arg/Gly Gly/Gly P GIn/GIn GIn/GIu GiulGIu P 
Subjects 36 78 92 98 50 8 
Meanage±SD 53.0 ± 10.5 54.1 ± 10.98 51.6 ± 9.1 >0.05 53.0 ± 10.7 52.9 ± 10.3 56.1 ±7.0 >0.05 
(years) 
BM! (kgm·2) 28.3 ± 5.1 29.8 ± 5.7 28.7± 5.28 >0.05 29.2 ± 5.6 29.4 ± 4.74 28.5 ±7.6 >0.05 
SBP(mmHg) 141.6 ± 19.8 146.4 ± 21.3 148.9 ± 23.9 >0.05 145.7 ± 21.2 146.4 ± 24.2 146.4 ± 12.6 >0.05 
DBP(mmHg) 87.6 ±9.8 89.85 ±9.2 92.1 ± 9.7 >0.05 90.4 ± 9.9 89.0 ±9.5 90.6 ±6.3 >0.05 
PP(mmHg) 54.0 ± 15.6 56.6 ± 16.8 56.8 ± 18.1 >0.05 55.4 ± 16.5 57.5 ± 18.4 55.8 ± 12.5 >0.05 
MAP (mmHg) 105.6 ± 11.9 108.7 ± 12.0 111.1 ± 13.5 >0.05 108.9 ± 12.5 108.1 ± 13.4 109.2 ± 6.7 >0.05 
HR (beats/min) 68.2 ± 12.1 70.13 ± 10.42 65.5 ± 9.21 >0.05 68.3 ± 11.0 67.8 ± 9.65 73.1 ± 10.7 >0.05 
AG/p2Itpl 142.0 ±34.7 138.2 ± 19.5 143.6 ± 23.5 >0.05 140.8 ± 25.8 140.3 ± 23.5 138.6 ±23.3 >0.05 
Lipids 
Total 5.58 ± 1.14 5.2 ± 0.93 5.2 ± 1.1 >0.05 5.24±0.98 5.3 ± 1.1 5.7 ± 1.0 >0.05 
Cholesterol 
mmols·1 
Triglycerides 
mmols·1 
1.48 ± 0.74 1.35 ± 0.75 1.4 ± 0.7 >0.05 1.35 ± 0.67 1.3 ± 0.65 2.1 ± 1.2 >0.05 
HDLmmols·1 1.32 ± 0.34 1.35 ± 0.38 1.25 ± 0.4 >0.05 1.3 ± 0.36 1.4 ± 0.66 1.2 ± 0.37 >0.05 
LDLmmols·1 3.57±0.95 3.29 ± 0.85 3.4 ± 0.37 >0.05 3.3 ±0.82 3.6 ±0.54 3.95 ± 1.1 >0.05 
VLDL mmols·1 0.58±0.18 0.65 ± 0.1 0.49 ± 0.09 >0.05 0.56 ± 0.14 0.58 ± 0.2 0.5 ± 0.21 >0.05 
HDLRatio 4.41 ± 1.28 4.3 ± 1.33 4.29 ± 1.15 >0.05 4.32 ± 1.3 4.2 ± 1.2 5.2 ± 1.65 >0.05 
Glucose mmols·1 5.14±0.67 5.3 ± 1.24 5.2± 1.5 >0.05 5.3 ± 1.2 5.1±1.3 5.25 ±0.96 >0.05 
-!J> 
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4.5 Discussion 
4.5.1 P""2 Adrenoceptor polymorphism and hypertension 
One of the aims of the study was to determine if the ~ 2 - A R R polymorphism 
contributed to the early development of essential hypertension in African 
Trinidadians. The main findings showed that the frequencies of both polymorphisms 
( A r g I 6 ~ G l y y and G l n 2 7 ~ G l u ) ) were similar in both normotensive and hypertensive 
subjects (Table 4.2). There are two possible explanations for these data. Firstly, there 
may be no contribution of the ~ - 2 2 AR locus to hypertension risk in this population. 
Secondly, it is possible the study-lacked power because of sample size and this maybe 
why the difference in frequency of alleles was not significant. To determine clearly if 
a specific gene is having an effect on a phenotype or ethnic group, larger cohorts are 
required to rule out a small contribution of a given polymorphism (Jindra et aI, 2002; 
Tomaszewski et aI, 2002; Meirhaeghe et aI, 2001; Kato et aI, 2001; Xie et aI, 2000; 
Candy et aI, 2000). 
4.5.2 Hardy-Weinberg equilibrium 
Hardy-Weinberg equilibrium was maintained in both NT and HT group as well as the 
total population. This was in keeping with previous studies on these polymorphisms 
(Jindra et aI, 2002; Tomaszewski et aI, 2002; Meirhaeghe et aI, 2001; Kato et aI, 2001; 
Xie et aI, 2000; Candy et ai, 2000). 
The normotensive and hypertensive groups were combined showing that allele 
frequencies were similar and therefore combined for Hardy-Weinberg analysis. The 
observed and expected in the combined population and for both polymorphisms were 
not significantly different. This is due to random mating in the absence of mutation, 
migration, random drift or natural selection. Although the cohort was not large it is 
noted that linkage disequilibrium did exist between codon 16 and codon 27. 
4.5.3 Linkage disequilibrium 
Linkage disequilibrium was seen in this population, although the relative rarity of the 
GIn 27 allele makes this less obvious than in Caucasian populations (Dewar et aI, 
1997). However, this was in keeping with previous studies (Jindra et aI, 2002; 
Tomaszewski et aI, 2002; Meirhaeghe et aI, 2001' Kato et al 2001' Xie et al 2000' 
, " " 
Candyet aI, 2000). 
4.5.4 Allele Frequencies 
The main findings showed that the frequencies of both polymorphisms (Arg 16---)GI Y 
and Gln27---)Glu) were similar in both normotensive and hypertensive subjects (Table 
4.2). The main conclusion of this preliminary study is the lack ofa difference with the 
allele frequencies and this could be due to lack of size of the sample (n=252, NT, and 
n=156, HT). The potential contribution of a given polymorphism requires significant 
numbers to determine an overall effect on a phenotype. The allele frequencies 
described in this study are not dissimilar to those results and outcomes found in Xie et 
ai, 2000 and Candy et aI, 2000. However, it is only Xie et aI, 2000 that has allele 
frequency and genotype data of both black and Caucasian individuals are compared. 
This study does have greater power in terms of individuals and specific ethnic 
definition, of which was not accurately determined in the other two studies. However, 
the resulting outcomes of the distribution of allele and genotypes of the tested ~ 2 2
adrenergic receptor variants were similar and no significant differences were found 
between normotensive and hypertensive groups. 
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4.5.5 ~ r A R R polymorphism III the African Trinidadian population and 
hypertension 
This study investigated the possibility that ~ 2 - a d r e n o c e p t o r r (ArgiGly 16 and Gln/Glu 
27) polymorphism contributes to the prevalence of hypertension and arterial stiffness 
in a black African Caribbean (Trinidadian) population. This population was chosen 
for specific reasons. 
Firstly, preliminary data using a restrictive fragment length polymorphism (RFLP) 
close to the ~ 2 - a d r e n o c e p t o r r locus has suggested an association between this 
chromosomal region and hypertension in black populations (Svetkey et aI, 1995; 
Kotanko et aI, 1997). 
Secondly, recent data has shown an association between the Gly16 form of the ~ 2 2
adrenoceptor and essential hypertension in African Caribbean individuals (Kotanko et 
aI, 1997). 
Lastly, black African populations have a blunted vasodilatory response to isoprenaline 
suggesting a primary defect in the ~ 2 - a d r e n o c e p t o r r function (Lang et aI, 1995). 
There appears to be no clear association between ~ r a d r e n o c e p t o r r genotype at either 
codon ArgiGly 16 or Gln/Glu27 and the relationship to hypertension. This is in 
contrast to the findings of Kontanko et aI, 1997, who observed a higher risk of 
hypertension in African Caribbean's carrying the Gly 16 allele. Despite the current 
study having more power due to a larger cohort, this effect was not observed. The 
results are similar to those seen by Candy et aI, 2000, despite a reversed proportion of 
hypertensives being represented «n=192) with a lower number of normotensives 
(n=123)). Also, in keeping with Candy et aI, 2000, was found that the Glu27 allele 
was much rarer in both the black South African (n=17 (5.4%)) and African 
Trinidadian (n=17 (4.2%)) population. This is further supported by data from Xie et 
161 
ai, 2000, which identified that the Glu27 homozygous genotype was more common in 
Caucasians than in black subjects. 
4.6 Summary 
.:. There is no difference in the frequency of Brpolymorphisms between 
normotensive and hypertensive African Trinidadians, and therefore, these 
are unlikely to be a contributing factor for essential hypertension. 
162 
Chapter 5 
Augmentation association data using 
Linear regression 
163 
5.1 Introduction 
The data shown in Chapters 3 and 4 give an indication of the variability in the 
phenotypic and genotype parameters studied in this population. However, the time 
contribution of individual factors to augmentation status can only be estimated by 
taking account of possible confounding variables. Therefore, the data described in this 
chapter make use of regression analysis approaches to examine this issue. 
Linear regression analyses the relationship between two or more variables. In this 
case the following figures and results determine the relationship between 
augmentation index (Alx) and the variables as expressed in table 3.1 in chapter 3. The 
following figures (graphs) will use the best-fit linear regression line with a 95% 
confidence interval, to establish relationships related to arterial stiffness in African 
Trinidadians. All statistical data is summarised in Tables 5.1, 5.2 and 5.3. using 
Bonferroni's multiple comparison test. 
GraphPad Prism® (GraphPad Software Inc., 1999) was used to combine linear 
regression (curve fitting), analyse biostatistics, and produce the scientific graphing. 
5.2 Results 
5.2.1 Augmentation index and Age 
In figure 5.1 the relationship of age and Alx is shown. It can be seen that AIx 
increases with age in both the NT and HT group and therefore have a positive 
correlation. The relationship is clearer in the NT group because of the wide age 
range. 
16..J 
5.2.2 Augmentation index and BMI 
In figure 5.2, the relationship of BMI and AIx is shown. It can be seen that Alx 
increases with BMI in the NT and HT group, and therefore have a positive 
correlation. 
5.2.3 Augmentation index and SBP 
In figure 5.3, the relationship of SBP and AIx is shown. It can bee seen that Alx 
increases with SBP in both the NT and HT groups and therefore have a positive 
correlation. 
5.2.4 Augmentation index and DBP 
In figure 5.4, the relationship of DBP and AIx is shown. It can be seen that Alx 
increases with DBP in both the NT and HT group. Therefore, there is a positive 
correlation between DBP and AIx in both NT and HT groups. 
5.2.5 Augmentation index and PP 
In figure 5.5, the relationship of PP and AIx is shown. It can bee seen that Alx 
increases with PP in both the NT and HT groups and therefore have a positive 
correlation. 
5.2.6 Augmentation index and MAP 
In figure 5.6, the relationship of MAP and AIx is shown. It can be seen that Alx 
increases with MAP in both the NT and HT groups and therefore have a positive 
correlation. 
16S 
5.2.7 Augmentation index and DR 
With reference to figure 5.7, the NT group there is a negative correlation between HR 
and AIx. The explanation for this remains unclear. It may be due to the wide age 
range of the NT group. This may suggest that normotensive African Trinidadians 
present with stiffer arteries as age advances but do not elevate heart rate. 
Interestingly, this is reversed in the HT group and a positive correlation is evident. 
This contradictory result may in part be due to a proportion of the HT cohort taking 
anti-hypertensive medication. Therefore, the HT group was further investigated and 
linear regression was performed on HT individuals on medication for high blood 
pressure and those who were not. This is demonstrated in Figure 5.15. Those 
individuals not taking anti-hypertensive medication show a positive correlation in HR 
as AIx increases. Those individuals taking anti-hypertensives show a negative 
correlation in HR as AIx increases. This suggests that anti-hypertensive medication in 
African Trinidadians may decrease HR and reduce cardiac load but does not 
necessarily have a protective effect on arterial stiffness. However, the confidence 
intervals are large in figures 5.7 and 5. 15 and therefore the significance of the impact 
on arterial stiffness may require further investigation. 
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Figure 5.1 Linear regression of age against augmentation in (a) normotensive and 
(b) hypertensive African Trinidadians. 
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Figure 5.2 Linear regression of body mass index against augmentation in (a) normotensive 
and (b) hypertensive African Trinidadians. 
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Figure 5.3 Linear regression of systolic blood pressure against augmentation in 
(a) normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.4 Linear regression of diastolic blood pressure against augmentation in 
(a) normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.5 Linear regression of pulse pressure against augmentation in (a) normotensive 
and (b) hypertensive African Trinidadians. 
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Figure 5.6 Linear regression of mean arterial pressure against augmentation in 
(a) normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.7 Linear regression of heart rate against augmentation in (a)normotensive and 
(b) hypertensive African Trinidadians. 
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5.2.8 Augmentation index and Total Cholesterol 
In figure 5.8, the relationship of total cholesterol and AIx is shown. It can be seen that 
Alx increases with total cholesterol in both the NT and HT groups and therefore have 
a positive correlation. 
5.2.9 Augmentation index and Triglycerides 
In figure 5.9, the relationship oftriglycerides and AIx is shown. It can bee seen that 
Alx increases with triglycerides in both the NT and HT groups and therefore have a 
positive correlation. 
5.2.10 Augmentation index and High Density Lipoprotein (HDL) 
In figure 5.10, the relationship ofHDL and AIx is shown. The NT group demonstrates 
a positive correlation as AIx increases. In the HT group, a negative correlation is seen 
in HDL as AIx increases. 
5.2.11 Augmentation index and Low Density Lipoprotein (LDL) 
In figure 5.11, the relationship of LDL and AIx is shown. It can be seen that Alx 
increases with LDL in both the NT and HT groups and therefore have a positive 
correlation. 
5.2.12 Augmentation index and Very Low Density Lipoprotein (VLD L) 
In figure 5.12, the relationship of VLDL and AIx is shown. It can be seen that Alx 
increases with VLDL in both the NT and HT groups and therefore have a positive 
correlati on. 
17.t 
5.2.13 Augmentation index and High Density Lipoprotein Ratio (HDL Ratio) 
In figure 5.13, the relationship ofHDL ratio and AIx is shown. It can be seen that AIx 
increases with HDL ratio in both the NT and HT groups and therefore have a positive 
correlation. 
5.2.14 Augmentation index and Glucose 
In figure 5.14, the relationship of glucose and AIx is shown. It can be seen that AIx 
increases with glucose in the HT and NT group and therefore has a positive 
correlation. 
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Figure 5.8 Linear regression of total cholesterol against augmentation in 
(a)normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.9 Linear regression of triglycerides against augmentation in 
(a)normotensive and (b) hypertensive African Trinidadians. 
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(a)normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.11 Linear regression of LDL against augmentation in 
(a)normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.12 Linear regression of VLDL against augmentation in 
(a)normotensive and (b) hypertensive African Trinidadians. 
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Figure 5.13 Linear regression of HDL Ratio against augmentation in 
(a)normotensive and (b) hypertensive African Trinidadians. 
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5.2.15 Summary of data values 
The following tables are summary data tables of descriptive and correlation statistics 
of regression analysis of Augmentation index against all variables except genotype. 
Pearsons' correlation demonstrates the extent or incline of the positive or negative 
linear slope in the figures as previously described in this chapter. 
Table 5.1 Normotensives descriptive and correlation statistics data values. 
Parameter Mean Standard Pearson's P value 
Deviation Correlation 
Age 43.41 11.55 0.489 < 0.001 
BMI 26.59 4.74 0.078 < 0.001 
SBP 118.2 12.9 0.143 < 0.001 
DBP 73.15 7.88 0.067 < 0.001 
PP 45.05 9.81 0.134 < 0.001 
MAP 88.17 8.68 0.111 < 0.001 
HR 67.02 9.90 -0.367 < 0.001 
Total 4.56 1.24 0.172 < 0.001 
Cholesterol 
Triglycerides 2.01 1.10 0.067 < 0.001 
HDL 1.24 0.39 0.179 < 0.001 
LDL 2.82 1.13 0.176 < 0.001 
VLDL 0.41 0.28 0.087 < 0.001 
HDL Ratio 3.83 2.54 0.051 < 0.001 
Glucose 4.55 1.32 0.047 < 0.001 
Table 5.2 Hypertensives descriptive and correlation statistics data values. 
Parameter Mean Standard Pearson's P value 
Deviation Correlation 
Age 53.14 10.47 0.138 < 0.001 
BMI 29.2 5.5 0.024 < 0.001 
SBP 146.0 21.96 0.065 < 0.001 
DBP 89.95 9.69 0.049 < 0.001 
PP 56.0 17.0 0.056 < 0.001 
MAP 108.6 12.6 0.063 < 0.001 
HR 71.0 34.2 0.082 < 0.001 
Total 5.29 1.03 0.174 < 0.001 
Cholesterol 
Triglycerides 1.38 0.73 0.144 < 0.001 
HDL 1.31 0.37 -0.099 < 0.001 
LDL 3.32 0.97 0.169 < 0.001 
VLDL 0.52 0.29 0.181 < 0.001 
HDL Ratio 4.32 1.28 0.195 < 0.001 
Glucose 4.98 1.55 0.039 < 0.001 
I 
I 
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5.3 Discussion 
5.3.1 Introduction 
Pulse Wave Analysis (PWA) is a simple and reproducible technique in which to 
measure arterial stiffness, and is suitable for large-scale population and intervention 
studies investigating clinical relevance of vascular stiffness (Wilkinson et ai, 1998b). 
It allows the accurate measurement of peripheral waveforms and generation of the 
corresponding waveform, from which augmentation index and central pressure is 
derived. In clinical studies (Wilkinson et aI, 1998b) PW A has shown to be a highly 
reproducible technique and easy to apply. It provides important information about 
arterial stiffness, which is under the functional control of the endothelium, releasing a 
number of vasodilatory mediators. Increased stiffness impairs arterial function and is 
associated with most cardiovascular risk factors and established athersclerosis. 
To date there are no studies of the use of PWA to examine augmentation of arterial 
compliance in African Trinidadians or African Caribbean's. However, it has been 
documented that PW A is a suitable methodology to be used for large-scale population 
and intervention studies, investigating the relevance of vascular stiffness (Wilkinson 
et aI, 1998). 
Aortic PWA is strongly related to the presence and extent of CHD, and has been 
shown to be a strong predictor of cardiovascular risk as determined by Framingham 
study (Kannel et ai, 1967) and the National Service Framework (NSF) for CHD. 
An important result of this study is that African Trinidadians may have an accelerated 
risk of CHD, over the age of forty-five, with increased arterial stiffness, associated 
with raised lipid levels (Cross et aI, 2003). The results are of interest as most prevIous 
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studies relating PWV to cholesterol or dyslipidemia have found minimal or 
inconsistent correlations (Barenbrock et aI, 1995). 
As described in other studies (Cameron et aI, 1998), raised augmentation in univariate 
analysis shows association with age, sex, height and heart rate. Results from this study 
with age and heart rate were as similar to Cameron et aI, 1998. Even after adjustment 
with heart rate, pressure augmentation was not associated with any antihypertensive 
treatment investigated. This means that age and heart rate but not the classification of 
antihypertensive medication may affect the degree of pressure augmentation. 
Similarly, the elevation of pulse pressure (PP) found mainly in hypertensive African 
Trinidadians, is regarded as a manifestation of increased arterial stiffness and 
augmentation. This combined with raised systolic blood pressure (SBP) are 
considered independent risk factors of CHD. These findings were also seen in studies 
conducted by Boutouyrie et aI, 2001 and Benetos et aI, 1997, who conducted large 
longitudinal studies in French populations. 
As approximately one quarter of the participants had already been treated for 
hypertension at baseline, the predictive value of PW A observed in the entire 
population of African Trinidadians may not be a time estimate. However, the 
predictive value of PWA as represented in tables 5.1, 5.2 and 5.3 suggests it may 
operate as a significant and independent association for an increased risk of 
developing hypertension. 
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5.4 Summary 
In conclusion, the cohort of normotensive and hypertensive subjects whether 
untreated or treated demonstrates the following points . 
• :. The collected phenotypic variables do have an impact on augmentation index . 
• :. Heart rate has a significant effect on augmentation index 
.:. HDL is shown to have a protective measure against an mcrease In 
augmentation index, in particular those who have hypertension. 
iRR 
Chapter 6 
Multiple Regression 
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6.1 Introduction 
The data shown in Chapter 5 demonstrated linear regression analysing the relationship 
between two variables. The figures and results determined the relationship between 
augmentation (AIx %) and the phenotypic variables, singularly. 
In this chapter multiple regression is employed as a statistical procedure to analyse the 
simultaneous effects of two or more independent variables on the dependent variable 
of augmentation (AIx %). This is accomplished by developing a model to define a 
response or function between the dependent variable and fitting data to a linear 
equation with two or more independent variables. 
Therefore the data described in this chapter make use of multiple regression analysis 
approaches to examine this issue. 
Statistical Package for the Social Sciences (SPSS) was used to combine multiple 
linear regression and analyse bio statistics. 
6.2 Analysis 
The process of constructing a linear equation that predicts the values of the dependent 
variable, (augmentation index) from knowledge of the specified values of an 
independent variable is extended in this chapter to situations where the data has two 
or more independent variables. Multiple regression is the construction of a linear 
regression equation with two or more independent variables. 
In this case simultaneous multiple regression was used whereby all the independent 
variables, which are known predictors of hypertension, as described in chapters 3, 4 
and 5 were entered directly. 
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6.3 Results 
6.3.1 Total Population Regression Model 
Firstly, simple scatterplots were developed to eliminate outliers in data sets and 
deselecting independent variables that showed no significant contribution to the 
model. The variables that showed to be significant contributing factors to AIx (AI), 
appeared to be correlated with a scatterplot. These were systolic blood pressure, heart 
rate, height, age and gender. 
Table 6.2 shows the regression ANOV ~ ~ which tested goodness of fit between the 
variables. F is the test statistic, being the ratio of the residual mean square and the 
residual mean squared. This means that the predictors or variables have a confirmed 
relationship with the dependent variable of central AIx. 
However, the examination of the scatterplots of the variables against AIx can confirm 
a genuine linear relationship. Figures 6.1, 6.2, 6.3 and 6.4 are scatterplots showing the 
correlations of the independent variables used in the model with Alx. 
Table 6.3 shows coefficients and is the representation of the regression analysis, 
regression equation and associated statistics. Column B indicates the relative weight 
of the independent variable in the regression equation. The remaining columns are t-
tests (analysing the difference between two means) with p values. 
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Figure 6.1 Scatterplot of correlation between age and Alx CAl) . 
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Figure 6.2 Scatterplot of correlation between systolic blood pressure and Alx (A I). 
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Figure 6.4 Scatterplot of correlation between heart rate and Alx (AI). 
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Table 6.1 R coefficient approach, indicating a good measure offit. 
Model R R Square Adjusted R Error of the 
Std. Square Estimate 
1 .752a .565 
.560 14.65368 
a Predictors: (Constant) systolic blood pressure, heart rate, height in ems, age, gender. 
Table 6.2 ANOV Ab for confirming significance association of regression line with 
AIx (AI). 
Modell Sum of df Mean F Sig 
Squares S ~ u a r e e
Re2ression 109504.535 5 21900.907 101.993 .000 
Residual 84174.300 392 214.730 
Total 193678.835 397 
a Predictors: (Constant) systolic blood pressure, heart rate, height in ems, age, gender. 
b Dependent Variable: central AIx (AI). 
Table 6.3 Contribution of each predictor to the model. 
U nstandardized Standardized t Sig 
Coefficient 
Model B Std. Beta 
1 Error 
(Constant) 234.435 22.554 10.394 .000 
Gender 11.964 1.969 .266 6.076 .000 
Age .635 .072 .350 8.822 .000 
Height in -.641 .110 -.258 -5.837 .000 
ems 
Heart rate -.887 .074 -.412 -12.054 .000 
Systolic .139 .039 .137 3.518 .000 
blood 
pressure 
a Dependent Variable: central AIx (AI). 
1 9 ~ ~
6.3.2 Linear Regression Analysis for A r g ~ G l y 1 6 6 and Gln---TGlu 27 genotypes 
groups using AIx (AI) Model 
Using the model for AIx (AI) demonstrated previously (Tables 6.1 and 6.2) I sought 
to establish whether genotype significantly improved the model. That is to say, 
whether possession of the polymorphism A r g ~ G l y 1 6 6 or G l n ~ G l u u 27 was 
significantly associated with AIx (AI) having taken the other model variables into 
account. This was performed using the general linear model function in SPSS. 
Tables 6.4 and 6.5 are the number of individuals in each gender and genotype 
combined. 
Table 6.4 Number of individuals for A r g ~ G l y 1 6 . .
Value Label 
Gender l.00 male 161 
2.00 Female 237 
A r g ~ G l y 1 6 6 1 Homozygote Arg 88 
2 Heterozygote 216 
3 Homozygote Gly 94 
Table 6.5 Number of individuals for G l n ~ G l u u 27. 
Value Label 
Gender l.00 male 161 
2.00 Female 237 
Gln---TGlu 27 1 Homozygote GIn 257 
2 Heterozygote 124 
3 Homozygote Glu 17 
19:" 
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Table 6.6 and 6.7 are the test results for the independent variables or subject effects 
on the dependent variable, this time with the added effect of Arg---7Glyl6 and 
G l n ~ G l u u 27 genotype. This analysis was conducted as a preliminary to examine if 
A r g ~ G l y l 6 6 and Gln--+Glu 27 genotype had an association with the phenotypic 
variables as well as the dependent variable of central AIx (AI). The F ratio and p 
value of significance demonstrates that there is no significant influence on AIx (AI) in 
this model. 
Table 6.6 Test between variables and the dependent variable central AIx (AI). 
Source Type III df Mean F Sig 
Sum of 
Squares Square 
Corrected Model 109681.968 7 15668.853 72.751 .000 
Intercept 31544.458 1 31544.458 146.462 .000 
Gender 7802.426 1 7802.426 36.227 .000 
Age 16772.458 1 16772.458 77.875 .000 
Heart rate 31048.273 1 31048.273 144.158 .000 
Height 7245.329 1 7245.329 33.640 .000 
Systolic BP 2605.230 1 2605.230 12.096 .001 
A r g ~ G l y l 6 6 177.433 2 88.716 .412 .663 
Error 83996.867 390 215.377 
Total 7206396.750 398 
Corrected Total 193678.835 397 
a R Squared = .566 (Adjusted R Squared = .559) 
1% 
Table 6.7 Test between variables and the dependent variable central AIx (AI). 
Source Type III df Mean F Sig 
Sum of 
Squares Square 
Corrected Model 109573.770 7 15653.396 72.586 .000 
Intercept 31820.471 1 31820.417 147.553 .000 
Gender 7984.915 1 7984.915 37.027 .000 
Age 16736.640 1 16736.640 77.609 .000 
Heart rate 31068.163 1 31068.163 144.065 .000 
Height 7337.331 1 7337.331 34.024 .000 
Systolic BP 2630.162 1 2630.162 12.196 .001 
Gln---+Glu 27 69.236 2 34.618 .161 .852 
Error 84105.064 390 215.654 
Total 7206396.750 398 
Corrected Total 193678.835 397 
a R Squared = .566 (Adjusted R Squared = .558) 
6.3.3. Regression Model for Hypertensive African Trinidadians 
The model for the hypertensive population used was that described in section 6.3.1 of 
this chapter. However, systolic blood pressure was not included, as this variable is 
already known in hypertensives. In this population AIx (AI) is negatively correlated 
with weight (see figure 6.5). 
The results of analysis and significance are demonstrated in tables 6.8, 6.9 and 6.10. 
Figure 6 .S is the scatterplot to confirm that the variables have genu ine linear 
relationship . 
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Figure 6.S Scatterplot of correlation between weight in kilograms (kg) and Alx (AI) 
of the HT group. 
Table 6.8 R coefficient approach, indicating a good measure of fit for African 
Trinidadian hypertensives. 
Model R R Square Adjusted R Error of the 
Std. Square Estimate 
1 .734a .538 .523 14.47052 
a Predictors: (Constant) weight in kg, heart rate, height in ems, age, gender. 
Table 6.9 ANOV Ab for confirming significance association of regression line with 
Aix(AI) in African Trinidadian hypertensives. 
Modell Sum of df Mean F Sig 
Squares Square 
Regression 36140.337 5 7228.067 34.519 .oooa 
Residual 30990.604 148 209.396 
Total 67130.942 153 
a Predictors: (Constant) weight in kg, heart rate, height in ems, age, gender. 
b Dependent Variable: central AIx (AI). 
Table 6.10 Contribution of each predictor to the model In African Trinidadian 
hypertensives. 
U nstandardized Standardized t Sig 
Coefficient 
Model B Std. Beta 
1 Error 
(Constant) 236.762 33.434 7.081 .000 
Gender 14.009 3.056 .330 4.585 .000 
Age .419 .115 .211 3.657 .000 
Height in -.426 .181 -.184 -2.356 .020 
ems 
.000 Heart rate -.775 .112 -.396 -6.924 
Weight in -.201 .074 -.173 -2.720 .007 
kg 
a Dependent Variable: central AIx (AI). 
6.3.4 Multiple Linear Regression Analysis for Hypertensive African 
Trinidadians 
The following analysis was performed to demonstrate if the A r g ~ G l y l 6 6 or G l n ~ G l u u
27 polymorphisms are associated with AIx (AI) in hypertensive African Trinidadians. 
Table 6.11 Multiple Linear Regression Analysis For African Trinidadians 
hypertensives for A r g ~ G l y y16. 
Source Type III df Mean F Sig 
Sum of 
Squares Square 
Corrected Model 36888.140a 7 5269.734 25.440 .000 
Intercept 13045.397 1 13045.397 62.978 .000 
Gender 4788.944 1 4788.944 23.119 .000 
Age 3013.631 1 3013.631 14.549 .000 
Heart rate 8887.590 1 8887.590 42.906 .000 
Height 922.228 1 922.228 4.452 .037 
Weight 1559.642 1 1559.642 7.529 .007 
Genotype16 747.803 2 373.902 1.805 .168 
Error 30242.801 146 207.142 
Total 3063172.500 154 
Corrected Total 67130.942 153 
8Dependent variable: Central AIx (AI). 
R Squared = .549 (Adjusted R Squared = .528) 
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Table 6.12 Multiple Linear Regression Analysis For African Trinidadians 
hypertensives for G l n ~ G l u u 27. 
Source Type III df Mean F Sig 
Sum of 
Squares Square 
Corrected Model 36291.287 7 5184.470 24.544 .000 
Intercept 14668.691 1 14668.691 69.444 .000 
Gender 4440.850 1 4440.850 21.024 .000 
Age 2683.095 1 2683.095 12.702 .000 
Heart rate 10080.301 1 10080.301 47.722 .000 
Height 1193.383 1 1193.383 5.650 .019 
Weight 1521.353 1 1521.353 7.202 .008 
Genotype27 150.950 2 75.475 .357 .700 
Error 30839.654 146 211.231 
Total 3063172.500 154 
Corrected Total 67130.942 153 
3Dependent variable: Central AIx (AI). 
R Squared = .541 (Adjusted R Squared = .519) 
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6.4 Discussion 
The main questions asked from multiple regression were if (i) the A r g ~ G l y l 6 6 or, (ii) 
the G l n ~ G l u u 27 polymorphism are associated with AIx (AI) in African Trinidadians. 
Multiple regression analysis shows that neither the A r g ~ G l y l 6 6 polymorphism nor 
the G l n ~ G l u u 27 polymorphism is independent variables of AIx (AI). The data 
suggest the polymorphisms do not have a significant influence on contributing to 
arterial compliance in African Trinidadians. These findings are complimentary to 
those as described by Tomaszewski et aI, 2002; Kato et aI, 2001; Candy et aI, 2000 
and Xie et aI, 2000. These studies suggest that although there are marked differences 
as regards ethnic distribution, the A r g ~ G l y 1 6 6 and G l n ~ G l u u 27 genetic 
polymorphisms of the ~ 2 - a d r e n e r g i c c receptor gene are not associated with 
hypertension in either European, American, Japanese and African populations. 
This is however, in contrast with the findings as described by Jindra et aI, 2002; Dishy 
et aI, 2001; Meirhaeghe et aI, 2001; Timmermann et aI, 1998; Kotanko et aI, 1997, 
suggesting that genetic variability of the ~ 2 - a d r e n e r g i c c receptor gene is implicated in 
the predisposition to essential hypertension. 
The apparent lack of consistency of these studies may be, at least partially, attributed 
to ethnic differences. Other possible explanations for discrepancies between these 
studies are a pleiotropic effect exerted by the ~ 2 - a d r e n e r g i c c receptor gene 
(Tomaszewski et aI, 2002). Its possible contribution to other cardiovascular and 
metabolic phenotypes (insulin resistance, cardiac failure, obesity) of different 
prevalence among hypertensive and normotensive individuals may act to confound 
studies (Bray et aI, 2000). 
Interestingly, in this study, obesity was a feature, as body mass index was 
significantly higher (P < 0.001) in the HT group. Therefore, analysis of weight was 
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investigated to assess whether arterial stiffness is associated with increasing body 
weight in this population. Body weight is correlated to AIx (AI) in both groups, but 
not associated to the P2-adrenergic receptor gene (P> 0.05). These results are in 
contrast to findings ofMeirhaeghe et aI, 2001, who suggested, that genetic variants in 
the P2-adrenergic receptor gene may be associated with obesity, altered physical 
activity profiles, nonesterified fatty acid levels and decreased insulin sensitivity. 
However, the findings reported here are consistent with Kato et aI, 2001, in that there 
was no confounding influence of obesity on the postulated association. 
Phenotypical variables such as age, gender and heart rate were proven to be 
predictors of AIx (AI), in both groups (P < 0.001). These findings are consistent with 
other studies. (Benetos et aI, 1997; Sa Cunha et aI, 1997; Mangoni et aI, 1996; 
O'Rourke 1995; Kelly et aI, 1989). 
6.5 Summary 
.:. There is no association between A r g ~ G l y 1 6 6 and G l n ~ G l u u 27 and AIx (AI) 
in normotensive Mrican Trinidadians even when other known predictors of 
AIx (AI) are taken into account. 
.:. There is no association between A r g ~ G l y 1 6 6 and Gln---+Glu 27 and AIx (AI) 
in hypertensive Mrican Trinidadians . 
• :. Gender, age, heart rate and height have a significant influence on AIx (AI) in 
African Trinidadians. 
20-l 
Chapter 7 
General Discussion and Conclusions 
7.1 General Discussion 
The National Health Service Framework for Coronary Heart Disease (DoH, 2000) had 
laid down the United Kingdom government's strategy for tackling heart disease and 
stroke. The national target is to reduce mortality by at least 50% by the year 2010, 
identifying groups or individuals at most risk and in greater need. It has been known 
for a long time that African Caribbean's are at great risk of essential hypertension 
even at an early age with an accelerated risk as age advances. The impact of further 
disease complications such as stroke, left ventricular hypertrophy and end stage renal 
failure that arise not only have a financial burden on society, but an emotional and 
social misery to their families. 
The evidence suggests that genetic and environmental factors predispose African 
Caribbean people to accelerated arterial stiffness, and this is reflected in African 
Trinidadians. In the current study, the influence of racial dilution was excluded as 
s e l ~ c t i o n n was based on screening the participants by asking for information on three 
forefathers who had to have a strong African Trinidadian background maternally and 
paternally and permanent residency in Trinidad or Tobago. Structural inequalities 
such as financial, social classification and the impact of environmental factors have 
previously been suggested to contribute towards increased cardiovascular risk. 
A comparison of the data obtained in several different studies, in the U.K., U.S.A., 
South Africa and Caribbean demonstrates that essential hypertension is common in 
African Caribbean's despite the differences in the political, socio-economic and 
environmental climate in their different countries (Jindra et aI, 2002; Tomaszewski et 
aI, 2002; Meirhaeghe et aI, 2001; Kato et aI, 2001; Xie et aI, 2000; Cockcroft et aI, 
2000; Candy et ai, 1999; Kotanko et aI, 1997). In view of this, I set out to investigate 
the potential contribution of genetic factors, which previously has been shown in at 
least some studies to alter vascular reactivity. 
Few studies have used pulse wave analysis (PW A) to assess vascular function and 
hypercholesterolaemia in particular ethnic groups identified as having a morbid 
predisposition to essential hypertension. Epidemiological interpretation of the data 
published to date (Jindra et aI, 2002; Tomaszewski et aI, 2002; Meirhaeghe et ai, 
2001; Kato et aI, 2001; Xie et aI, 2000; Cockcroft et al, 2000; Candy et aI, 1999; 
Kotanko et aI, 1997), demonstrate that hypertension in this ethnic group has a multi-
factorial aetiology. 
With regards to this, the major aim of this thesis was to investigate whether there was 
a genetic predisposition to vascular function in African Trinidadians, and also to 
validate the use of PW A as a diagnostic and effective research tool, in order that large 
groups of people could be studied. 
7.2 The ~ 2 - A d r e n o c e p t o r r
This thesis was designed to investigate the frequency of 132 -adrenoceptor coding 
region polymorphism in a random African Trinidadian population and the 
contribution of these polymorphisms (if any) to pathogenesis of hypertension and or 
altered AIx (AI). The 132 -adrenoceptor is important in the control of vascular function 
and relevant mutations may be responsible for altering vascular behaviour. 
7.2.1 B-2 adrenoceptor polymorphism and vascular function 
Hypertension is not generally due to a single gene abnormality. Since clear Mendelian 
models of inheritance cannot readily be assigned in essential hypertension it is 
probable that there is variable penetrance of susceptibility genes. 
More recent investigations have focused on the two common polymorphisms of the ~ 2 2
adrenoceptor: A r g ~ G l y y16, and G l n ~ G l n 2 7 . . In vitro studies of Arg 16 receptors 
demonstrate altered down regulation (Green et aI, 1995). Consistent with the in vitro 
data, clinical studies have demonstrated increased responsiveness to ~ - a g o n i s t t
stimulation, and an increased risk of hypertension among Arg homozygotes 
(McNamara et aI, 2002). Functional changes which are associated with ~ : :
adrenoceptor polymorphisms become even more complex when the strong linkage 
disequilibrium between the known polymorphisms is considered (Barbier, 2001). 
Investigation into the vasodilatory responses to isoprenaline and desensitisation in 
patients with three different genotypes for two common alleles at positions 16 and 27 
revealed that the Glu27 polymorphism is associated with enhanced responsiveness to 
agonists (Cockcroft et aI, 2000). However, the Arg16 polymorphism is associated 
with increased desensitisation (Dishy et aI, 2001). The Glu27 polymorphism is found 
more often in Caucasians than African populations, and could contribute to the well-
documented differences in vascular reactivity between the two racial groups. Further 
investigation of the clinical implications of these common variants of ~ - a d r e n o c e p t o r s s
is needed and this was a major aim of the work described in this thesis. My findings 
suggest that the two common B2-receptor polymorphisms do not contribute 
significantly to the determination of augmentation index (Alx), (i.e. arterial 
compliance). Importantly, the pharmacogenetic impact of these variants of 
effectiveness of B-adrenergic blockage remains unknown. 
7.3 PW A and the Implementation in a Clinical Setting 
The application of Pulse Wave analysis (PW A) has offered a simplistic, reliable, 
efficient and non-invasive tool to detect sub-clinical, vascular data on cardiovascular 
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disease process. As it is more sensitive and specific than conventional blood pressure 
monitoring it can facilitate precise treatment and management of not only vascular 
disease but also drug therapy and risk stratification. The use of a non-invasive 
approach enabled study on a large cohort of subjects encompassing a wide range of 
ages and blood pressures and was appealing to subjects, as it was not regarded as 
physically an uncomfortable experience. This had an attraction not only to the public 
but also to health professionals. Alongside lipid and blood pressure analysis and 
possibly genetic screening a tailor made service on cardiovascular risk assessment 
could potentially be employed to identify and implement advice and intervention 
strategies to meet client's needs. This does not just apply to minority ethnic groups 
but to all ethnic backgrounds where cardiovascular disease is widespread. The validity 
of the application of such a technology is the amount of data that is possible to collect 
in a short time, efficiently, reliably, and cost effectively with minimal discomfort to 
subjects. However, there is significant opposition in the use of PW AIV as a clinical 
tool for the diagnosis and management of hypertension or other cardiovascular 
diseases. In the case of hypertension, ambulatory blood pressure has been viewed as 
the 'gold standard' and a conclusive diagnostic tool for hypertension, and is widely 
used (Verdecchia et aI, 1998). PWV is considered a more accurate method of 
assessing arterial stiffness. However, ambulatory blood pressure monitors may not be 
as accurate or conclusive as some health practitioners may believe. The equipment is 
temperamental and may be uncomfortable for the patient, whilst intermittent blood 
pressure measurements are taken over a twenty-four hour period. It is not subjected to 
rigorous controlled environments and cannot predict precisely the impact of 
therapeutic drug intervention over a short duration of time (pickering et aI, 1996). 
Some patients need drug therapy intervention, in advance of monitoring to cover 
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potential cardiovascular risks, due to the long waiting list for an appointment for 
fitting and monitoring. Such intervention of therapy may mask the patients 'tnle' 
blood pressure readings (Pickering et ai, 1996). 
The advantages of using pulse wave analysis (PW A) or pulse wave velocity (PWV) 
would enable the health practitioner a more efficient tool for not only seeing many 
patients in a shorter time-frame, but effective and conclusive evidence for the specific 
diagnosis and management of hypertension. This does not mean that PW AIV should 
replace the use of ambulatory blood pressure monitoring, but be complementary. The 
health practitioner should therefore consider the patient condition with regards to 
hypertension carefully and use either monitoring tool or both, to ascertain the true 
cause and successful treatment regime. 
7.4 Study Strengths and Limitations 
As described in section 7.3, the use of PW A, allows a comprehensive and detailed 
collection of cardiovascular data, quickly, effectively and reliably with exceptional 
validity. However, the additional data or use of pulse wave velocity (PWV) would 
have been strengthened by giving an indication of the compliance of the artery. Serial 
measurement of PWV in a section of artery indicates the magnitude of change in 
arterial compliance. Similarities and differences between augmentation index and 
pulse wave velocity in the assessment of arterial stiffness have been identified 
(Yasmin et aI, 1999). However, augmentation measurement is technically the easiest 
and quickest of available methods to assess arterial stiffness and is sufficient to be 
incorporated into a clinic visit. The justification in this instance is that a large cohort 
of people were able to participate in this study, with augmentation measurement being 
sufficient alone to assess arterial stiffness. Augmentation and PWV are influenced by 
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gender and height (Yasmin et aI, 1999), yet the focus of study of arterial stiffness was 
ethnicity and genetic determination. PWV has technical difficulties of application are 
as the location and measurement of the carotid artery may be laborious and there is a 
slight risk of carotid rubbing. As emergency cover was not always readily available, 
PW A was used in this study due to the ease of augmentation measurement. 
Practically, PW A is very operator dependent and requires experience to obtain 
reliable measurements. It is also argued that AIx is a composite of both vascular tone 
and arterial stiffness, but lacks addition information to accurately interpret such 
pathology. Others will add that AIx has not been validated and cannot be considered a 
robust parameter (Kelly et aI, 2001). However, augmentation alone can predict long-
term morbidity to justify measurement of arterial stiffness in everyday practice 
(Yasmin et aI, 1999). 
The limitation of nurse prescribing meant delays in getting newly diagnosed 
hypertensive participants emergency treatment, before referral. This led to a 
dichotomy of responsibility and accountability of the investigator. Specialist nurses 
should have authority to prescribe anti-hypertensive medication in such emergency 
situations with an appropriate protocol and procedures in place, with follow-up clinics 
for the participant who has become a patient. Some newly diagnosed hypertensive 
participants were seen by a cardiologist, but this was not always consistent and 
African Trinidadians did fear any additional cost to treatment in perusing this offer, 
despite it being free. The investigator did provide follow up after treatment whether 
commenced by the cardiologist or general practitioner. 
Pseudohypertension and 'whitecoat hypertension' are features of blood pressure 
studies and clinics. In accordance to strict adherence of procedure of blood pressure 
measurement (described in Chapter 2) detection was limited. If participants were 
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suspected of having p s e u d o h y p e r t e n s i o ~ ~ especially if the participant was relatively 
young or was over anxious, they were asked if they wished to return to the clinic at 
another time. This allowed familiarisation with the procedure to allay apprehension 
and to check if a young participants' plateau of systolic blood pressure and relatively 
low central aortic pressure augmentation corresponded on separate occasions. 
It is in these incidences that the use of ambulatory blood pressure monitoring would 
have been beneficial and could have determined over a longer period of time with 
changeable environmental factors if a diagnosis of hypertension was appropriate. 
However, the technology and computer software for analysis was not available. 
Despite this l i m i t a t i o ~ ~ referral was available. All participants were asked prior to 
participating to adhere to the inclusion criteria as regards dietary and fluid intake. 
There was no confirmed and clear indication that the patient had adhered to the 
dietary requirement and the investigator had to be sure that the participant had 
conformed to the requirement of entry by close questioning prior to PW A. Salt 
restriction was not a prerequisite for entry, as this would have taken considerable time 
and effort to enforce and would have decreased the cohort size if implemented. 
The renin-angiotensin system (RAS) plays an integral part in the control of blood 
pressure, but polymorphisms of the angiotensin converting enzyme gene, although 
associated with left ventricular hypertrophy, do not have a clear association with 
hypertension, and thus was not investigated. Again, PWV may have been beneficial to 
examine this question in this case as PWV and MAP are greater in populations with 
high salt intake, increasing age and high prevalence of hypertension compared to 
populations with low salt intake, increasing age and low prevalence of hypertension 
(Avolio et aI, 1985; Ergul et aI, 2000; Safar et aI, 2000). 
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Subjects treated with antihypertensive medications contribute important information 
regarding genetic components on blood pressure variance. This is demonstrated when 
treated subjects are excluded by the reduction in both genetic and shared 
environmental components of variance compared with other approaches (Cui et aI, 
2003). Valuable information is not only lost, but statistical power is weakened 
because of reduced numbers of subjects. The use of measured pressures from treated 
subjects is not ideal and represent a biased distortion in a quantitative analysis 
because treatment lowers blood pressure and is usually applied to those with the 
highest values. Treatable subjects might be expected to provide genetic and 
environmental clues to elevated blood pressure, that relate to blood pressure 
phenotypes and genotypes. A potential solution is to adjust measured pressures in 
treated subjects so that they reflect the inherent untreated levels (Cui et aI, 2003). 
However this was not undertaken in this study, but subjects were analysed for arterial 
stiffness and genetic predisposition separately. There are less robust data on the effect 
of treatment on AIx and this was corrected for in the current study. 
Data did reflect an ethnic difference in the frequency of the Glu 27 homozygote 
genotype in African Trinidadians, which is compatible when compared to other 
findings of studies (Candy et ai, 2000; Xie et aI, 2000). A population based case 
controlled association study, or comparison with a different ethnic group would have 
demonstrated marked ethnic differences in their distribution of the genetic 
polymorphisms. However, this was not feasible due to the geographical location of 
the study and the time available. 
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7.5 Future Work 
Some published data have suggested that the effect of the ~ r a d r e n o c e p t o r r
polymorphism is more dependent upon haplotypes than single nucleotide 
polymorphisms (SNPs) (Drysdale et aI, 2000). Four common haplotypes exist which 
appear in part to predict clinical responsiveness in the airways (Drysdale et al , 2000). 
These haplotypes can be defined by genotyping for the four SNPs at bp -367, -47, 
codon 16 and codon 27, due to strong linkage disequilibrium between these SNPs and 
other SNPs forming extended haplotypes. No studies to date have used haplotype-
based approaches to delineate contribution of this locus to vascular reactivity. 
Therefore, determination of haplotypes for all individuals in these two African 
Trinidadian cohorts could have examined if individuals were carrying a specific 
haplotype that increases vascular stiffness. Similarities in phenotypic expression 
between hypertension in blacks and patients with Liddle's syndrome (Skimkets et aI, 
1994), a monogenic form of hypertension, have suggested that abnormalities of the 
distal tubular epithelial sodium channel, a major regulator of overall control of 
sodium balance, may underlie the development of high blood pressure in Mrican 
Trinidadians and Caribbean's (Schild et aI, 1995). A number of variants of the sodium 
channel ~ - s u b u n i t t coding sequence have been identified in subjects with hypertension 
(Chang et aI, 1996; Dong et aI, 1997; Persu et aI, 1998) and it would have been 
interesting to study this locus, perhaps in combination with the ~ 2 2 adrenoceptor locus 
in this population. 
A further polymorphism, G460W, of the a-adducin gene has been associated with 
essential hypertension (O'Byrne et aI, 1998; Cusi et aI, 1997). Also, the TM59M 
polymorphism in the gene for the beta2-subunit of the epithelial sodium channel has 
been found to have an association hypertensive black people in London U.K. (Baker 
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et aI, 1998). This may influence blood pressure response to sodium loading or 
depletion and response to long-term treatment with a thiazide diuretic. Further studies 
are needed to clarify this, which may determine the reasons why monotherapy using 
thiazides is predominant and successful in treating hypertension in African 
Trinidadians. 
Overall, findings from the BRIGHT (BRItish Genetics of HyperTension) study, 
(Caulfield et aI, 2003), suggest that essential hypertension has an oligogenic element 
with interaction or relation to more minor genetic predispositions. 
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7.6 Summary 
.:. In summary, the data presented in this thesis suggest that common SNPs at 
codon 16 and 27 of the fh-adrenoceptor receptor locus do not contribute to 
AIx either in normotensive or hypertensive African Trinidadians . 
• :. The use of pulse wave analysis is an effective and efficient and non-invasive 
diagnostic tool for diagnosing and managing hypertension in fast track 
cardiovascular clinics. African Trinidadians would benefit from CHD and 
CVD risk factor screening, after the age of forty-five. This achieved by 
primary prevention strategies incorporated in cardiovascular screening clinics . 
• :. Essential hypertension III African Trinidadians may have an oligogenic 
element. 
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